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ABSTRACT
The binding of the antitumour antibiotics pyrindamycin A

(duocarmycin C2) and

pyrindamycin B (duocarmycin Ci) to self-complementary oligonucleotides has been studied
using electrospray ionisation mass spectrometry (ESI-MS) and tandem mass spectrometry
( M S / M S ) . The pyrindamycins bind via non-covalent interactions in the minor groove of
D N A with subsequent alkylation of the N 3 of adenine (particularly within 5'-AAA and 5'T T A sequences). The relative stability of adducts with different oligonucleotides can be
inferred from the ESI mass spectra. M S / M S spectra of alkylated adducts enable facile
identification of the site of alkylation. W e show here that the site(s) of alkylation by the
pyrindamycins are strongly influenced by the location of the preferred high affinity binding
sites within these short oligonucleotides. Alkylation of guanine by pyrindamycin A is
shown to occur only upon binding to single-stranded oligonucleotides, providing further
confirmation of the importance of the initial non-covalent interaction in conferring
sequence selectivity. These data clearly demonstrate value of using E S I - M S / M S to prescreen ligand-oligonucleotide complexes prior to performing more detailed structural
studies.

In the second part of this work, the binding of nogalamycin to unusual DNA structures wa
explored by nuclear magnetic resonance ( N M R ) spectroscopy. The first of these was an
oligonucleotide 5 ' - d ( G C G A A G C A C G A A G T ) - 3 ' , which was designed to form a double
hairpin or loop sequence. T w o further oligonucleotides, 5 ' - d ( G T G C G A A G C T A C ) - 3 ' and
5 ' - d ( G C T A C G A A G T G C ) - 3 ' were designed to incorporate a mispaired thymine, which may
then form a bulge. The folding of the hairpins was evidenced by anomalous chemical shift
values for the sugar H4', H 5 ' and H 5 " protons (characteristic of the adenine involved in the
loop) and the presence of imino protons (protected from exchange by hydrogen bonding
interactions in the stem).

Nogalamycin formed 1:1 complexes with each of the oligonucleotides with the ligand
bound at the T p G step. U p o n ligand binding, changes in chemical shift values for the D N A
resonances were observed, with the largest differences noted for the nucleotides in the

intercalation site. Nogalamycin bound to 5 ' - d ( G C G A A G C A C G A A G T ) - 3 ' at the nicked site
and stabilised the double hairpin structure through co-axial stacking interactions. The
intercalation of nogalamycin to 5'-d(GTGCGAAGCTAC)-3' gave rise to an equilibrium in
solution between a frame-shifted conformation and bulged conformation. The binding of
nogalamycin to 5'-d(GCTACGAAGTGC)-3' stabilised the bulge positioned at T 3 . Finally,
ESI-MS and melting temperature data indicate that the relative stability of the complexes
formed with nogalamycin is in the order: 5 ' - d ( G C G A A G C A C G A A G T ) - 3 ' - N g > 5'd ( G C T A C G A A G T G C ) - 3 ' - N g > 5'-d(GTGCGAAGCTAC)-3'-Ng.
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C H A P T E R O N E : DNA

and the DNA-interactive ligands

1.0 Introduction
Nucleic acids were discovered in 1868 when Friedrich Miescher isolated the nuclei
from human pus cells. (Miescher, 1879) Subsequently, it was shown that nucleic acids
were a major component of cells and tissues, however, at that time there was no
understanding of the function of these nuclear materials. Hydrolysis of the nucleic acids
from thymus glands was found to yield the nucleobases adenine (A), guanine (G),
cytosine (C) and thymine (T), a deoxypentose sugar and phosphoric acid, whilst from
yeast, uracil (U) instead of thymine and a pentose sugar in the place of a deoxypentose
were identified. These sugars were later determined to be deoxyribose and ribose
forming the basis of the names deoxyribonucleic acid ( D N A ) and ribonucleic acid
( R N A ) . (Adams et al, 1992) It was hypothesized, from the approximately equimolar
proportions of bases present, that D N A consisted of repeating units of the four bases,
i.e. the purines (adenine and guanine) and the pyrimidine (cytosine and thymine). Better
quantitative methods and work by Chargaff (Chargaff, 1955) in the early 1950's helped
to disprove this theory. Regularities were discovered in the composition of D N A , such
as that the sum of the amino bases (A and C ) equaled the sum of the keto bases (G and
T) and that adenine and thymine were present in equivalent amounts, as were guanine
and cytosine. This information was combined with X-ray diffraction data (Astbury,
1947; Pauling & Corey, 1953; Wilkins et al, 1953; Franklin & Gosling, 1953) in the
proposed double-helical structure composed of specifically hydrogen-bonded base pairs
(Watson-Crick base pairs). (Watson & Crick, 1953) Proposals for the mechanism of
D N A replication were then forthcoming, in which one strand of D N A would act as a
template for the other. It was demonstrated that upon infection of bacteria with
bacteriophage, there was synthesis of R N A complementary to the D N A (transcription),
l

and that this R N A associated with bacterial ribosomes to produce bacteriophage protein
(translation). (Brenner et al, 1961)

Many proteins interact with DNA owing to the essential roles that DNA plays in cellul
replication and transcription. (Beck et al, 2001) The disruption of DNA or these

protein-DNA interactions may have a dramatic and possibly fatal effect on the cell an

cellular processes. A large number of bacteria exploit this through the production of
compounds that inhibit normal cellular operation. These compounds are known as
antibiotics and may possess antitumour, anti-viral or antimicrobial properties. Many
these drugs interact with DNA in a sequence-specific manner. These effects are most

pronounced on cells that grow and divide at an accelerated rate, however, the drugs a

affect normal cells. Rational drug design is aimed at producing novel compounds, whic

affect the target with minimal impact on other cells. In order to accomplish this goa
however, an understanding of the mode of interaction between these drugs and DNA is

required. These studies aim to explore the interaction between existing medicinal ag
and DNA so as to aid in the design and evaluation of a new generation of superior
analogs with greater specificity and fewer side effects.
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1.1 DNA Structure

Nucleic acids are polymers comprised of nucleotides linked together by phosphodiest
bonds, in which the internucleotide linkage involves the 3' and 5' hydroxyls of the
sugar, so as to form a 3'-5'-phosphodiester linkage. Information relating to the

secondary structure of DNA first came from X-ray diffraction studies (Astbury, 1947
Pauling & Corey, 1953; Wilkins et al, 1953; Franklin & Gosling, 1953) and was
complemented by early modelling attempts. (Watson & Crick, 1953) In these models,
two complementary strands associate together to form a right-handed double-helical

structure. The planar bases occur in the center of the helix and stack on top of ea
other. There are two grooves present on the surface of the B-form of DNA, (more
below) known as the major and minor grooves. As their names suggest, the major
groove is wide, whilst the minor groove is narrow. These grooves create unique
environments for the binding and recognition of ligands. (Long, 1996) The floors of
major and minor grooves vary depending on the base-pair sequences, which provide

hydrogen-bond donor and acceptor sites, thus giving rise to the sequence selectivit
binding for different ligands as shown in figure 1.1.

The sugar-phosphate backbone lies on the outside of the helix and is polyanionic (o
negative charge per phosphate at neutral pH) making it hydrophilic in nature. The

stacked bases form a hydrophobic core, however, the amino and keto groups present o

the bases point into the grooves allowing for non-covalent interactions with the so
and/or other molecules.
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Figure 1.1: Watson-Crick base pairs indicating major and minor grooves and hydrogen
bond donor and acceptor sites.

1.2 Polymorphism: B-form versus A andZ-forms
DNA has been shown to adopt a number of conformations depending on both its

sequence and environmental conditions as shown in figure 1.2. The B-form is the
handed helical conformation adopted by DNA under physiological conditions. The

form is also right-handed, but differs in the pitch, the number of bases per tu

widths and depths of the minor and major grooves. A-form differs from B-form in
sugar conformation (CV-endo versus CT-endo). DNA is known to adopt the A-form
owing to protein associations or in different solvents (i.e. in low humidity).

an even more unusual structure formed by alternating purine-pyrimidine sequence

which takes on a left-handed helical in solutions with high salt content. The p
these different conformations of DNA in solution has been confirmed by various
techniques. (Neidle etal, 1987; Cohen, 1987; Delepierre etal, 1986)
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Figure 1.2: Polymorphism of D N A : (a) A-form D N A ; (b) B-form D N A and (c) Z-form
D N A . (Williams, 2000)

1.3 Novel Structures
D N A also adopts a number of conformations that do not exclusively involve WatsonCrick base pairing. These include triple-stranded structures, tetraplexes, some D N A drug complexes and hairpin loops (figure 1.3).

Antisense oligonucleotides (i.e. oligonucleotides that stop mRNA from being translat
into protein) and modified oligonucleotides have been quite widely used for the
regulation of gene expression, in particular, for genes associated with cancer or in the
replication of viruses and parasites (Agrawal, 1992) However, these oligonucleotides
are susceptible to degradation by nucleases. A s such, there is an ongoing interest into
the modification of these D N A fragments to protect against degradation. Modifications
to the phosphate backbone (e.g. conversion to phosphothioates) have lead to increased
nuclease resistance, although these modified oligonucleotides are still degraded over
5

time. (Iverson, 1991) A s degradation most commonly occurs from the 3'-terminus,

modifications at this site are most effective. Structures, such as DNA hairpins (f

1.3 and 1.4), have been shown to be useful in the antisense strategy owing to thei

resistance against nucleases. (Hirao et al, 1993; Khan & Coulson, 1993; Tang et al,
1993; Jolles etal, 1997; Chraibi etal, 1999)
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Figure 1.3: Unusual D N A conformations: (a) D N A structure showing bulge, loop and
hairpin features; (b) triple-stranded DNA (triplex); and (c) guanine quartet of a
tetraplex. (Nelson & Cox, 2000)

Hairpin loops form w h e n nucleic acid strands fold back on themselves to form base

pairs. They consist of a single stranded loop region, which is closed by a base pair

stem region. Generally, the greater the number of base pairs in the stem region, the

greater the stability of the hairpin structure. (Yoshizawa et al, 1997) Hairpins are

dominant secondary structural feature in RNA. They have high thermodynamic stability

and define nucleation sites for folding, determine tertiary interactions in RNA enz
protect mRNAs from degradation and are recognised by RNA binding proteins. (Varani,
1995) They are far less common in DNA and consequently they have been less
frequently reported. (Vallone et al, 1999) There have, however, been a number of
recent reports exploring the RNA and DNA sequences that form hairpin structures,
which are extraordinarily stable. (Hirao et al, 1989, 1992, 1993; Tang et al, 1993;
Khan & Coulson, 1993; Crooke, 1992; Varani, 1995; Yoshizawa et al, 1994, 1997;

Chraibi et al, 2000) As well as their possible application to the antisense strateg
novel structures allow the creation of a nicked site through.the co-axial stacking
hairpins (more later).

Examination of the structures of numerous nucleic acid hairpins have shown that the

exceptional stability observed for such structures is a consequence of several stab
interactions, the most obvious of which are the Watson-Crick base pair interactions

the stem region of the hairpin. Non-Watson-Crick base pairs, base-phosphate and base

sugar contacts also further stabilise the loop section. The loop of the GAA mini-hai

is composed of a single nucleotide, i.e., the central A. The first (G) and third (A)
nucleotides take part in a non-Watson-Crick base pair and the entire structure is
stabilised by base stacking interactions.
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Hirao and co-workers (Hirao et al, 1992) compared a variety of sequence variants of
the 5'-d(GCGAAGC)-3' mini hairpin as well as the corresponding RNA fragments.
Rapid mobility of these structures in denaturing electrophoretic conditions was
observed. The GAAA and GAA loops were found to be more stable than hairpins of
other sequences and the different stabilities noted for DNA and RNA mini-hairpins

were proposed to arise from the different conformations of the stem structure in ea
i.e., B-form for DNA and A-form for RNA. The structure of the 5'-d(GCGAAGC)-3'

oligonucleotide was determined by NMR spectroscopy. (Hirao et al, 1994) The hairpin
structure was found to be folded back between A4 and A5, and stabilised by two

Watson-Crick base pairs and an additional non-Watson-Crick G-A base pair in the GAA
loop. Extensive base stacking interactions, especially between GiC2G3A4 and A5G6C7
were observed to further stabilise the hairpin structure.

Hi iii HA
3'-C-G-A'
Figure 1.4: Schematic of the DNA mini-hairpin. (Hirao et al, 1994)

In a study by Yoshizawa et al, (Yoshizawa et al, 1997) all 64 variants of the 5'd(GCNNNGC)-3' sequence (where N=A, G, C, T) were synthesised and characterised
in terms of their ability to form stable hairpin structures. Mobility studies on
polyacrylamide gels were conducted to determine which DNA fragments formed a more

compact structure. They also examined the resistance of each fragment to exonucleas
activity of T4 DNA polymerase. NMR studies, including NOESY, 31P-decoupled DQFCOSY and HOHAHA (see section 2.6) experiments, allowed the elucidation of much

structural information and highlighted the importance of the base-stacking interac
8

Overall, these workers found that only hairpins with G N A loops formed extraordinarily
stable trinucleotide-loop hairpins. The stability is proposed to arise as a result
additional G-A pair formed between G3 and A5 and the extensive base stacking
interactions between G1C2G3A4 and A5G6C7 as mentioned previously. The mini-hairpin
structures described in this paper have increased thermostability and show high
resistance against nucleases. This in turn makes the structures amenable to the
stabilisation of oligonucleotides through tagging the mini-hairpin sequence to the
termini. This method has been applied to the protection of antisense DNAs (Khan &

Coulson, 1993; Poddevin et al, 1994; Tang et al, 1993) and primers. (Caetono-Anolles
& Gresshoff, 1994)

1.4 Bulged DNA Sequences

Bulged structures in DNA are of general biological significance and are potential t
for therapeutic drugs. They are simple and common, non-helical features of RNA and
DNA and may vary from single nucleotide bulges to multiple base bulges. Bulges are

known to be important in RNA for protein binding and tertiary folding. (Peattie et a
1981; Romaniuk et al 1987; Flor et al, 1989; Cate et al, 1996, 1997) In DNA, bulges

play a role in frame shift mutagenesis in sequences with repeating base pairs. (Oka

al, 1972) There have been relatively few reports involving the characterisation of t
interactions of bulged oligonucleotides with ligands.
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Figure 1.5: Schematic of bulged bases in D N A , where S = deoxyribose and P =

phosphate groups in backbone: (a) bulged adenine in staked-in conformation; an
bulged cytosine in looped-out conformation.

Nucleic acid duplex regions often contain bulge loops in which there are one o
consecutive bases on one strand with no paired bases on the other strand. The

bulge loop has one unpaired base and is termed a single nucleotide bulge. Stru
studies have shown that single base bulges can assume two different types of
conformations: a 'stacked-in' structure in which the unpaired base is stacked

neighbouring bases; and a 'looped-out' structure in which the unpaired base fa

from the helical axis (figure 1.5). The extrahelical base and the resultant bu

result in the partial misalignment of the primer and template strands during D

replication so that addition or deletion of bases may take place in what is co
known as frame shift mutagenesis. (Streisinger et al, 1966) The importance of

sites as recognition elements has been established by a number of studies, inc

binding of the intercalator, ethidium to bulged DNA sequences. Selective bindi

10

ethidium bromide to oligonucleotides containing cytosine bulges was found to be an
order of magnitude greater in strength than binding to normal duplexes. (Nelson &
Tinoco, 1985; White & Draper, 1987) The subsequent stabilisation and extended
lifetime of the bulged structure would further increase the probability of frame shift
mutagenesis occurring. Further evidence of the heightened affinity of drugs for bulge
sites in DNA came from the results of competition dialysis experiments, in which 9aminoacridine preferentially bound molecules that contained an extrahelical base.
(Woodson & Crothers, 1988c) The resultant complex was determined to have additional
stabilisation relative to the non-defective DNA complex through examination of the
optical meting curves. (Woodson & Crothers, 1988c)

During the 1980's, an intensive research effort focussed on the determination of the
conformation of these single nucleotide bulges within short DNA sequences. Patel and
co-workers (Patel et al, 1982; Hare et al, 1986) demonstrated that an extra adenine
stacks into an otherwise self-complementary oligonucleotide in solution, leaving the
flanking base pairs intact. In contrast, studies undertaken by others (Morden et al,

1983) found that the flanking bases to the unpaired cytosine were stacked on top of eac

other and that the base must be in fact extrahelical. X-ray analysis (Miller et al, 198
Joshua-Tor et al, 1988, 1992) of oligonucleotides containing a single, unmatched
adenine have revealed that the adenine bulge takes up the looped out conformation,

whilst NMR studies of similar sequences indicate that the adenine is intrahelical. (P
et al, 1982; Hare et al, 1986; Niconowicz et al, 1989, 1990) These contrasting results

were proposed to arise from differences in hydration in the solid and solution states
the effect of hydrophobic contributions. Conformational search and energy
minimisation studies gave results in agreement with the NMR data suggesting that
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adenine remains in the 'stacked in' conformation. (Zacharias & Sklenar, 1997) A series
of papers by Woodson and Crothers (Woodson & Crothers, 1987; Woodson & Crothers,
1988a; Woodson & Crothers, 1988b; Woodson & Crothers, 1988c) examined the

conformation and overall structure of oligonucleotides containing guanine bulges. The

results showed that the guanine stacked in to the helix and added further weight to t
hypothesis that additional unpaired purines remain stacked in to the helix, while
pyrimidines are in exchange between stacked and unstacked conformations. (Woodson
& Crothers, 1988a; Patel et al, 1982; Hare et al, 1986) Bulge migration in
homopolymeric sequences was investigated, in which the migration of the guanine

bulge over several sites had a lower destabilising effect than when fixed at a parti
site. Energy minimisation work revealed the importance of contributions from base

stacking interactions toward stabilisation of the 'stacked in' conformation at the b

site. The helix unwinding owing to the presence of unpaired bases was determined to b
ca. 21° from gel electrophoresis studies. (Rice & Crothers, 1989)

A temperature-dependence has been noted for the transition between the 'looped out'

and 'stacked in' conformations for the pyrimidine bases at bulge sites. (Kalnik et al
1989a; Woodson & Crothers, 1988c) At low temperatures, cytosine was observed to

take the 'looped out' conformation, whilst at elevated temperature, it takes the 'sta
in' conformation, immediately prior to the helix-coil melting transition. (Kalnik et
1989a) The conflicting conformations observed for adenine (Patel et al, 1982) and
cytosine (Morden et al, 1983) were postulated to result from the base stacking

contributions of either the extra base (i.e. purine or pyrimidine) or the flanking ba

the stability of the helix at the bulge site. Patel and co-workers (Kalnik et al, 198

Kalnik et al, 1989b; Kalnik et al, 1990) examined the effect that changing the flanki
12

bases had on the conformation of the extrahelical base at the interrupted site. They
found that adenine stacked into the helix independent of the flanking bases, whilst
thymine exhibited the same equilibrium behaviour as cytosine between 'looped out' at

low temperature and 'stacked in' at higher temperature when it was flanked by guanine
When the thymine was flanked by cytosines, however, the 'looped out' conformation
was observed at all temperatures examined. (Kalnik et al, 1990) The influence of
neighbouring base pairs on the stability of single base bulges was examined by

temperature gradient gel electrophoresis. (Ke & Wartell, 1995) The results showed tha

purine bases were less destabilising than pyrimidines, and that when the unpaired bas
was identical to one of its adjacent bases, the resultant structure was more stable
flanked by differing bases.

The cleavage of duplex DNA by the neocarzinostatin chromophore (NCS-Chrom), at

the 3'-side of cytosine and thymine bulges, has been extensively investigated. (Kapp
& Goldberg, 1993a; Kappen & Goldberg, 1993b; Stassinopolous & Goldberg, 1995)
These studies have examined oligonucleotide sequences containing different types and
numbers of bases within the bulge. In this work, the covalent monoadduct produced
from the reaction of NCS-Chrom with a bulged DNA substrate has been characterised.
(Kappen & Goldberg, 1997) More recently, the roles of bulged DNA in this interaction
have been investigated and shown to enhance the binding of the wedge-shaped drug
through allowing greater access to the DNA substrate. (Xi et al, 1999)

Saito and co-workers (Nakatani et al, 1999) recently showed that an altromycin
analogue selectively alkylates guanines opposite a bulge. These types of drugs

intercalate at 5'-GG-3' steps prior to forming a covalent linkage with the 5'-guanin
13

•2 1

P-labelled oligonucleotide containing four possible binding sites (two G G G triplets
and two GG doublets) was used. The complementary sequence was modified to include

a single thymine bulge opposite three of these binding sites. The results of these stu
and of the molecular modelling of the oligonucleotide,
d(CATG4G5TAC/GTACi2Ti3Ci4ATG), suggests that the selectivity observed for
alkylation at guanines opposite bulge sites arises from stabilisation of the structure
through stacking interactions between the ligand and the G5 and T13 bases.

The synthesis of drugs designed to bind specifically to duplex DNA containing a single
guanine bulge was carried out by Nakatani et al (Nakatani et al, 2000) These

naphthyridine derivatives acted as recognition molecules that differentiated between t
different types of bulged bases.

Caceres-Cortes and Wang (Caceres-Cortes & Wang, 1996) used nogalamycin (figure
1.7) as a probe for the binding of intercalators to bulged sites in DNA. In this work,
duplex DNA containing a single thymine base bulge was utilised, and the resulting
complex was investigated using NMR spectroscopy. This study found that upon binding
of the ligand, the bulged thymine and opposing base in the duplex are induced by the
nogalamycin to stack on the aglycone chromophore, resulting in a frame-shift. Hence,
the weaker base pair interaction is perturbed and the overall structure contains
'dangling' 3'-nucleotides.

1.5 Ligand-DNA Interactions
DNA has been viewed as a potential target for drugs designed to alter a variety of
biological functions. There is considerable interest in studying the interaction of
14

different ligands with D N A , either to understand the role of xenobiotic compounds in
carcinogenesis, or to evaluate potential DNA-interactive antitumour drugs. The

difficulty in using DNA as a target for drug interactions is that in doing so, there i

risk of disturbing normal cellular function. For this reason, DNA has only been used a
a target for serious, life-threatening diseases such as cancer.

The process of designing antitumour drugs or ligands is aided by detailed understandin
of their mode of interaction with DNA. Small molecules or ligands can bind to the
double helix in a variety of ways as shown in scheme 1.1. The binding may be
reversible (or non-covalent), irreversible (or covalent) or be a two-stage process
involving an initial non-covalent interaction followed by irreversible binding of the
ligand to DNA. Moreover, reversible binding may involve one of several different

mechanisms, i.e. intercalation or minor groove binding, and irreversible interaction m

involve either covalent binding such as alkylation, or co-ordinative metal ion binding

One of the important features of DNA is the electrostatic interactions that occur
between the negatively charged deoxyribose-phosphate backbone and various cations.
DNA is stabilised by cations such as Na+ and Mg

+

through the screening of the

repulsive interactions of the phosphate anions. (Long, 1996) Interactions may also occ
between positively-charged proteins and DNA via groove binding interactions. In this
case, the nucleic acid and ligand are bound via weak intermolecular forces, such as
hydrogen bonding and Van der Waals forces. These bonds between the ligand and the

oligonucleotide usually involve base pairs on the floor of the major and minor grooves

Generally, macromolecules such as proteins interact with the major groove, whilst smal
molecules interact with the minor groove. Minor groove-binding molecules interact

15

preferentially with A - T base pairs owing to steric factors. Additionally, the greater

negative electrostatic potential of AT-rich regions, when compared to GC-rich region

may account for the AT-selectivity of specific ligands, which bear a positive charge
(Mountzouris & Hurley, 1996) Examples of minor-groove binding ligands include
netropsin, (Fish et al, 1988) distamycin (Boehncke et al, 1991) and Hoechst 33258,
(Teng et al, 1988) which are shown in figure 1.6.
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Figure 1.6: Structure of the minor groove binding ligands netropsin, Hoechst 33258 and
distamycin.

Intercalation, another reversible non-covalent interaction, occurs when a planar, aromat

molecule slides between the stacked base-pairs of the hydrophobic interior of the helica

DNA. (Long, 1996) The classical intercalating model was proposed in the 1960's, (Lerman,
1961) following observations that some DNA associating drugs were seen to increase the
viscosity of DNA. (Blackburn & Gait, 1996) Intercalation generally causes structural

distortion of the DNA such as partial unwinding and lengthening (up to 3.4 A), which may

lead to changes in the hydrodynamic behaviour of the polymer and thermal stabilisation o

the duplex structure. Examples of intercalating agents include daunomycin (Taatjes et al
18

1996) and nogalamycin, (Bhuyan & Dietz, 1965; Bhuyan & Reusser, 1970) which are
shown in figure 1.7.
CH 3 OH

H3C

vNOCH;

OCH3
OCH 3
O

OH

Daunomycin

Figure 1.7: Structures of the intercalating agents nogalamycin (Ng) and daunomycin.

Nucleic acids can also be covalently modified through alkylation or metallation reactions.

Agents that modify DNA covalently are often mutagenic or carcinogenic and/or ma

possess antitumour properties. Some carcinogenic compounds are alkylating agent
result in direct modification of the DNA, whilst other carcinogenic compounds

metabolised into alkylating agents in cells, e.g., polyaromatic hydrocarbons (P
converted to epoxides in vivo by the effects of cytochrome P450s. (Stemmler et
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Examples of ligands that covalently interact with D N A include nitrogen mustards (Ojwang

et al, 1989) and platinum complexes such as cisplatin and its analogues (Murray e

1992) as shown in figure 1.8. The co-ordinate binding of metal ions may also resu
modification of DNA.

Carboplatin
Cisplatin

Q

H3N. ci /\r-0- /NH3

Pt(
H3NT

V \

Pt

v

CI

}-0
NH 3
O
Figure 1.8: Structure of the anti-tumour agent cisplatin and its analogue carboplatin.

1.6 CC-1065 and the Duocarmycins

CC-1065 represents the oldest member of a growing class of potent antitumour anti

that also includes the duocarmycins and is one of the most cytotoxic antitumour a

known. (Boger et al, 1990, 1994; Gomi et al, 1992; Boger & Johnson, 1995, 1996) It

produced by a soil culture, Streptomyces Zelensis. (Chidester et al, 1981) The in

of CC-1065 with DNA has been studied extensively. (Hurley et al, 1988, 1990; Boger

al, 1991, 1994) CC-1065 exerts its biological activity through the covalent and i

alkylation to DNA in a sequence selective manner. (Boger, 1995; Boger & Sakya, 199

structure, shown in figure 1.9, is characterised by three repeating pyrroloindole
the first of which contains a reactive cyclopropyl function (Hurley et al, 1988)

alkylating potential. (Scahill et al, 1990) (+)-CC-1065 was shown to be efficacio

treatment of experimental tumours in mice. (Reynolds et al, 1986; Martin et al, 1

development of this drug was halted, however, upon the discovery of its delayed t

mice at therapeutic doses. (McGovren et al, 1984) This delayed toxicity was thoug
20

a consequence of the large extent of stabilisation by non-covalent binding, which renders
the DNA alkylation irreversible. (Boger & Yun, 1993) Synthetic analogues have been
prepared which are more effective and do not cause delayed death and therefore show
promise as therapeutic agents. (Warpehoski, 1986; Li etal, 1987)

Figure 1.9: Structure of CC-1065.

CC-1065 and the duocarmycins interact with DNA via the minor groove. High selectivity
for covalent reaction at adenine N3 within duplex DNA has been observed. (Hurley et al,
1988; Boger, 1995; Boger & Yun, 1994) The stereoelectronically-controlled,. adenine N3

addition to the least substituted carbon of the activated cyclopropane occurs within sel
AT-rich sites of the minor groove. (Boger et al, 1990; Boger & Yun, 1994; Boger, 1995)
The DNA alkylation sites and relative selectivity for CC-1065 and the duocarmycins have
been determined through thermally-induced depurination and strand cleavage of labelled
DNA, following exposure to the agents as shown in scheme 1.2. (Boger, 1995; Reynolds et

al, 1985) The elucidation of alkylation sites is possible as strand cleavage preferentia

occurs at the site of covalent alkylation. Since the thermally-induced cleavage of coval
modified DNA only detects adducts which are susceptible to thermal glycosidic bond

21

cleavage, i.e. adenine N 3 and/or guanine N 3 and N 7 , the occurrence of additional
alkylation reactions would not be detected.

CC-1065 binding to DNA has been shown to occur at a five-base-pair, AT-rich alkylatio

site. (Boger & Johnson, 1996) Each site of alkylation proved to be an adenine flanked
two 5'-A or T bases. There was also a strong preference for the fourth 5'-base to be

T, a weaker preference for the fifth 5'-base to be an A or T and a weak preference fo

3'-base preceding the alkylation site to be a purine. The preference for the 3-base al

site followed the order: 5'-AAA-3' > 5'-TTA-3' > 5'-TAA-3' > 5'-ATA-3'. The selectivi

of the agent for the AT-rich sites corresponds to the length of the agent and hence the

of the binding site required. (Boger & Johnson, 1996; Boger, 1994; Hurley et al, 1988

1.7 The Pyrindamycins (Duocarmycins)
Duocarmycins A, Ci (pyrindamycin B) and C2 (pyrindamycin A),1 produced by

Streptomyces sp. isolated from soil samples, are antitumour antibiotics related to CC-1

They are active against both Gram-positive and Gram-negative bacteria, and exhibit stro

therapeutic effects against drug-sensitive and resistant cells of P388 leukemia in mice

(Ichimura et al, 1988; Ohba et al, 1988; Takahashi et al, 1988; Ishii et al, 1989; Go
al, 1992)

1

The different names for this class of compounds arises as a result of the simultaneous dicovery of them by
two different Japanese research teams. In September, 1988, Ichimura et al. published their findings on
duocarmycin C, (Ichimura et al., 1988) and C 2 . (Yasuzawa et al, 1988) In October, 1988, Ohba et al (Ohba
et al, 1988) published a report on the structure of both pyrindamycins A and B.
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The structures of both pyrindamycin A and B, as shown in figure 1.10, were deduced and

confirmed by a number of studies which utilised electron ionisation mass spectrometry (
MS), (Ichimura et al, 1988) high resolution EI-MS, (Yasuzawa et al, 1988) NMR
spectroscopy, (Ichimura et al, 1988; Yasuzawa et al, 1988; Ohba et al, 1988; Takahashi
et al, 1988) ultra-violet visible (UV-Vis) and infrared (IR) (Ichimura et al, 1988;
Takahashi et al, 1988) and X-ray crystallography. (Ohba et al, 1988) Pyrindamycins A
and B possess a pharmacophore similar to that of CC-1065 as shown in figure 1.10.

Figure 1.10: Structure of the ligands used in this study pyrindamycins A and B.

In a similar manner to CC-1065, the pyrindamycins (or duocarmycins) exert their
biological activity through a sequence selective alkylation of DNA. However, this
alkylation is reversible and as such they do not exhibit the same highly toxic effects

CC-1065. (Gomi et al, 1992; Hurley et al, 1988) The rate, or ease, of reversibility prove

to be dependent on the relative reactivity of the agent, the stability of the adduct for
well as the extent of non-covalent binding interactions. (Boger et al, 199A) The DNA

alkylation reaction was also dependent on the stabilising effect of the non-covalent bi

interactions. The site of alkylation for the duocarmycin A and the pyrindamycins (A and B

proved to be nearly indistinguishable and proceeds through the 3'-adenine N3 alkylation
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the activated cyclopropane similar to that observed for the (+)-CC-1065 covalent alkylation
to DNA-. (Boger et al, 1990) It is thought that pyrindamycin A and B are converted to a
common agent, duocarmycin A (as shown in figure 1.11), prior to alkylation (although
pyrindamycin A may act as an alkylating agent in its own right), (Boger et al, 1990) and
hence these ligands and other duocarmycins display identical alkylation properties.

Duocarmycin A

OMe

Figure 1.11: Structure of the alkylating agent duocarmycin A.

Figure 1.11 shows the structure of duocarmycin A. The conversion of the pyrindamycins to
duocarmycin A would require the cleavage of the halogen in vitro in the culture media or
vivo in the cells. (Gomi et al, 1992)

The preference for the 3-base sequence follows the same order as described for CC-1065

(section 1.6). A strong preference for the fourth 5'-base to be an A or T versus G or C w
also observed. (Boger et al, 1990; Boger, 1995) Thus, it was shown that the sequence

selectivity extends in the 5'-direction from the site of modification. The binding of th
antibiotics to AT-rich regions of the DNA minor groove was shown to span 3.5 base-pairs,

which explains the absolute requirement for the first three base-pairs and the preferenc
the fourth base-pair. Scheme 1.2 shows the adenine N3 addition to duocarmycin A.
24

Alkylation has also been found to occur to the N 3 of guanine in sequences, which lack the
high affinity binding sites. (Mitchell et al, 1993; Boger et al, 1994)

Scheme 1.2: The reaction between the duocarmycin A and D N A .
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Boschenok et al. (Boschenok, 1997) studied two oligonucleotides containing preferred sites
for alkylation by electrospray mass spectrometry, but did not observe the intact adduct
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either sequence. They did, however, observe the pyrindamycin-adenine adduct, a product

of the depurination of the oligonucleotide. They hypothesised that the adducts formed w
relatively labile and decomposed during ionisation.

1.8 The Anthracydines
The anthracyclines are a family of DNA-intercalating agents that have found common use
as chemotherapeutic agents. The best-known members of this family are daunomycin and
doxorubicin (adriamycin), which are used in the treatment of acute leukaemia and solid
tumours respectively. (Crooke & Reich, 1980; Acramone & Penco, 1988) Nogalamycin is
an antibiotic with a related structure, but is more structurally complex than the other
members of the family. (Arora, 1983) Nogalamycin (Ng) was isolated from Streptomyces
nogalator and has been shown to be active against Gram-positive bacteria and some
varieties of experimental tumours (Bhuyan & Dietz, 1965; Bhuyan, 1967; Bhuyan &

Reusser, 1970) and it inhibits DNA-directed RNA synthesis in vivo. (Li et al, 1979; Enni
1981) Nogalamycin consists of a planar aglycone chromophore with bulky sugar
substituents at both ends, which gives rise to a dumbbell-shaped molecule. The nogalose

sugar is attached to the C7 position of ring A, whilst the aminoglucose sugar is attach
the CI and C2 positions of ring D of the aglycone chromophore. (Bhuyan & Reusser, 1970)
Nogalamycin forms a stable intercalation complex (Searle et al, 1988) with slow
association and dissociation rates. (Fox & Waring, 1984; Fox et al, 1985) A number of

studies have been carried out to show the relationship between the structure of nogalam
and its analogues and their biological activity. (Gao et al, 1990; Wiley et al, 1982)
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Nogalamycin (figure 1.7) is known as a topoisomerase I (TOP I) poison. Its analogue,

menogaril, which lacks the nogalose sugar, is a topoisomerase II poison. Both drugs ex

antitumour activity, however, they have been shown to have different cellular activit
target different stages of the cell cycle. It is known that nogalamycin induces a 22°

DNA. (Robinson et al, 1994) It can trap topoisomerase I-cleavable complexes at specifi
sites on DNA. (Sim et al, 1997) Similar behaviour has also been noted for some minor

groove binding ligands (Hoechst 33342 and the terbenzimidazoles). The stimulation of s
specific topoisomerase I-mediated DNA cleavage has been linked to the groove binding
properties of these ligands. (Xu et al, 1998) It has been shown that these compounds
preferentially bind and stabilise bent DNA domains suggesting a possible correlation
between drug-induced bending and TOP I poisoning. (Pilch et al, 1997) The replacement

of the DNA sequence at the binding site, with the DNA bending sequence (A5) also resul

in the stimulation of TOP I mediated DNA cleavage. (Wu & Crothers, 1984) Hence, it was
suggested that nogalamycin binding to DNA stimulated TOP I mediated DNA cleavage by
inducing a bend in the DNA structure. (Sim et al, 2000)

The binding of nogalamycin to a number of short oligonucleotides, has been studied

extensively by X-ray crystallography (Williams et al, 1990; Liaw et al, 1989; Gao et a
1990; Smith et al, 1995, 1996) and NMR spectroscopy. (Searle et al, 1988; Zhang &

Patel, 1990; Searle & Bicknell, 1992; Searle & Lane, 1992; Williams & Searle, 1998, 19

These studies showed that Ng molecules are intercalated between 5'-TpG (or 5'-CpG) st
in a B-DNA double helix with the nogalose and aminoglucose occupying the minor and
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major grooves respectively. M o r e recently, the binding of a variety of drugs to unusual
DNA structures has been reported. (Caceres-Cortes & Wang, 1996)

1.9 Outline of this Thesis
In this thesis, the analytical techniques of mass spectrometry and nuclear magnetic
resonance (NMR) spectroscopy have been applied to the study of pyrindamycinoligonucleotide complexes and complexes of nogalamycin with unusual DNA structures.
These techniques and their application to the study of modified and unmodified

oligonucleotides are reviewed in chapter two. In chapter three, studies of the interaction
the minor groove binding alkylators, the pyrindamycins, with a variety of oligonucleotides
by electrospray ionisation tandem mass spectrometry are described with particular
emphasis on the sequence selectivity of these agents. The engineering of novel DNA
structures that contain nogalamycin intercalation sites is described in chapters four and
NMR spectroscopy is utilised for the complete structural characterisation of the free and
complexed forms of these unusual structures. These studies show that where one technique
may be applied to one ligand-DNA interaction another technique may be more applicable
to the study of another. Whilst NMR spectroscopy yields detailed structural information,

mass spectrometry is a powerful tool for the rapid elucidation of information pertaining to
sites of binding, stoichiometry and stability of the interaction.
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C H A P T E R T W O : Instrumental Methods for Investigating Ligand-DNA

Complexes

2.0 Introduction
The study of the structure, binding specificity and dynamics of ligand-DNA complexes is
of great importance in the understanding of the nature of the interactions between the ligand
(or drug) and nucleic acids. T w o of the most extensively used methods for the structural
characterisation of D N A are nuclear magnetic resonance ( N M R ) spectroscopy and X-ray
crystallography. These techniques can yield detailed structural information for nucleic acids
and DNA-ligand complexes. They have some fundamental limitations, however, in that
they are time consuming and require either large amounts of sample ( N M R ) (Searle, 1992;
Krugh, 1994) or that the sample be crystalline (X-ray crystallography). (Kennard

&

Salisbury, 1993)

Conventionally, the sequencing of DNA has been achieved by molecular biology
techniques, i.e. the Sanger method, (Sanger et al, 1977) or by chemical means, i.e. the
Maxam-Gilbert method, (Maxam & Gilbert, 1977, 1980) technologies. (Limbach, 1996)
Both methods result in the production of a series of oligonucleotides, which differ in length
and have a chemical or radio-labelled end. The Sanger method uses dideoxynucleotides as
chain-terminating inhibitors of D N A polymerases, whilst the Maxam-Gilbert method relies
upon base-specific reactions. Automation and technological advances, such as the
development of the polymerase chain reaction (PCR), have improved the sensitivity and
efficiency of the Sanger-based technique for determining the primary sequence of D N A .
Molecular biology techniques play an important role in the determination of the sequence
specificity of ligand-DNA interactions. (Murray, 1999) The combination of gel based
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sequencing with radioactive labelling, (D'Andrea & Haseltine, 1978; Haseltine et al, 1980)

linear amplification, (Ponti et al, 1991) PCR (Pfeifer et al, 1989; Mueller & Wold, 1989;
Grimaldi et al, 1994) and/or footprinting (Portugal, 1989) have enabled the sequence

specificity of a range of different DNA-interactive agents to be elucidated, however, the
techniques may be quite time consuming. Mass spectrometry, on the other hand, may be
used to readily gain sequence information concerning modified DNA together with limited
structural information concerning ligand-DNA complexes.

In recent years, the development of two new ionisation methods for mass spectrometry,
namely electrospray ionisation (ESI) and matrix-assisted laser desorption ionisation
(MALDI), has enabled for the first time, the analysis of large segments of DNA by mass

spectrometry. Electrospray ionisation mass spectrometry does not provide direct structura
information, unlike NMR and X-ray crystallography, however, it does provide important
information concerning the stoichiometry of ligand-DNA complexes and sites of binding
and it does so in far less time from much less material. (Loo, 1997)

There have been relatively few studies of ligand-DNA interactions by mass spectrometry,
so that the general utility of the technique has yet to be fully exploited (more below).

Hence, this thesis is concerned with two aspects of the analysis of ligand-DNA interactio
First, exploring the utility of ESI-MS for the study of relatively labile ligand-DNA
complexes. The second aspect of the study uses NMR spectroscopy to derive detailed
structural information on novel DNA structures, and their drug complexes.
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Investigations of this nature require a multi-disciplinary approach including the evaluation
of the preferred binding sites, thermodynamic studies to examine complex stability and
high-resolution structural studies for probing the molecular basis for sequence recognition.
The current studies have utilised electrospray ionisation mass spectrometry (ESI-MS) for
the determination of the sequence selectivity, in combination with a wide range of
biophysical methods (UV-Vis and thermal denaturation) and the high-resolution structural
analysis by N M R spectroscopy.

2.1 Mass Spectrometry Instrumentation
Mass spectrometry is a technique used to determine the molecular mass of chemical and
biological molecules, by measurement of the mass-to-charge ratio (m/z) of gaseous ions
derived from the molecule of interest. A mass spectrometer is usually comprised of an
ionisation source, a mass analyser and a detector, along with a computer system for data
storage and processing.

Many different types of samples may be analysed using mass spectrometry. These include
low molecular weight organic and inorganic compounds (Ahrer & Buchberger, 1999),
sugars (Reinhold & Carr, 1983), peptides (Biemann & Martin, 1987), proteins (Biemann &
Martin, 1987; Beavis & Chait, 1990) and oligonucleotides (Sindona et al, 1982; Neri et al,
1983). Recently, mass spectrometry has found extensive use for the characterisation of both
naturally-occurring D N A (Krahmer et al, 2000) and synthetic oligonucleotides, (Reddy et
al, 1994) as well as the products resulting from covalent binding of carcinogens and antitumour drugs to D N A . (Chiarelli & Lay Jr., 1992)
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2.1.1 Ionisation Methods
The method of ionisation for mass spectrometry depends upon the volatility and thermal

stability of the molecule to be analysed. Each ionisation technique is usually suitable f
different types of compounds and produces gas phase ions via different chemical and
physical processes.

Electron ionisation, or impact, (EI) and chemical ionisation (CI) are the well-establishe
techniques for MS analysis of volatile compounds. Over the last 20 years much of the

development in ionisation techniques has been aimed at ionising thermally labile, involat
compounds. These so called 'soft' ionisation techniques include fast atom bombardment
(FAB), (Barber et al, 1981) plasma desorption (PD), (Cotter, 1982) secondary ion mass
spectrometry (SIMS), (Sindona, 1989) matrix-assisted laser desorption/ionisation
(MALDI), (Karas et al, 1991) field desorption (FD), (Sindona, 1989) electrospray
ionisation (ESI) (Smith et al, 1990) and thermospray (TS). (Schmelzeisen-Redeker et al,
1989)

These earlier ionisation techniques (FAB, PD, FD, EI and CI) have been largely superseded
by electrospray ionisation mass spectrometry (ESI-MS) and matrix-assisted laser
desorption/ionisation mass spectrometry (MALDI-MS). Together these techniques, have
revolutionised the analysis of biomolecules by allowing the routine characterisation of

proteins up to 150kDa (Siegel et al, 1997) and nucleic acids up to 500 base pairs (in the
case of MALDI-MS) (Tang et al, 1994).
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2.1.2 Matrix-Assisted Laser Desorption/ionisation (MALDI)
Developed in 1988 by Karas and Hillenkamp, matrix-assisted laser desorption ionisation
(MALDI) was based on older laser desorption techniques and studies of the desorption
(ionisation) of small organic molecules, mainly amino acids and dipeptides. (Karas et al,
1987, 1991) In the MALDI technique, the matrix material, generally a low molecular
weight organic acid present in large excess, minimises radiation damage to the sample and
acts as a 'solvent' for the analyte molecules. (Chapman, 1996) The sample is irradiated
with a high intensity pulsed laser beam which is tuned to the wavelength at which the

matrix has a high extinction coefficient. The matrix also acts as an energy transfer medi
(Karas et al, 1987) Mass analysis is most often accomplished by time-of-flight (TOF) mass
spectrometry (more below). The principles of the MALDI-TOF are shown in figure 2.1.

MALDI has overcome the limitations of 'older' laser desorption/ionisation techniques,

namely low-mass range and sensitivity, and enables routine analysis of proteins in the ma
range 10 to lOOkDa with only picomole amounts of sample required. (Karas et al, 1991)
MALDI has allowed the structural characterisation of modified nucleic acids and has been
used, for example, to enable a better understanding of biological abnormalities such as
those that occur with certain forms of cancer. (Hettich & Buchanan, 1991) A recent major
improvement in MALDI-MS has been the implementation of delayed extraction (DE) or
time-lag focussing which has dramatically improved the resolution of the technique and

overcome one of the major difficulties for nucleic acid analysis, namely base fragmentati

at high laser power, by enabling analysis at lower laser intensities. (Vestal et al, 1995)
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Figure 2.1: Schematic of the most c o m m o n configuration used with M A L D I ion sources.
The reflectron improves the energy resolution for analysis of ions below m/z 3000.

2.1.3 Electrospray Ionisation (ESI)
Electrospray ionisation (ESI) was developed in 1968 by Dole and coworkers. (Dole et al,
1968) This pioneering work showed that macroions of definite mass-charge states could be
produced in the gas phase by electrospray ionisation. The ensuing decade saw little ESI

development, however, because of the difficulty of analysing the masses of these large io
Fenn and coworkers continued this work and in 1984 published a paper showing the
application of ESI to large organic molecules that were too complex, too fragile or too

involatile for the conventional ionisation methods. (Yamashita & Fenn, 1984) Electrospray
however, has only been in widespread use since 1988 when it was shown to be capable of
generating intact ions of large biomolecules. (Mann & Fenn, 1992)
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A significant advantage of ESI-MS is that a distribution of multiply charged ions is
normally produced w h e n large molecules are analysed. Hence, the m/z range of the mass
analyser need not be large because, as a result of extensive multiple charging, ions
generally fall within the range of m/z 1000-4000 (Mann, 1990; Jardine, 1990). Multiple
charging also increases the accuracy of molecular weight determinations (to 0.01% or
better) since the mass of the sample is determined from more than one peak. (Deroussent et
al, 1995) Electrospray also had advantages of high sensitivity (low picomole range) and
generally, little fragmentation is observed since the ionisation does not impart a large
amount of energy to the ions. Owing to the gentle nature of the electrospray ionisation
process, non-covalent interactions occurring in solution m a y also be detected. (Smith &
Light-Wahl, 1993) Examples of non-covalent biomolecular complexes studied to date
include enzyme-substrate, (Ganem & Henion, 1991) protein-ligand, (Schwartz et al, 1995;
G a n e m & Henion, 1991; Jaquinod et al, 1993; Huang et al, 1993; Przybylski et al, 1995;
Schwartz et al, 1994) DNA-duplex (Light-Wahl et al, 1993) and DNA-ligand complexes.
(Gale et al, 1994; G a o et al, 1996; Gale et al, 1995; Gabelica et al, 1999, 2000; Kapur et
al, 1999)

During the electrospray ionisation process, the sample solution is pumped through a metal
capillary held at a potential of several kilovolts relative to a counter electrode as shown in
in figure 2.2. This results in charging of the liquid as it is sprayed from the capillary
resulting in a fine mist of charged droplets. Evaporation is assisted by a flow of w a r m bath
gas (usually nitrogen). Evaporation of the solvent increases the charge density on the
droplet surface until electrostatic repulsion is greater than surface tension at which point the
droplets explode (Coulombic explosion) as is shown in figure 2.3. If the sample solution is
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sufficiently dilute, a sequence of such explosions results in droplets with such small size
that each would contain one analyte molecule. (Mann & Fenn, 1992)
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Figure 2.2: Schematic showing a configuration of the electrospray ionisation source in the
triple quadrupole instrument used in this study.

The resulting ions from the electrospray ionisation process pass through a skimmer or
orifice2 where the analyte ions are separated from the drying gas and solvent vapour and
enter the mass analyser.

2

More recent electrospray instruments employ a variety of different methods to separate the ionisation source
(at atmospheric pressure) from the low vacuum of the analyser. These include orthogonal ionisation, heated
nebulisers and the Z-spray configuration used in the Micromass Q-TOF 2 that was employed for some of the
later experiments in these studies.
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A n alternative mechanism for the ionisation process has been proposed by Iribarne and
Thompson. (Iribarne & Thomson, 1976) The mechanism is similar to that described above
to the point of producing a fine spray of charged droplets. The workers proposed that the
droplets evaporate in the bath gas, and as they decrease in size, the charge density

increases. The decrease in radius of curvature results in electric fields sufficiently str
result in the desorption of the analyte ions before the droplets explode. Definitive
experimental evidence to support either mechanism has not been forthcoming, however, in
general the charged residue mechanism is the more frequently-cited mechanism.
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Figure 2.3: Mechanisms of electrospray ionisation: (a) Charged residue model; (b) Ion
evaporation model.

As noted above, electrospray ionisation may result in a distribution of molecular ion spe
with different number of charges being observed in the mass spectrum. The molecular
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weight can be determined very accurately from these by solving two simultaneous

equations. These are given below for the analysis of negative ions formed by d
m2 = M-nH ...(1)
n
mi = M - fn+DH ...(2)
(n+1)
In equations 1 and 2, mi and m2 are the m/z values for two peaks differing by

protons respectively, M is the molecular weight of the species, n is the numbe

and H is the mass of a proton. In most cases, commercial electrospray mass spe

have software that facilitates molecular mass calculations based on this princ

2.1.4 Mass Analysers

The function of the mass analyser is to separate ions according to their mass-

ratio. Electrospray ionisation mass spectrometry has been coupled with quadrup

of-flight, (Verentchikov et al, 1994) quadrupole ion trap, (McLuckey et al, 198

magnetic sector (Meng et al, 1990) and Fourier Transform (FT) (Buchanan & Hett

1993) mass analysers. More recently, hybrid analysers such as quadrupole-time-

(Q-TOF) (Morris et al, 1996) have been effectively coupled with ESI sources. T

analyser used for the majority of experiments in this study was a quadrupole m
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2.1.5 Tandem Mass Spectrometry

(MS/MS)

Tandem MS or mass spectrometry/mass spectrometry (MS/MS) is very useful for obtaining
structural information on a variety of compounds and also the identification of compounds
in complex mixtures. Tandem mass spectrometry involves two stages of mass analysis with
the stages separated in space (triple quadrupoles and hybrid instruments) or in time
(quadrupole ion traps or FT-MS instruments). Figure 2.4 shows a schematic of a tandem
mass spectrometry involving spatial separation. The first stage is the mass selection of

precursor ion from a mixture of ions formed in the ion source. Any other ions present, i.e
non-selected m/z values are filtered out. The precursor ion then fragments to a series of
product ions and neutral fragments (in the case of singly charged precursors), i.e.
Mp+ -> Md+ + Mn ...(3)
where Mp+ is the precursor ion mass, Md+ is the product ion mass and Mn is the neutral
fragment mass.

Multiply charged precursors may also fragment to yield charged product ions, i.e.
Mpn+ -> Mdi(n'x)+ + Md2x+ ...(4)

Fragmentation of the precursor ion is achieved by collision-induced dissociation (CID) in

reaction region, or collision cell, containing an inert gas such as argon. In the second s
of mass analysis, the mass spectrum of the product ions, which result from the
fragmentation of the precursor ion is recorded.
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Figure 2.4: Tandem Mass Spectrometry. (Busch et al, 1988)

2.1.6 ESI-MS of Oligonucleotides
Mass spectrometric techniques have been used extensively for the characterisation of

nucleic acid constituents, such as nucleosides and nucleotides. (Crain, 1990) Electr

ionisation, (EI) and chemical ionisation (CI) mass spectrometry have been utilised f

study of small species, such as nucleosides and bases. (Crain, 1990; Wilson & McClosk
1975) Field desorption also provided information on the structure of nucleosides and

nucleotides, but is technically very difficult to implement. (Norwood & Vouros, 1994)
Plasma desorption (PD) (McNeal & MacFarlane, 1981) and fast-atom-bombardment (FAB)

(Crain, 1990; Grotjahn & Taylor, 1985) were used to observe larger species. PD allowe

the observation of an oligonucleotide up to 12 bases in length, (McNeal & MacFarlane,

1981) whilst FAB was used to analyse up to 13-base oligonucleotides. (Grotjahn et al,

1988) These were the largest species analysed by mass spectrometry prior to the adve

electrospray ionisation (ESI) and matrix-assisted laser desorption ionisation (MALDI)
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The introduction of electrospray ionisation enabled mass spectrometry to be used for the
routine analysis of oligonucleotides, which had previously proven very difficult to analyse
by those older M S techniques. Covey et al. (Covey et al, 1988) were amongst thefirstto
examine the application of ESI-MS to oligonucleotides up to 14 bases in length. The very
small amounts of sample required (picomole) gave rise to the rapid ascendancy of ESI for
oligonucleotide analysis. The application of M A L D I and ESI to nucleic acid analysis has
been the subject of comprehensive reviews. (McCloskey & Crain, 1992, 1998; Limbach et
al, 1995; Nordhoff et al, 1996; Miketova & Schram, 1997) High-resolution tandem mass
spectrometry has been utilised extensivley for the sequencing of oligonucleotides. (Little et
al, 1994; O w e n s et al, 1998; Lichtenwalter et al, 2000) Electrospray mass spectrometry
has also found applications for the analysis of modified nucleotides (Reinhold & Carr,
1983; Reddy et al, 1994; Chapman, 1996; Tito, 1998; Reddy & Iden, 1993; Potier et al,
1994; Kowalak et al, 1993; Ni et al, 1998; W u & Aboleneen, 2000, 2001), intact plasmid
D N A (Cheng et al, 1996; Lichtenwalter et al, 2000) and non-covalent ligand-DNA
complexes (Gale et al, 1994; Loo, 1997; Smith et al, 1997; Beck et al, 2001).

Routine analysis of oligonucleotides by ESI-MS, however, is more difficult than for
proteins owing to the highly labile nature of the oligonucleotides, which makes them prone
to fragmentation. The high affinity of the polyanionic backbone for alkali metals
(especially sodium) also causes problems. Since the presence of sodium both reduces
ionisation efficiency and limits mass accuracy owing to the presence of multiple species
with different numbers of sodium ions. Methods commonly employed for desalting
oligonucleotides include ethanol precipitation (Potier et al, 1994) and the use of a variety
of base additives. (Connolly et al, 1984) In the work described in this thesis, the problems
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with salt adduction were overcome by the use of a m m o n i u m acetate in the H P L C
purification of the oligonucleotides, which results in a m m o n i u m ions replacing any
adventitious sodium ions.

ESI-MS has also been applied to study non-covalent biomolecular complexes. (Light-Wahl
et al, 1993) McCloskey and co-workers observed non-covalent interactions including
duplexes of an 8-mer, 20-mer and a tetraplex, which was observed in the presence of N a +
ions. (Limbach et al, 1995) These studies have been extended by Smith et al. to encompass
specific metal ion binding to oligonucleotides ( W u et al, 1995). The early work by Gale
and co-workers on the binding and stoichiometry of the distamycin A - D N A interaction
explored the optimisation of the sample conditions required for the detection of these noncovalent complexes (Gale et al, 1994). These studies were extended to include the minor
groove binding ligands pentamidine and Hoecsht 33258 (Gale & Smith, 1995) and a
number of other studies examining the non-covalent binding of ligands to D N A have been
carried out (Triolo et al, 1997; Kapur et al, 1999; W a n et al, 2000a, 2000b; Gabelica et
al, 1999, 2000; Gao et al, 1996). The binding of the intercalators actinomycin D (Hsieh et
al, 1994; W a n et al, 2000a, 2000b), daunomycin (Triolo et al, 1997; Kapur et al, 1999)
and nogalamycin (Kapur et al, 1999) have been investigated in terms of their binding
affinity through competition experiments. The relative binding strengths of a variety of
minor groove binding ligands has been explored through the examination of the
dissociation profiles (Wan et al, 2000b). Gabelica and co-workers found good correlation
between the gas-phase dissociation and solution data resulting from the thermal
denaturation of the ligand-DNA duplexes of Hoechst 33258 and netropsin (Gabelica et al,
2000).
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2.1.7 ESI-MS/MS

of Oligonucleotides

Tandem mass spectrometry combined with ESI, has potential for the characterisation of

oligonucleotides (Doctycz et al, 1994) and modified oligonucleotides (Barry et al, 1995)
as well as covalent ligand-oligonucleotide complexes. (Wickham et al, 1995a, 1995b;
Iannitti-Tito et al, 2000)

The fundamentals of oligonucleotide decompositions were first studied by McLuckey and
co-workers (McLuckey et al, 1995; McLuckey & Habibi-Goudarzi, 1993, 1994;
McLuckey et al, 1992) on a quadrupole ion trap. These workers proposed a nomenclature
scheme for the characterisation of oligonucleotide fragmentation similar to the scheme
which has been widely used for peptides. (McLuckey & Habibi-Goudarzi, 1993) Scheme
2.1 shows the nomenclature for a 6-mer with the variation introduced by Vouros and co-

workers, (Barry et al, 1995) whereby the oligonucleotide appears as a neutral species. T

vertical lines show the possible sites of cleavage along the phosphodiester backbone. Th

lower case letters represent the nomenclature given to these cleavages with the subscrip

denoting the position along the backbone at which the cleavage occurs. Bi to B6 represen

the bases. McLuckey et al. demonstrated that two series of ions, the 5'-(a-Bn) series and
complementary 3'-(wn)-sequence ions, are most commonly observed in MS/MS spectra of
oligonucleotides.
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Scheme 2.1: Oligonucleotidefragmentationby tandem mass spectrometry.

McLuckey proposed that the ions are formed following fragmentation of multiply charged

oligonucleotide anions proceeds via the loss of a base followed by the subsequent cleavage
of the 3'-C-0 of the sugar from which the base is lost. (McLuckey & Habibi-Goudarzi,
1993) When the charge is retained on the 5'-terminus, an (a-B) ion results, with the
complementary w ion being formed if the charge is retained on the 3'-terminus. They also
observed that the order for base loss tended to follow the order A>T»C>G, and that the
loss of the 3'-base was unfavourable. The loss of a phosphate group from phosphorylated

ions can compete with the loss of a base. Neutral base loss was also found to compete with
charged base loss. (McLuckey & Habibi-Goudarzi, 1993) The higher the charge state of the
precursor ion, the greater is the preference for charged base loss. Increasing solvation

stabilises both the products resulting from neutral base loss as well as charged base loss

with the product of highest charge being stabilised to the greatest extent. Hence increasi
solvation tends to favour neutral base loss. (McLuckey et al, 1995)
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The same tendency for loss of adenine was not found under more energetic collision
conditions by Boschenok and Sheil (Boschenok & Sheil, 1996) and Barry et al (Barry et
al, 1995) on triple quadrupole instruments. Based on ESI-MS/MS, Ni et al. have
developed an automated sequencing algorithm, which allows the sequence elucidation of
unknown oligonucleotides up to 15-mers. (Ni et al, 1996)

In addition to the (a-B) and w sequence ions, many other product ions are observed in ESIMS/MS spectra that result from cleavages along the phosphodiester backbone. In many

cases, it is difficult to identify these ions conclusively owing to the sugar, C5H4O (80.0
Da) and HP03 (79.97 Da) and sugar + H20, C5H602, (98.04 Da) and H3PO4 (97.98 Da)

having the same nominal mass. This results in difficulties in the analysis of these spectr
peaks may occur at the same or very similar m/z value requiring high resolution to allow
their identification. A typical mass spectrum may contain hundreds of peaks. Hence ESIMS/MS has not been used routinely for the sequencing of oligonucleotides as it has been
with peptides.

There have been relatively few MS/MS studies of covalently modified oligonucleotides.

(Barry et al, 1995) The relative stabilities and sequence selectivity of adducts formed f
the reaction of aflatoxin Bi with DNA was explored. (Marzilli et al, 1998) The covalent
interactions of hedamycin, cisplatin and n-phenanthridinium bromides with

oligonucleotides were explored by MS/MS. (Iannitti-Tito et al, 2000; Iannitti et al, 1997)
The alkylation of guanine labilises the 3'-glycosidic bond, resulting in cleavage on the
side adjacent to the alkylation site. The sequence ions resulting from this fragmentation
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pathway allow the identification of the binding site. The E S I - M S / M S analysis of the H P L C

purified adducts formed from the reaction of the carcinogen benzo[<z]pyrene with an 11-m
showed guanine N2 alkylation. (Ni et al, 1998) The fragmentation pattern was not as
predominant as was observed for hedamycin and aflatoxin Bi, suggesting that guanine N2
alkyaltion does not have the same destabilising effect on the DNA backbone as alkylation
to the N7 of guanine.

Reports of MS/MS studies of non-covalent complexes are even more scarce. Gabelica and

co-workers utilised a quadrupole-time-of-flight (Q-TOF) mass spectrometer to examine the
interaction of Hoechst 33258 and netropsin with oligonucleotides. (Gabelica et al, 1999)
Their results indicated that netropsin showed selective binding to the GC-rich strand of
DNA, whilst Hoechst 33258 showed no preference. The stabilities of the DNA complexes
of the antibiotics distamycin (Gale & Smith, 1995) and paromomycin (Griffey et al, 1999)
have also been examined by tandem mass spectrometry. The 2:1 complex of distamycin
with duplex DNA was found to have greater stability than the 1:1 complex. The binding of
paromomycin was found to protect oligonucleotides from the common fragmentation
pathway involving loss of adenine and cleavage of the 3'-C-0 glycosidic bond. Recently,
Gross and co-workers looked at a range of drugs, including minor groove binding agents
(distamycin, Hoechst 33258, Hoechst 33342, beneril, FeTMpy-P4 and MnTMpy-P4) and

an intercalator (actinomycin D). (Wan et al, 2000b) The energy of dissociation, of each o
the complexes, was determined and found to correlate with the number of hydrogen bonds
involved in stabilising the complex.
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2.2 Other Techniques for the Structural Analysis ofLigand-DNA

Complexes

M a n y studies have been conducted on ligand-DNA complexes by both the high-resolution
techniques of nuclear magnetic resonance ( N M R ) spectroscopy and X-ray crystallography.
Although X-ray crystallography m a y have the advantage of allowing direct structural
determination, there are numerous significant differences between such determinations in
the solid and solution states. In the case of nucleic acids, their conformation is often
different in solution owing to hydration and/or crystal packing. (Luxon & Gorenstein,
1995) Also, studies to examine the kinetics of the interaction between the ligand and the
D N A or to probe conformational changes, i.e. by altering the temperature or salt
composition are far more easily undertaken in solution. For the same reason, N M R is
preferable to X-ray crystallography for investigating the stoichiometry of complex
formation (although mass spectrometry m a y also be used in this regard).

2.3 Ultraviolet (UV) Spectroscopy and the Thermal Denaturation of DNA
Ultraviolet ( U V ) spectroscopy is a useful tool for the characterisation of nucleic acids. The
U V absorbance at 260 n m is generally used for estimating the concentration of nucleic
acids using the Beer-Lambert L a w and calculated extinction co-efficients. Absorbance
versus temperature (melting curves) can be used to determine the melting temperature (Tm)
of an oligonucleotide duplex giving an indication of its stability and also for determining
the G C content in normal double-stranded D N A . (Mathews & van Holde, 1990) W h e n an
oligonucleotide is heated in solution, the absorbance increases. For double-stranded D N A ,
there is a sigmoidal increase as the duplex dissociates into single-stranded D N A owing to a
reduction in stacking interactions between the bases. The melting curve is characterised by
the melting temperature, T„, which is defined as the temperature at the midpoint of the
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absorbance transition. The Tm is concentration independent, but m a y be influenced by the
salt concentration.

UV spectroscopy can be used to study the melting behaviour of DNA, which gives an
indication of the stability of the duplex or ligand-DNA complex. Hence, it can be used to
compare the relative binding affinities of different DNA ligands. The transition from the
double stranded DNA helix to single strands, or DNA melting, occurs when sufficient
energy has been supplied to overcome the interactions between the strands. Owing to base
pair stacking, the energy required is greater than just the energy to disrupt the hydrogen
bonding interactions. DNA melting is a highly cooperative event. Therefore, when the

DNA begins to melt, the helix is destabilised and rapidly un-zips into its component single
strands. So when the DNA melting is followed by rising temperature, the transition from
double stranded helix to single strands occurs over a very narrow temperature range.

DNA melting can be examined by UV spectroscopy because when the two strands form a
double helix, the aromatic nucleobases display hypochromicity. That is, the stacking
interactions alter the electron density in the rings and they display a reduction in UV
absorbance at 260 nm. When the helix separates, the UV absorbance is restored, giving rise
to the familiar DNA melting curve. Therefore, the temperature of denaturation, Tm, or
melting temperature, is found by following the change in absorption at 260 nm with
increased temperature. The Tm is the point of inflexion of the curve.
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Changes in the melting temperature of the D N A sample (AT W ) indicate changes in the

stability* of the helix. An increase in Tm shows that the helix is being stabilised, and t

usually indicates that the ligand is binding to the double helix. It is also possible tha
ligand could destabilise the helix by binding preferentially to single stranded DNA.

2.4 Analysis of Ligand-DNA Complexes by NMR Spectroscopy
Regardless of the mode of binding, one of the most important properties of a ligand-DNA
system from the viewpoint of NMR studies is binding specificity. The most desirable
ligands are those that are highly specific, so that when reacted with DNA sequences,

binding at a single site may be obesrved. This dramatically improves the resulting spectr
in comparison to those obtained when several bound complexes co-exist in an equilibrium
mixture. For example, actinomycin D has been extensively studied in terms of its binding
specificity. (Reid et al, 1983; Brown et al, 1984; Zhou et al, 1989) Mass spectrometry

may be utilised in the early stages of analysis to screen for binding specificity prior t
larger scale, more detailed, structural studies by NMR spectroscopy.

Selection of the DNA sequence is to a large extent determined by the binding properties o

the drug. For a drug displaying a high level of binding specificity, a single site may be

incorporated into a duplex, but depending on the exact binding site, it may or may not be
possible to use a self-complementary sequence, for example, d(ATGCAT)2 has one site,
whilst d(CGTACG)2 has two sites for actinomycin D. Examples of drugs whose complexes
with nucleic acids have been examined include daunomycin, (Quigley et al, 1980; Odefey
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et al, 1992) echinomycin (Gilbert & Feigon, 1992; Park & Choi, 1995) and mithramycin.
(Banville et al, 1990; Sastry& Patel, 1993; Keniry et al, 1991, 1993)

2.5 NMR Spectroscopy
Nuclear magnetic resonance spectroscopy has become an important tool for structural
investigations of ligand-DNA interactions as a result of the m a n y recent developments in
technology. These include the production of reliable, super-conducting magnets coupled to
the application of the pulse technique and the associated Fourier transform (FT). Increased
sensitivity has lead to smaller sample requirements (microgram range), whilst the greater
control and manipulation of a sample's magnetisation arising from the pulse technique has
resulted in N M R providing more detailed structural information than any other single
technique. (Derome, 1995) N M R

spectroscopy has one great advantage over X-ray

crystallography in its requirement for the sample to be in solution rather than a crystalline
state. This means the environment around the D N A is closer to in vivo conditions and also
allows the structure and dynamics of interacting molecules to be observed.

2.5.1 Theory of NMR
N M R is concerned with the interaction between an oscillating magneticfield(the rf field),
Bi, and the net magnetisation of a sample, which arises as a result of the application of a
static magneticfield,B 0 . In a magneticfield,nuclei are observed to occupy different energy
levels according to their orientation to thatfield.The number of different orientations that
can be adopted within a magnetic field is 21+1, where I represents the spin quantum
number for the nucleus. Most NMR-active nuclei within biological systems possess a spin
number of V2. The spin-V2 nuclei can adopt one of two orientations within a magnetic field
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referred to as + V 2 and -V2. The nuclei that adopt an orientation with the magneticfieldare
of lower energy than those aligned against. This energy difference is the basis of the NMR
signal. The NMR absorption is a consequence of transition between these two energy states

and is stimulated by the applied rf field. A number of different nuclei that possess spin- /
exist in nucleic acids, namely !H, 13C, 31P and i5N which can all be detected using NMR.

+1/2

A

AE
-1/2

Increasing B 0

v

Figure 2.5: The energy levels of the two spin states in an applied magnetic field.

The difference in energy can be quantified using equation 5. AE is the energy separating th

high and low energy spin states, B0 is the magnetic field strength (typically in Tesla), h i

Plank's constant, and y is the magneto-gyro ratio, a constant specific to the isotope being
observed.
AE=y/zBo •••(•5)

2n

The energy required to excite the transition between the two energy levels occurs in the
radio frequency (rf) region of the electromagnetic spectrum. Magnet strengths are often
described in terms of the frequency at which protons resonate, for example a 2.35 or 11.74
Tesla magnet causes protons to resonate at about 100 MHz or 500 MHz respectively. The
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distribution between the energy levels can be described by the Boltzmann equation. This
shows the excess of nuclei that reside in the lower energy state at thermal equilibrium
(Equation 6). The equation reveals that there is only an excess of one *H nuclei in the low
energy state for every hundred thousand at 298 K and a field strength of 2.35 Tesla (100
MHz). This small excess even in very strong magnetic fields accounts for the relative
insensitivity of NMR as a spectroscopic technique.
Na ...(6)
N * = e("AE/kT)
Equation 6 shows the populations of the high energy state Np over low energy level Na for
a specific energy gap AE, where k is Boltzmann's constant (1.3805xl0"23 J/Kelvin) and T is
the temperature in Kelvin.

The insensitivity is further compounded by the natural abundance of some NMR active
nuclei studied. To overcome these problems, sensitive electronics, signal averaging
techniques and relatively high concentrations of sample (compared with other techniques)
are required to obtain high quality spectra.

An alternating voltage is applied across the ends of the coil in the NMR probe, which
induces an alternating magnetic field (Bi) throughout the sample. The amplitude of this
field is much smaller than that of the static magnetic field, Bo, and its frequency covers
of the NMR resonances to be observed. At equilibrium, the spins are all aligned with the
applied magnetic field, which defines the z-axis, with no component along the x- or v-axes.
However, when a pulse of rf radiation is applied to the spins, an x-y component is induced,
and the z-component is altered from its equilibrium value. The spins return to their
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equilibrium values following afirst-orderexponential decay. The plot of intensity versus
time is referred to as the Free Induction Decay (FID) in an NMR experiment. The actual
FID obtained comprises the sum of many overlapping sine waves and the individual
frequencies are obtained by a Fourier transform (FT). The result is a plot of amplitude
versus frequency as shown in figure 2.6.

FT

v
Figure 2.6: FID to frequency plot (FT).

Signal averaging involves the repetition of experiments in order to gain a better signal-to
noise ratio, however, this may be time consuming owing to the relatively long relaxation
times required by some nuclei. T\ is known as the longtitudinal or spin-lattice relaxation
time. It describes the behaviour of the magnetisation in the z-component, and is the time
taken for the z-component of the magnetisation to return to its equilibrium value. There is
second type of relaxation known as transverse or spin-spin relaxation. It occurs in the x-y
plane, is described by the time constant, T2 and is owing to the inhomogeneity of the
magnetic field. The relaxation time, T2, is inversely proportional to the resonance peak
width.

The NMR spectrum represents the frequencies at which the transitions are induced between
the two allowed states of the spin +V2 and -V2. (Wemmer, 2000) Spins of a given type, i.e.
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'H, resonate around a givenfrequency,i.e. 500 M H z in afieldof 11.74 T. However, nuclei
of the same type, but in different chemical environments, have slightly different

frequencies. These differences are known as chemical shifts. The chemical shift (8) def
the location of the NMR line and is calibrated against a reference compound,

tetramethylsilane (TMS) or 3-trimethylsilylpropionate (TSP) for the *H nuclei. In frequ
units, the chemical shift is proportional to the applied static magnetic field, and as
commonly quoted in parts per million (ppm). The relative line intensity in a 1D-NMR

experiment is representative of the number of nuclei associated with each resonance lin
(Wuthrich, 1986)

2.5.2 2D NMR Techniques
Two-dimensional NMR techniques provide increased resolution and information over 1DNMR spectra. One major advantage of 2D-NMR is the ability to investigate the tertiary
structure of protein and DNA molecules up to ca. 10000 Da in molecular mass. To obtain
2D spectrum (amplitude versus two frequencies), two Fourier transforms must be carried

out, one for rows and one for columns. Some spins may exchange magnetisation during the

mixing period, which gives rise to cross-peaks in the 2D spectrum. These cross-peaks ar
great interest and use in the assignment of the resonances, which may be either close
through bonds or through space.

2.5.3 DQF-COSYand TOCSY
Double quantum filtered correlation spectroscopy (DQF-COSY) and total correlation
spectroscopy (TOCSY) are the two most common ]H-NMR experiments used to determine
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through bond information. They involve scalar spin-spin coupling and identify spin
systems. (Piantini, 1982; Ranee et al, 1983; Bax & Davis, 1985)

DQF-COSY (Piantini, 1982; Ranee et al, 1983) observes connectivities between protons
that are up to three bonds away. This type of experiment has advantages over normal

COSY (Bax & Freeman, 1981) experiments in that there is a significant reduction in single
resonances (eg, methyl or methoxy) and improved resolution owing to the diagonal and
cross peaks being in phase, compared to 90° out of phase for COSY experiments.

A DQF-COSY experiment allows the assignment of spin systems within each nucleotide
for an oligonucleotide. However, no information may be gained as to the position of the
base or sugar within the sequence as each deoxyribose is an isolated spin system.

A disadvantage of DQF-COSY is the overlap of resonances that occurs, especially of sugar

resonances, as well as the peaks being anti-phase, which leads to cancellation, which lim
the usefulness of this technique. This may be overcome by the use of TOCSY (Bax &
Davis, 1985) experiments, which have the advantage of resolving longer-range
connectivities.

2.5.4 NOE: the Nuclear Overhauser Effect
Experiments based on the nuclear Overhauser effect (NOE) examine the interaction
involved in the direct magnetic coupling between nuclei (dipolar coupling). (Derome,
1987) The information gained from this technique pertains to internuclear distances and
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molecular motion. The N O E is a change in intensity of an N M R resonance when the
transitions of another are perturbed.

2.5.5 NOESY: Nuclear Overhauser Effect Spectroscopy
The N O E S Y (Jeener et al, 1979; K u m a r et al, 1980) experiment determines correlation
between nuclei that are close in space. Cross-peaks are observed in N O E S Y spectra as a
result of mutual (cross) relaxation between nuclei that are close in space. The magnitude of
the effect is dependent on the distance between spins and h o w fast the molecule, or the part
of the molecule that contains the spins, is moving.

2.5.6 Water Suppression and Exchangeable Resonances
To avoid the large proton signal that occurs in water (H 2 0), samples m a y be dissolved in
D 2 0 . However, the more acidic nuclei, such as those attached to O or N , have very short
lifetimes and rapidly exchange with deuterium. To characterise such resonances, water
must be used as the solvent and thus, special methods for solvent suppression must be
employed. There are two c o m m o n approaches. The first involves saturating the solvent
with a weak rf pulse before the normal pulse sequence, i.e. presaturation. This is a simple
and easy method to use. The second method involves designing a n e w pulse sequence,
which excites the resonances of interest, but not those of the solvent.

Many of the exchangeable protons are involved in H-bonding and thus can be used as an
indicator of secondary and tertiary structure of the nucleic acid. The difference in chemical
shift of the imino and amino protons means that they can be independently assigned. The
hydrogen-bonded iminos resonate between 12-15 ppm, whilst the amino protons appear in
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the 6.5-8.5 p p m range. In a N O E S Y spectrum of D N A , it is possible to observe cross-peaks
from each imino to to the imino groups of its immediate neighbours and also to the amino
and H 2 protons within the base pair.

2.5.7 Chemical Shift Perturbations Arising from Ligand Binding
B y examining the alterations in chemical shift of a ligand resonance resulting from noncovalent binding, an indication of whether a particular substituent is involved in binding
can be obtained.

Intercalating agents produce the most dramatic changes in DNA conformation since the
process of intercalation results in the unwinding of the helix to accommodate the
intercalating agent. (Searle, 1988) This effect m a y be observed on neighbouring protons as
well as protons further away from the intercalation site.

2.5.8 Typical Chemical Shifts of Short Olignucleotides
The assignment of oligonucleotides and complexes was achieved using established
techniques based on the combined analysis of D Q F - C O S Y , T O C S Y and N O E S Y spectra.
(Wijmenga et al, 1993; Chazin et al, 1986)

The typical 'H-NMR spectrum of a short oligonucleotide can be divided into five distinct
regions. Aromatic resonances that arise from the four bases of D N A (i.e. H 6 , H 8 and A H 2 )
occur between 6.5 and 8.5 ppm. Cytosine H 5 and H I ' sugar resonances occur between 5.0
and 6.5 ppm. H 3 ' sugar resonances are found between 4.5 and 5.5 ppm, while H4', H 5 ' and
H 5 " resonances are usually overlapping between 3.5 and 4.5 ppm. H 2 ' and H 2 " resonances
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occur further upfield between ca. 1.8 and 3.0 ppm. Thymine methyl resonances are
generally the most upfield resonances, being observed between -1.0 and 1.8 ppm.

5,

u»

HO-V 5

OH

AH3'H*\
OH H2

Figure 2.7: Structure of deoxyribose including standard nomenclature scheme.

Exchangeable imino resonances of thymine and guanine and amino resonances of guanine,
adenine and cytosine can be observed in H20 solvent. Imino resonances occur between 12
and 15 ppm, while amino resonances are found between 6.5 and 8.5 ppm.

2.5.9 Comparison of Techniques: Mass Spectrometry vs NMR spectroscopy

Both mass spectrometry and nuclear magnetic resonance spectroscopy can provide detaile

sequence and structural information on biomolecules and their complexes with ligands. T
information obtained differs between the two techniques, however, the combination of
modern mass spectrometric and multi-dimensional NMR spectroscopic techniques allows
the structural investigation of intact biomolecules such as proteins, oligonucleotides
complex carbohydrates.

Mass spectrometry gives accurate mass measurement and can yield detailed information o
primary structure (sequence), whilst NMR spectroscopy allows the elucidation of the
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secondary and tertiary structure of peptides, proteins and other biomolecules. In addition,
MS can-also provide insight into higher order structure and inter- and intramolecular
interactions, whilst NMR can pinpoint the position and orientation of a bound ligand and
can provide information about the ligand-receptor contacts. Mass spectrometry holds the
potential of providing structural information on proteins with larger masses (>100 kDa)
than can be studied with nuclear magnetic resonance (NMR) spectroscopy (40 kDa). Mass
spectrometry also requires considerably smaller sample sizes (picomolar) than NMR
(millimolar).
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CHAPTER THREE:

Sequence

Selectivity, Stability, the Pyrindamycins

and

Mass

Spectrometry

3.0 Introduction
A s n e w DNA-interactive compounds become available, through discovery of natural
products or synthetic drug development, there is a need to investigate their chemical,
biological and toxicological properties. A s outlined in chapter two, mass spectrometry
readily enables the examination of ligand-DNA interactions, with particular capabilities for
the determination of the sequence selectivity and stability of the ligand-DNA adducts. This
chapter details the study of pyrindamycin-oligonucleotide adducts by mass spectrometry.
The pyrindamycins are minor groove alkylating agents (see section 1.7). They were
selected for study because they are still of interest because of their biological activity
against bacteria and some tumour cell lines and their lower toxicity compared to the lethal
related compound CC-1065. Further, compared to earlier studies of guanine alkylators by
ESI-MS and M S / M S , (Iannitti, 1999; Iannitti-Tito et al, 2000) pyrindamycins alkylate
adenine, are more labile and it is more difficult to isolate the intact adducts. Hence, the
compounds provide a more demanding test case of the potential of mass spectrometry for
rapid characterisation of sequence selectivity.

3.1 Oligonucleotides Used in this Study
A s noted in chapter one (section 1.7), the pyrindamycins bind in a sequence selective
manner to the adenine N 3 in a minor groove alkylation. This binding spans 3.5 base-pairs.
Hence, there is an absolute requirement for the sequence of three bases, whilst a preference
for the identity of the fourth base has also been observed. (Boger et al, 1990) The
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oligonucleotides used were designed to incorporate the high affinity binding site 5'-(AAA)-

3'. We varied the base composition in the fourth 5'-position to examine the effect o

binding and stability. From the literature, (Boger et al, 1990) it was expected that
binding and stability of the adducts formed would follow the trend:
5'-(AAA)-3' > 5'-(TTA)-3' > 5'-(TAA)-3' > 5'-(ATA)-3'

Moreover, alkylation should exhibit a strong, but not requisite specificity, preferr

or T versus G or C in the fourth 5'-position. For the lower affinity sites, 5'-(TAA)

(ATA)-3', the preferred fourth 5'-base would be expected to be a purine (A or G) ve
pyrimidine (C or T).

The oligonucleotides 5'-CGCAAATTTGCG-3' (ONI), 5'-CGGAAATTTCCG-3' (ON2),
5'-CGAAAATTTTCG-3' (ON3), 5'-GCAAAATTTTGC-3' (ON4), 5'-CGTAAATTTACG3' (ON5), 5'-CTAAAATTTTAG-3' (ON6), 5'-CGTTTATAAACG-3' (ON7), 5'CGCAAAGCTTTG-3' (ON8), 5'-GCGTTTCGAAAC-3' (ON9), 5'-CGAAAGCTTTCG-3'
(ON10) and 5'-CGCAAAGCTTTGGGC-3' (ON11) were purchased from Bresagen,

(Adelaide, Australia) where they were synthesised on a 1 umol scale. All oligonucleo
were purchased in the crude form with the dimethoxytrityl (DMT) protecting group
attached to the 5'-hydroxyl end of the nucleoside as shown in figure 3.1.
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Figure 3.1: DMT-protected nucleoside, attached to controlled glass pore solid support
(CPG). B is one of the four bases: cytosine(C), thymine(T), adenine(A) or guanine(G).

The majority of the sequences used were self-complementary which means that they can
form specific base pairs with an antiparallel strand of the same sequence resulting in

double-stranded, or duplex, oligonucleotides. Several of the oligonucleotides were desig
to be non-self complementary to investigate whether alkylation would occur to singlestranded oligonucleotides, e.g., 5'-d(CGCAAAGCTTTG)-3' (ON8). The oligonucleotide
5'-d(GCGTTTCGAAAC)-3' (ON9) was designed so that, when combined in solution with
ON8, a double-stranded complex would be formed. The oligonucleotide 5'd(CGAAAGCTTTCG)-3' (ON 10) was designed to incorporate the same binding site as
ON8, whilst being self-complementary, so that a double-stranded complex could also be
formed in solution. Cytosine and guanine bases were included at the termini in order to
increase the stability of the double-stranded conformation since CG-containing
oligonucleotides have elevated melting temperatures owing to the increased hydrogen
bonding interactions relative to AT-containing oligonucleotides. (Metzler, 1977). The
oligonucleotide 5'-d(CGCAAAGCTTTGGC)-3' (ON11) was designed to exclude the
formation of an offset duplex as will be discussed in more detail in section 3.6.5.
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3.1.1 Oligonucleotide Synthesis
The oligonucleotides were synthesised by Bresagen using the automated P-cyanoethyl
phospharamidite solid phase method. (Sinha et al, 1984; Caruthers et al, 1987) In this
method, the bases are protected by the groups shown in figure 3.2, i.e. benzoyl groups on
the adenine and cytosine bases and isobutyryl groups on the guanine bases. The cyanoethyl

group protects the reactive phosphate oxygen during the coupling step. The oligonucleotide
is attached to a controlled glass support (CPG) via an N-succinimide linkage.

°A1

o
HN

NH
N

//

N

N
n

AJ
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A vi
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CH(CH3)2
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on guanosine
B n B

DMTO
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M

o

-0~-ACPG

\

CH2CH2CN

y

Cyanoethyl phosphate
protecting group

Benzoyl protecting group
on cytosine

Figure 3.2: Protecting groups used for the bases in oligonucleotide synthesis.

The major steps in the phosphoramidite method are shown in figure 3.3. (Sinha et al, 1984;
Caruthers et al, 1987) The first stage in the synthesis involves the removal of the DMT-

protecting group from the 5'-end of the nucleotide that is attached to the CPG support. Th
free hydroxyl group may then participate in a coupling step with the 3'-nucleoside, which

occurs as a result of nucleophilic attack. The next stage of synthesis involves the cappin

any unreacted nucleotides which are attached to the solid support, i.e. the failure sequen
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This prevents these failure sequences from further reaction with nucleotides in subsequent
coupling steps. The last stage in the synthesis cycle involves the oxidation of the
internucleotide phosphite linkage formed in the coupling step to a phosphate triester. The
above cycle is then repeated for every addition of a base to the oligonucleotide chain. The
5'-DMT protecting group is generally left on for the purpose of purification as discussed in
section 3.1.3.
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Figure 3.3: Phosphoramidite Synthesis Cycle.
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3.1.2 Cleavage and Deprotection

As notedabove, the oligonucleotides were received from Bresagen still attached to the CPG
support and fully protected. Cleavage of the oligonucleotide from the solid support was
achieved by treatment with concentrated ammonia for one hour, which also removes the
cyanoethyl protecting group. The process was repeated twice to ensure complete cleavage.
The oligonucleotide was then heated in ammonia solution at 55°C for 15 hours to remove
the exocyclic amine protecting groups. After complete deprotection, the solution was
cooled and stored at -4 °C Nitrogen gas was bubbled through the solutions to remove
excess ammonia, which were then freeze-dried in a Savant Speedivac™ vacuum centrifuge.

3.1.3 HPLC Purification
The oligonucleotides were purified on a Beckman high performance liquid chromatography
(HPLC) system (Sydney, Australia), which consisted of 77251 sample injection valve, 127s
programmable solvent module and a UV visible 166 detector module set to measure
absorbance at 254 nm. Purification was achieved by reversed phase HPLC using a CI8
octadecasilyl column (8x100 mm Waters Deltapak Radial Pak cartridge).

The dry product, after removal of ammonia, was redissolved in a minimum of 10 mM
ammonium acetate, pH 7.0. Purification of the oligonucleotide required two stages of
HPLC as illustrated in scheme 3.1. The DMT protecting group was retained on the
oligonucleotide for the first stage of purification by HPLC. This enhances separation of

oligonucleotide, which is hydrophobic owing to the presence of the trityl group, from the
capped failure sequences and other synthesis impurities, which are not tritylated.

88

Scheme 3.1: Scheme showing the steps involved in the purification of oligonucleotides.

Crude oligonucleotide

V

HPLC (ReversedPhase, C-18)
0-60% acetonitrile in 10 m M a m m o n i u m acetate
-removes cappedfailure sequences and synthesis

by-products.

DMT-protected oligonucleotide

V

80% acetic acid, 30 mins, 95% ethanol, freeze-dry.
-removes DMT protecting group.
HPLC (Reversed Phase, C-18)
0-60% acetonitrile in 10 m M a m m o n i u m acetate

Detritylated, biologically
active oligonucleotide

In thefirststage of H P L C , a linear gradient of 0 to 6 0 % acetonitrile in 10 m M a m m o n i u m
acetate over 30 minutes was used. The "trityl-on" fraction was then collected and freezedried.
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of the
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profile of the protected oligonucleotide

5'-DMT-

d(CGCAAATTTGCG)-3\

Figure 3.4 shows the H P L C

CGCAAATTTGCG-3'. The cluster of peaks occurring at retention times between 10 and
12 minutes arise from the capped failure sequences and synthesis by-products. There may
also have been peaks in this region owing to any of the desired oligonucleotide that has

been detritylated. The peak at approximately 16 minutes is thought to be benzamide, whic

is produced when the benzoyl protecting group is cleaved during the deprotection step. T
major peak, which elutes at a time of 18 minutes, is from the desired 5'-DMT-
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C G C A A A T T T G C G - 3 ' . The difference in elution times between the protected and
deprotected oligonucleotides is a consequence of the hydrophobic nature of the DMT group
and its increased affinity for the non-polar reverse phase column.

The oligonucleotides were detritylated by treating the dried fraction with 80% acetic acid
room temperature for 30 minutes. After this time, an equal volume of ethanol was added to
the solution and the sample was again freeze-dried. The detritylated oligonucleotide was
purified by RP-HPLC to remove any remaining tritylated oligonucleotide and DMT-cations
on the same column and HPLC system that was used in the first stage. A linear gradient of
0 to 60% acetonitrile with 10 mM ammonium acetate buffer at a flow rate of 1 mL/min
over 30 minutes was used in this stage of purification. The detritylated oligonucleotide
fractions were collected, freeze-dried and stored in the freezer prior to analysis by
electrospray ionisation mass spectrometry (ESI-MS).

91

A'I

!

^ 0.8 -

D
<

g 0.6

1 0.4 <

0.2 0 -

—•

0

, ••

, „—

U

.ml

10

V
20

30

Time (minutes)
Figure 3.5: H P L C profile of the detritylated oligonucleotide 5 ' - d ( C G C A A A T T T G C G ) - 3 '

Figure 3.5 shows the HPLC profile for the detritylated oligonucleotide, 5'CGCAAATTTGCG-3'. The chromatogram consists of one major peak eluting at a
retention time of 12 minutes corresponding to the detritylated oligonucleotide. The absence
of a small peak at -18 minutes owing to any remaining tritylated oligonucleotide, indicates
complete detritylation occurred in this instance.

All the remaining oligonucleotides used in the experiments described in this chapter gave
very similar H P L C profiles for both "trityl-on" and "trityl-off' purifications, with the
exception that the retention times varied slightly with sequence. The purity of each of the
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oligonucleotides after the second stage of H P L C was confirmed by examining the resultant
product by ESI-MS on the VG Quattro triple quadrupole mass spectrometer.

3.1.4 Concentrations of Oligonucleotide Solutions

The concentration of the solutions of purified oligonucleotides was estimated by measurin
the UV absorbance on a model 265 Shimadzu UV Visible spectrophotometer.

The purine and pyrimidine bases strongly absorb light with maxima near 260 nm. The
concentrations were determined using Beers Law by measurement of UV absorbance at 260
nm (in a 1 cm quartz cuvette) using estimates of the molar extinction coefficient (8260)
based on the proportion of adenine, guanine, cytosine and thymine with 8260 of 15400,
11700, 7300 and 8300 M"1 cm"1 respectively. (Sambrook et al, 1989) The freeze-dried
oligonucleotide samples were redissolved in a known volume of distilled, deionised water

and diluted within the absorbance range of 0.2-1.2 so that errors owing to deviations fr
Beer's Law were minimised. (Sambrook et al, 1989) The absorbance was measured at 260
nm in a 1 cm quartz cuvette. The oligonucleotide stock solutions prepared with a
concentration of 100 pmol/uL in 50% aqueous acetonitrile containing 1% ammonia
solution (pH~9.0).

3.2 Ligand-Oligonucleotide Binding Reactions
For reactions between pyrindamycin A and the oligonucleotides, the ligand (Pyrindamycin
A) was dissolved in a minimum amount of dimethylformamide (DMF) and the resulting
solution was added to the 1.0 mM oligonucleotide solution, in 0.1 M Na2HP04/NaH2P04
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buffer (pH~8.0), in a 5:1 ratio. The reaction mixtures were kept under nitrogen in the dark
at room temperature for 7 days.

The adducts were further purified by HPLC using the same conditions as for
oligonucleotide purification except the gradient from 0 to 60% acetonitrile with 10 mM
ammonium acetate buffer was over a longer time (40 mins). This additional step of HPLC

was utilised to remove the unreacted products and the high concentration of sodium used i
the reaction mixture. The HPLC did not give sufficient resolution to yield fractions
containing only one adduct and as such the fractions were then pooled and analysed by
ESI-MS.

3.3.1 Electrospray Ionisation Mass Spectrometry (ESI-MS) Studies
The electrospray ionisation mass spectra were obtained on a VG Biotech Quattro™ mass
spectrometer (VG Biotech Ltd. (now Micromass), Altrincham, UK) equipped with an
electrospray ionisation source and a quadrupole/hexapole/quadrupole mass analyser, which
has a mass range up to m/z 4000. The instrument was upgraded to meet Quattro II™

specifications prior to the commencement of this study. A schematic diagram of the triple
quadrupole mass spectrometer is shown in Figure 3.6.
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Figure 3.6: Schematic illustration of the triple quadrupole mass spectrometer showing the
quadrupole/hexapole/quadrupole mass analyser employed.

ESI mass spectra were acquired for oligonucleotides in 5 0 % aqueous acetonitrile. The stock
oligonucleotide solutions (100 pmol/uL) were dissolved in this solvent and subsequently
diluted to give a concentration of single-stranded DNA of approximately 5 pmol/uL for

conventional electrospray. The solutions were directly infused via a Harvard syringe pump,
model 55-1111 (Holliston, MA) at a flow rate of 5 |j.L/min. Total sample consumption for a
typical experiment was 125 pmol. No attempt was made in this study to explore the
absolute sensitivity of the technique, which could have been improved via the use of
nanoelectrospray or capillary LC-MS on the Q-TOF, as it was deemed unnecessary.

Mass spectra were acquired over a range of 400-1000 m/z which were calibrated using a
solution of sodium iodide at a concentration of 3 mg/mL. Calibration was undertaken after
all other data had been acquired so as to avoid the introduction of sodium ions into the
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ionisation source prior to the analysis of the oligonucleotide samples. Datafiles were then
recalibrated accordingly.

A DEC Personal Computer workstation equipped with Micromass Mass Spectrometry Data
System software MassLynx™ (version 3.1) was used for all data acquisition and
processing.

The temperature of the electrospray ionisation source was maintained at 80°C The

operating voltage of the electrospray capillary was set at -3 kV for negative ions and 3 k

for positive ions. ESI mass spectra were typically recorded with a cone voltage of 25V. Al
ESI mass spectra were obtained by scanning in the multi-channel analysis (MCA) mode

with a scan time of 1 second per m/z 100. The resulting spectra presented in this thesis a
generally the sum of 10-15 scans. The ESI mass spectra presented here have been
background subtracted and smoothed using standard algorithms provided in the Mass Lynx
™ software. Other MS parameters are given in table 3.1.
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Table 3.1: Typical tuning parameters for ESI-MS on the V G Quattro mass spectrometer.
Source parameter

-ve ion m o d e

Capillary

3.0-3.5 kV

Cone

20-50 V

H V Lens

0.1 kV

Lens 3

1.0 V

Source Temperature

80 °C

L M Resolution

15.0

arbitrary units

H M Resolution

15.0

arbitrary units

Ion Energy

1.0

arbitrary units

Ion Energy R a m p

0.0

Lens 5

30-50 V

Lens 6

-2.0-8.0 V

M S I Photomultiplier

650 V

Comments

sample dependent

sample dependent

3.3.2 Electrospray IonisationTandem Mass Spectrometry (ESI-MS/MS) Studies

Tandem mass spectrometry experiments in negative ion mode were undertaken on the tri

quadrupole mass spectrometer using 5 pmol/uL solutions of the products resulting fro

reactions between the ligands and the various oligonucleotides. An ESI mass spectrum

obtained first to determine if the ion of interest was present. This ion was then vi

tuning monitor and optimised in MSI before being selected for MS/MS in MS2. A collis

energy ramp was utilised with high collision energy at low m/z and low collision ene
high m/z. This involved scanning m/z 250-1250 while the collision energy was ramped
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from 50-10 eV. The collision gas (argon) was introduced into the collision cell initially at
low pressure (lxlO"4 mbar) and gradually increased until the point where the intensity of
ion of interest had dropped to approximately 40% transmission and product (or daughter)
ions were observed. Typically, a collision gas pressure of ~lxl0"3 mbar was sufficient to
yield good levels of fragmentation in the MS/MS spectra of ions of interest in this study.

MS/MS data were acquired in product (or daughter) ion mode over the range m/z 250-1250.
A scan time of 10 seconds with an interscan time of 0.10 seconds was used. Typically, 1020 scans were summed to give a final spectrum.

The mass spectrometer was tuned in negative ion mode with a solution of the
oligonucleotide to be analysed at a concentration of 5 pmol/uL. Typical tuning parameters
for MS/MS experiments are given in table 3.2.

The mass range was calibrated with a sugar mixture for negative ions and with a solution of
sodium iodide for positive ions. The sugar mixture consisted of corn syrup
(maltooligosaccharide), raffinose, maltose and maltotetraose at a concentration of 100
pmol/)j.L in 50% aqueous acetonitrile. The sodium iodide solution had a concentration of 3
mg/mL.
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Table 3.2: Typical tuning parameters for ESI-MS/MS on the V G

Quattro mass

spectrometer.
Source parameter

-ve ion mode

Comments

L M Resolution

12.0

arbitrary units

H M Resolution

12.0

arbitrary units

L M Resolution

10.0

arbitrary units

H M Resolution

10.0

arbitrary units

Ion Energy

0.5

arbitrary units

Ion Energy R a m p

0.0

Lens 7

-330 V

Lens 8

-280 V

Lens 9

-15 V

Photomultiplier

650 V

MSI:

MS2:

3.4 Nomenclature
Throughout this thesis, the letter 'M' is be used to denote the neutral form of the
oligonucleotide being examined. The designation ONI through ON11 is given in

parentheses after each oligonucleotide sequence to facilitate cross-referencing bet

in tables and the discussion in the text. Standard nomenclature i.e. adenine (A), g

(G), cytosine (C) and thymine (T) is used for the bases. All of the oligonucleotides
this study had hydroxyl groups present at each terminus. The anti-tumour agents,

pyrindamycin A and B, are abbreviated to PyA and PyB in their free state, whilst in
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form, i.e. after the loss of HC1, they are abbreviated to Py. For example, the [M+Py-4H] 4 '

species represents a pyrindamycin bound to the intact oligonucleotide with a charge of 4"
arising from loss of 4 protons from a neutral oligonucleotide backbone, whilst [M-A-3H]3"
represents a triply charged ion of a depurinated oligonucleotide.

For the designation of product (or sequence) ions we have used a variation of the system
nomenclature for oligonucleotide fragmentation introduced by McLuckey and co-workers,
(McLuckey & Habibi-Goudarzi, 1993) whereby the oligonucleotide is assumed to be
uncharged. (Boschenok & Sheil, 1996; Barry et al, 1995) Depurination of the

oligonucleotide occurs following alkylation. Subsequent cleavage of the 3'-C-0 bond in t

depurinated residue results in the formation of a w-ion when the charge is retained by th
fragment and the corresponding 5'-cleavage product is designated as an (a-Bn)-ion, where
Bn denotes the base lost as shown in scheme 2.1 (chapter two).
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Table 3.3(a): Major species observed in ESI mass spectra of the reaction mixtures of pyrindamycins and
oligonucleotides.
Calculated m/z"

O N 1,2, 8, 9,10"

Species

O N 3, 4, 5, 7

ON 6

ON 11

[M]

3645.4

3644.4

3643.4

4263.8

[M-5Hf
[M-4H]4[M-3H]3"

728.1
910.3
1214.1

727.9
910.1
1213.8

727.7
909.9
1213.5

851.8
1064.9
1420.3

[M+Py]

4152.9

4151.9

4151.0

4771.3

[M+Py-5Hf[M+Py-4H]4[M+Py-3Hf-

829.6
1037.2
1383.3

829.4
1037.0
1383.0

829.2
1036.7
1382.6

953.3
1191.8
1589.4

[M-A]

3510.3

3509.3

3508.3

4112.7

[M-A-5H]5[M-A-4H]4"
[M-A-3H]3-

701.1
876.6
1169.1

700.9
876.3
1168.8

700.7
876.1
1168.4

-

[Py+A-HJ-

641.6

641.6

641.6

-

[M-G]

3494.3

-

-

4112.7

[M-G-5H]5"
[M-G-4H]4"
[M-G-3H]3-

697.9
872.6
1163.8

-

-

821.5
1027.2
1369.9

[Py+G-H]-

657.6

-

-

657.6

a.

Calculated m/z values are given since there are small variations in m/z (0.1-0.5) between
individual spectra

b.

O N 1 = 5'-d(CGCAAATTTGCG)-3'

O N 2 = 5'-d(CGGAAATTTCCG)-3'

O N 3 = 5'-d(CGAAAATTTTCG)-3'

O N 4 = 5'-d(GCAAAATTTTGC)-3'

O N 5 = 5'-d(CGTAAATTTACG)-3'

O N 6 = 5'-d(CTAAAATTTTAG)-3'

O N 7 = 5'-d(CGTTTATAAACG)-3'

O N 8 =» 5'-d(CGCAAAGCTTTG)-3'

O N 9 = 5'-d(GCGTTTCGAAAC)-3'

O N 10 = 5'-d(CGAAAGCTTTCG)-3'

O N 11 =5'-d(CGCAAAGCTTTGGC)-3'
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Table 3.3(b): Major species observed in ESI-MS and MS/MS spectra of the reaction mixtures of
pyrindamycins and oligonucleotides.
Species

ON1

ON 2

O N 3, 4

ON 5

[Wl]"

346.2

[w2]"
[w6-2H]3"
[w6-Hf

635.4
625.1
938.1

611.7
918.1

616.7
925.6

[w7-2H]3"
[w7-H]2-

1082.2

[a5-B5-4H]3[a5-B5-3H]2"

446.6
670.4

[a6-B5-4H]3"
[a6-B6-3H]2"

619.7
930.1

624.7
937.6

721.1

543.0
815.0

556.4
835.1

551.0
827.1

[a10-B10-5H]4[a10-BI0-4H]3'

717.2
956.6

[Zu-BnSHf
[airB„-4H]3-

789.3
1052.7

Species

ON 7

[w,]"
[w2]"

635.4

ON 8

ON 9

O N 10

ON 11

306.2

[w5-2H]3"
[w5-H]2[w6-2H]3'
[w6-H]2-

ON 6

515.3
773.5
625.7
939.1

625.1
938.1

625.1
938.1

[w7-2H]3'
[w7-H]2'

721.5

721.5

1082.7

1082.7

[a5-B5-4H]3[a5-B5-3H]2"

446.6
670.4

[ae-Bs^H]3"
[a6-B6-3Hf

543.0
815.0

[a7-B7-4H]3"
[a7-B7-3H]2'

647.4
971.6

[aI0-B10-5H]4[a,0-B10-4H]3[a„-Bu-5H]4[an-Bn-4H]3-

543.0
815.0
647.4
971.6

717.2
956.6
799.7
1066.7
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Table 3.3 shows the calculated m/z values for the ions commonly observed in the ESI mass

spectra of the reaction mixtures. The calculated m/z values for the sequence ions obse
in both the ESI-MS and ESI-MS/MS spectra are given in table 3.3(b).

3.5 Electrospray Ionisation Mass Spectrometry (ESI-MS) Results
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Figure 3.7: ESI mass spectra of: (a) 5'-d(CGCAAATTTGCG)-3' (b) Pyrindamycin A
(PyA) and Pyrindamycin B (PyB)
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The ESI mass spectrum of the free oligonucleotide 5'-d(CGCAAATTTGCG)-3' is shown

in figure 3.7(a). The peaks at m/z 455.9, 520.6, 607.0, 728.4 and 910.6 represent the [
8H]8', [M-7H]7", [M-6H]6', [M-5H]5" and [M-4H]4' ions of the free oligonucleotide. The ESI
mass spectra of all oligonucleotides studied showed very similar spectra and were
examined to ensure the purity of the DNA sequences after HPLC purification. Figure 3.7
also shows the ESI mass spectra recorded for the free ligands, pyrindamycin A and

pyrindamycin B (figure 3.7b). In each case, the peaks at m/z -542 represent the [PyA-Hf

[PyB-H]" ion of the unmodifed ligand, whilst the peaks observed at m/z 506 correspond t

the hydrolysed form of the ligand, [Py-H]". This modification corresponds to a neutral l
of HC1 with a m/z difference of 36.
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Figure 3.8: Electrospray ionisation mass spectrum of 5'-d(CGCAAATTTGCG)-3' (ONI)
and PyA: (a) m/z scale (b) mass scale

Figure 3.8 shows the ESI mass spectrum of the mixture formed on reaction between 5'd(CGCAAATTTGCG)-3' (ONI) and PyA on both an m/z scale (figure 3.8a) and converted

to a mass scale (figure 3.8b). In the spectrum shown in figure 3.8a, there are peaks f
unreacted oligonucleotide at m/z 728.0 [M-5H]5", m/z 910.2 [M-4H]4" and m/z 1213.8 [M-

105

3H]A The peaks at m/z 829.5, 1037.1, and 1383.0 represent the [M+Py-5Hf~, [M+Py-4H]
and [M+Py-3H] " ions of the Py-oligonucleotide adduct. Fragmentation of this adduct

results in the depurinated oligonucleotide, for which ions were present at m/z 701.4 [M
5H]5", m/z 876.9 [M-A-4H]4" and m/z 1169.6 [M-A-3H]3". The 3'-sequence ion [w6-2H]3"
(i.e. [d(TTTGCG)+H20-3H]3"), m/z 625.0, was also observed in the ESI mass spectrum.

The corresponding doubly charged ion m/z 938.1 was also present, but was of low intensi
Figure 3.8(b) provides a better representation of the relative abundance of the major

species, showing the depurinated oligonucleotide at 3512 Da (there is also a small peak
3534 Da owing to the corresponding sodium adduct of this species), the unreacted
oligonucleotide at 3646 Da and the intact adduct at 4152 Da.

[M-A-nH] "•
701.4(5-)
641.0 [ P y + A - H F - T - 8 7 6 9 ; 4 . j
1169.6(3-)
PyA
G c G
C
A
A
A
T T T

C
G
3'
5'
§
HO -®-\ -®~\ ~®\ ~®\ ~®~\
€K^N^eK|^r W^Aj\0H

[M+Py-nH] n"
829.5 (5-)
1037.1 (4-)
1383.0(3-)

[(a6-B6)-nH] ^>i-Iw e -nHl ( n + 1 ) 6 6
625.0(3-)

Scheme 3.2: Fragmentation of the [M+Py-4H] 4 " ion of 5'-d(CGCAAATTTGCG)-3' (ONI)
and PyA.

Scheme 3.2 shows the fragementation that was observed for 5'-d(CGCAAATTTGCG)-3'
(ONI). Pyrindamycin A alkylated the oligonucleotide at position 6 (A6) of the sequence,
resulting in the labilisation of the 3'-glycosidic bond and cleavage as illustrated.
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Table 3.4: Relative intensities of the major species observed in the ESI-MS spectra of pyrindamycin A
oligonucleotide reaction mixtures.
Relative Intensity (%)
ONla

Species

ON 2

ON 3

ON 4

ON 5

ON 6

ON 7

.

5
6

8
5

-

47
30
7

-

20
11
3

[M-5Hf
[M-4HJ4"
[M-3H] 3 '

18
64
20

-

-

[M+Py-5H]5_
[M+Py-4H]4_
[M+Py-3H]3'

100
86
31

16
100
54

69
100
11

8
100
30

28
100
18

33
100
12

21
82
18

[M-A-5H] 5[M-A-4H]4"
[M-A-3H] 3-

32
70
23

-

9
38
8

7
11
6

58
66
3

59
15
3

100
62
5

[Py+A-H]"

-

17

15

22

39

47

31

[wj

-

-

-

16

2

-

-

30
6
31
5

-

6

14
3

-

.
-

-

"

-

5

-

6

-

8
19

-

3

[w6-2H] "
[w 6 -Hf
[w7-2H]3"
[w7-H]2'
[alo-BI0-4H]3lau-Bir5Hf
[a n -B„-4Hf

-

-

"

a. O N 1 = 5'-d(CGCAAATTTGCG)-3'
O N 3 = 5'-d(CGAAAATTTTCG)-3'
ON 5 = 5'-d(CGTAAATTTACG)-3'

ON 2 = 5'-d(CGGAAATTTCCG)A
ON 4 = 5'-d(GCAAAATTTTGC)-3'
ON 6 = 5'-d(CTAAAATTTTAG>3'

ON 7 = 5'-d(CGTTTATAAACG)-3'

Table 3.4 shows the relative intensities of the major species and sequence ions observed in
the ESI-MS spectra for reaction of pyrindamycin A with seven of the oligonucleotides

studied. The ESI mass spectra of the remaining oligonucleotides were similar to that of th

reaction mixture with ONI, with the exception that the relative intensities of the differe

species varied. For example, in the ESI mass spectrum of the mixture formed on reaction of
5'-d(CGGAAATTTCCG)-3' (ON2) and PyA (not shown), the peaks arising from
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depurinated species are absent (apart from [Py+A-H]") and only the [w6-2H]3" sequence ion
was present in very low abundance (2%).

ON1

ON2

ON3

ON4

ON5

ON6

ON7

Oligonucleotide
D M H[M+Py] • [M-A]/[Py+A] • Sequence ions

Figure 3.9: Relative intensity (% total ion current) of ions from the intact adduct (M+Py),
the depurinated species (M-A)/(Py+A) and sequence ions compared to ions from the free
oligonucleotide (M).

The differences between the relative intensity of ions from the intact (M+Py) adducts
compared to ions from depurinated species (M-A) and (Py+A) and cleavage products (w
and a-B ions) are demonstrated more clearly in figure 3.9. In the figure, the relative
intensities of different ions from each species (i.e. [M+Py-5H]5" [M+Py-4H] 4 " and [M+Py3H] 3 " for (M+Py) etc) are compared for each of the ESI mass spectra of the pyrindamycin
A reaction mixtures with ON1-ON7. Some marked differences between the stabilities of
different oligonucleotide adducts are evident from these data. For example, for O N 2 (and,
albeit to a lesser extent, O N I , O N 3 and O N 4 ) the (M+Py) adduct represents the major
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species, whereas for O N 5 , O N 6 and 0 N 7 , ions from depurinated species were of
comparable or greater abundance to those of the intact adducts.
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Figure 3.10: ESI mass spectrum of reaction mixture between 5'-d(CGTAAATTTACG)-3'
(ON5) and (a) pyrindamycin A and (b) pyrindamycin B

Figure 3.10 shows the ESI mass spectra of the mixture from the reaction of pyrindamycin A
(figure 3.10a) and pyrindamycin B (figure 3.10b) each with 5'-d(CGTAAATTTACG)-3'
(ON5). There were a number of ions of different charge present for each species. For
example, for the intact adduct (M+Py) there are peaks at m/z 829.0, 1036.7 and 1382.7
from the [M+Py-5H]5", [M+Py-4H]4" and [M+Py-3H]3" ions respectively. The peaks
observed at m/z 727.7 and 909.7 represent the [M-5H]5" and [M-4H]4" ions of the intact
oligonucleotide, whilst those at m/z 700.7 and 876.1 are from the [M-A-5H]5" and [M-A-

4H] " depurinated species. It is interesting to note that the [w2]" and [ai0-Bio-4H]3" seque

ions are present at m/z 635.3 and 956.6 respectively. This indicates that the binding of th

ligand occurred at the adenine at position 10 in the oligonucleotide rather than at the hi
affinity site at A6 (more below).

In the spectrum of the reaction mixture of ON5 and pyrindamycin B (figure 3.10b), peaks

are also observed owing to the intact adduct, free oligonucleotide, depurinated species an
the cleavage products. It is notable, however, that upon reaction with pyrindamycin B, the
intensity of the depurinated species (m/z 700.5, 875.8 and 1168.3), pyrindamycin-adenine
adduct (m/z 641.1) and sequence ions (m/z 635.0 and 956.2) are the most intense. In
contrast, the spectrum from the reaction with pyrindamycin A shows peaks of greater

intensity for the intact adduct at m/z 829.0, 1036.7 and 1382.7. The ESI mass spectra for a
of the oligonucleotides reacted with pyrindamycin B displayed very similar results and
MS/MS spectra revealed identical fragmentation pathways. The two agents are thought to
alkylate DNA via a common agent, duocarmycin A and the data collected is consistent with
this hypothesis.

no

The ESI mass spectra of the remaining self-complementary oligonucleotides O N 2 , O N 3 ,
ON4, ON6 AND ON 10 (not shown) were similar to those already presented here, with the
exception that the relative intensities of the different species varied.
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Figure 3.11: ESI mass spectrum of reaction mixture between 5'-d(CGCAAAGCTTTG)-3'
(ON8) and pyrindamycin A

Some differences were observed for the non-self-complementary sequences. For example,
figure 3.11 shows the ESI mass spectrum of the mixture formed on reaction between the
non-self-complementary sequence, 5'-d(CGCAAAGCTTTG)-3' (ON8), and PyA. The ions
at m/z 691.0, 829.5, 1037.2 and 1383.4 represent the [M+Py-6H]6_, [M+Py-5H]5", [M+PyA. i

4H] " and [M+Py-3H] of the Py-oligonucleotide adduct. The depurinated oligonucleotide
gives rise to the ions [M-A-4H]4" (m/z 876.3) and [M-A-3H]3" (m/z 1168.5). The adduct
formed between pyrindamycin and adenine is observed at m/z 641.2 and a low intensity
peak is also seen at m/z 657.2 which corresponds to the adduct formed after guanine

il

alkylation. The intact adduct was then analysed by M S / M S and the results of these
experiments will be discussed in section 3.6.8.

3.6 Electrospray Ionisation Tandem Mass Spectrometry (MS/MS) Results

Since sequence ions are not observed for all adducts in the ESI mass spectra, tandem mas
spectrometry (MS/MS) was necessary for definitive identification of the ligand binding

sites. Hence, each of the major species observed in the ESI mass spectra of the reaction
mixtures were analyzed further by MS/MS. Table 3.5 shows the major ions observed in the
MS/MS spectra of the [M+Py-4H]4" and [M-A-4H]4" ions for each of the oligonucleotide
adducts formed with pyrindamycin A and for adducts of ONI, ON2, ON3, ON5, and ON7
with pyrindamycin B. In cases where guanine alkylation was observed, the [M+Py-4H] "
and [M-G-4H]4" ions were also analysed by MS/MS. Additionally, for the 14-mer studied,
5'-d(CGCAAAGCTTTGGC)-3', the [M+Py-5H]5" ion was also analysed by MS/MS as it
was of much greater intensity in the ESI mass spectrum, and therefore was more readily
analysed than the [M+Py-4H]4" ion. In each case the MS/MS spectra readily enabled the
binding site(s) to be identified as described below.
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Table 3.5(a):

Precursor and product ions observed in the ESI-MS/MS spectra of pyrindamcin A and B
with oligonucleotides ON1-ON6.

Precursor Ions
Species
m/z"
ONla

ON2

ON3

[M+PV-4H]4"

ON5

ON6

Species
[M-A-3H]3"
[M-A-4H]4"

1169.6
876.9

[Py+A-H]"
[Py+A]°

Binding Site

m/z

876.9

[w6-Hf

938.0

[at-B^ttf-

814.2

[M+Py-4H]4"

1036.8

[M-A-3H]3"
[M-A-4H]4"

1168.9
876.6

[Py+A-H]"
[Py+A]°

640.6

876.6

[w6-H]2"

917.4

[ae-Bg-SH]2"

833.6

[M+PV-4H]4"

1036.1

[M-A-3H]3"
[M-A-4H]4"

1167.3
875.6

[Py+A-H]"
[Py+A]°

641.0

[w7-H]2"

[w6-Hf

1081.5
925.4

[a7-B7-3H]2"
[a6-B6-3H]2"

669.2
827.2

[M-A-3H]3"
[M-A-4H]4"

1168.0
875.4

[Py+A-H]"
[Py+A]°

641.2

[M+PV-4H]4"

1037.0

A6

A6

A6

A5
A6

A5
A6

A5
A6

d

A10

A10

All

d

c

875.4

[w7-H]2"
[w6-H]2'

1081.2
925.9

[a7-B7-3H]2"
[a6-B6-3H]2"

[M+Py-4H]4"

1036.5

[M-A-3H] 3 '
[M-A-4H]4"

1168.1
875.6

[Py+A-H]"
[Py+A]°

640.8
C

[M-A-4H]4"

875.6

[w2]"

634.4

[a]0-B]0-3H}2-

956.6

[M+Py-4H]4"

1035.8

[M-A-3H] 3[M-A-4H]4"

1167.8
876.2

[Py+A-H]"
[Py+A]°

640.9

[w,r

346.4

[au-Bn-3K\2-

1053.2

876.2

A6

C

[M-A-4H]4"

[M-A-4H] 4 '

PyB

c

[M-A-4H] 4-

875.6

PyA

c

[M-A-4H]4-

[M-A-4H]4-

ON4

1037.1

Product Ions
Wz"
Species

c

a. O N 1 = 5'-d(CGCAAATTTGCG)-3'

O N 2 = 5'-d(CGGAAATTTCCG)-3'

O N 3 = 5'-d(CGAAAATTTTCG)-3'

O N 4 = 5'-d(GCAAAATTTTGC)-3'

O N 5 - 5'-d(CGTAAATTTACG)-3'
O N 6 = 5'-d(CTAAAATTTTAG)-3'
b. Observed m/z
c. This species is neutral and therefore not detected
d. These oligonucleotides were not reacted with pyrindamycin B
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Table 3.5(b): Precursor and product ions observed in the ESI-MS/MS spectra of pyrindamcin A and B
with oligonucleotides ON7-ON11.

Precursor [ons
Species
m/zb
ON7a

ON8

ON8

[M+Py-4H] 4 "

1036.1

Species

Prot uctIons
Species
m/zb

Binding Site
m/r*

M-A-3H] 3 "
[M-A-4H] 4 "

1167.5
875.2

[Py+A-H]"
[Py+A]°

641.3

PyB

A10

A10

A6
G7

A6
G7

A6(l)
All(2)

d

A5

d

G7

d

C

[M-A-4H] 4 "

875.2

[wj"

635.0

[a10-B,0-3H]2"

956.4

[M+Py-4H] 4 "

1036.7

[M-A-3H] 3 "
[M-A-4H] 4 "
[M-G-3H] 3 "
[M-G-4H] 4 '

1168.8
875.2
1162.3
871.6

[Py+A-H]"
[Py+A]°
[Py+G-H]"
[Py+G]°

641.3
c

656.8
c

[M-A-4H] 4 "
[M-G-4H] 4 "

875.2

[w6-H]2"
[w5-H]2"

937.0
773.1

[^-B6-3Hl2[a7-B7-3H]2"

814.5
971.3

[M+Py-4H] 4 "

1036.4

[M-A-3H] 3 "
[M-A-4H] 4 "

1168.4
877.4

[Py+A-H]"
[Py+A]°

640.8

[w6-Hf
[Wl]"

937.5
-

[a6-B6-3H]2"
[a ir B„-3H] 2 -

1066.8

[M-A-3H] 3 "
[M-A-4H] 4 "

1168.6
874.5

[Py+A-H]"
[Py+A]°

641.3

&

PyA

c

ON9
[M-A-4H] 4 -

ON10

ON11

[M+PV-4H] 4 "

877.4

1036.5

c

[M-A-4H] 4 "

874.5

[w7-H]2"

1081.1

[a5-B5-3H]2"

[M+Py-5H] 5 "

952.6

[M-G-4H] 4 "

1027.1

[Py+A-H]"

657.5

[M-G-4H] 4 "

1027.1

[w7-H]2"

1082.4

[a7-B7-3H]2"

970.2

a.

-

O N 7 = 5'-d(CGTTTATAAACG)-3'

O N 8 = 5'-d(CGCAAAGCTTTG)-3'

O N 9 => 5'-d(GCGTTTCGAAAC)-3'

O N 10 = 5'-d(CGAAAGCTTTCG)-3'

O N 11 = 5'-d(CGCAAAGCTTTGGC)-3'
b. Observed m/z
c. This species is neutral and therefore not detected
d. These oligonucleotides were not reacted with pyrindamycin B
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Figure 3.12: ESI-MS/MS spectrum of the [M+Py-4H]4~ ion of the major adduct formed
between pyrindamycin A and 5'-d(CGGAAATTTCCG)-3' (ON2)
[M-A-nH] n640.6 [Py+A-Hr-T-?i6869%
C
5'
HO

G

G

-®A-®-^

A

A

T

T

T

C

C
<I

[M+Py-nH]'
1036.8(4-)

G
3'

sNNAH^r^r^N- NKoH
[(a6-B6)-nH] n - - [w6-nH](n+1)833.6(2-)
917.4(2-)

Scheme 3.3: Fragmentation of the [M+Py-4H]4" ion of 5'-d(CGGAAATTTCCG)-3' (ON2)
and PyA.

The M S / M S spectrum of the precursor ion, [M+Py-4H]4", formed in the reaction between
pyrindamycin A and 5'-d(CGGAAATTTCCG)-3' is shown in figure 3.12. The major

pathway is depurination which gives rise to the [M-A-4H]4" and [M-3H]3" ions at m
and 1168.9 and the [Py+A-H]" ion at m/z 640.6. The [M-A-4H]4" ion then decomposes
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yield the sequence ions [W6-H] 2 " and [a6-B6-3H]2" ions, which are observed at m/z 917.4 and
833.6 respectively. These data enables the identification of the site of alkylation to be
A6 as the subsequent labilisation of the 3'-glycosidic bond results in the formation of the
above-mentioned sequence ions. It is notable that the spectrum of the [M-A-4H]4" species at
m/z 876.6 showed the same sequence ions as that of the intact percursor [M+Py-4H]4". This
provides support for the notion that loss of the [Py+A] either as a neutral or anion are
intermediates in the fragmentation pathway(s) leading to the formation of the sequence
ions.

For the oligonucleotides, 5'-d(CGCAAATTTGCG)-3' (ONI) and 5'd(CGGAAATTTCCG)-3' (ON2), alkylation occurred at A6, the preferred binding site
within the 5'-(AAA)-3' sequence, based on earlier sequencing studies. (Boger et al, 1990)
With ON2, however, the intact adduct is the major ion in the ESI mass spectrum (table 3.4)
indicating that the resulting adducts are more stable when there is a guanine in the fourth
position preceding the binding site, rather than a cytosine.
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Figure 3.13: ESI-MS/MS spectrum of the [M+Py-4H]4" ion of the major adduct formed
between pyrindamycin A and 5'-d(CGAAAATTTTCG)-3' (ON3)

641.0 [Py+A-H]
PyA

PyA

I

[M-A-nH] "875.6(4-)
1167.3(3-)
T T T T C G
3'

A

[(a5-B5)-nH] WX
669.2 (2-)

[M+Py-nH] n1036.1 (4-)

[w 6 -nH] (n+1) "
925.4 (2-)
[w7-nH] (n+1)721.4(3-)
1081.5(2-)

Scheme 3.4: Fragmentation of the [M+Py-4H]4" ion of 5'-d(CGAAAATTTTCG)-3' (ON3)
and PyA

In some cases, more than one binding site was evident from the M S / M S spectra. For

example, figures 3.13 and 3.14 shows the ESI-MS/MS spectra of the [M+Py-4H]4" ion o
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the

major

adduct

formed

when

pyrindamycin

A

was

reacted

with 5'-

d(CGAAAATTTTCG)-3' (ON3) and 5'-d(GCAAAATTTTGC)-3' (ON4) respectively. In

these examples, there were three fragmentation pathways evident, namely decomposition t
yield the [M-A-3H] " ion (m/z -1168) and [Py+A]" (m/z -641) ion and loss of neutral

(Py+A) to yield the [M-A-4H]4" ion (m/z -875), which are not sequence specific. The latte
9 9

ion decomposes to either the complementary [W6-H] " (m/z 926) and [a6-B6-3H] " ions or
the [w7-H]2" (m/z 1081) and [a5-Bs-3H]2" ions. These sequence ions show that the ligand
binding to both A6 and A5 respectively and therefore that the mass-selected precursor

arise from two different positional isomers. The intensities of the w-ions resulting fr
two binding sites were comparable, however, it would be unwarranted to attach too much

significance to this in terms of the relative abundances of each adduct in the reaction

mixture (more below). Binding to both these sites was also observed for the reactions o

pyrindamycin B with the same oligonucleotide (i.e. ON3) and for pyrindamycin A with 5'd(GCAAAATTTTGC)-3' (ON4).
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Figure 3.14: ESI-MS/MS spectrum of the [M+Py-4H] 4 " ion of the major adduct formed
between pyrindamycin A and 5'-d(GCAAAATTTTGC)-3' (ON4)
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Scheme 3.5: Fragmentation of the [M+Py-4H] 4 " ion of 5 ' - d ( G C A A A A T T T T G C ) - 3 ' (ON4)
and PyA

The oligonucleotides 5'-d(CGAAAATTTTCG)-3' (ON3) and 5'-d(GCAAAATTTTGC)-3'

(ON4) each incorporate a run of 4 adenines i.e. 5'-AAAA and in each case it was found th
two major adducts were formed on reaction with pyrindamycin A (with similar results for
ON3 and pyrindamycin B). The resulting adducts have the same mass and were not

separated by HPLC. The evidence for the presence of two adducts is based on the presence
of two pairs of sequence ions in the MS/MS spectra [M+Py-4H]4" ions of each

oligonucleotide (table 3). The sequence ions [w7-H]" and [a5-B5-3H]2" indicate that binding

occurred at A5 and the [w6-H]" and [a6-B6-3H]2" ions show that binding to A6 also occurs.

In the case of the M S / M S spectra of ions from adducts formed with O N 3 , the sequence ions
from the A6 adduct were of much lower abundance. There are two possible explanations

for this. First, that the A5 adduct is the major species produced from the reaction, thu

resulting in more abundant sequence ions. Alternatively, the higher abundance of cleavage
products from this adduct may indicate it has lower stability relative to the A6 adduct
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the former adduct fragments more readily). Given that other work (Boger et al, 1990)
suggests that when adenine is the base in the fourth 5'-position the non-covalent

interactions are stronger than when guanine is in that position, the latter explanati
likely.
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Figure 3.15: ESI-MS/MS spectrum of the [M+Py-4H]4" ion of the major adduct formed
between pyrindamycin A and 5'-d(CGTAAATTTACG)-3' (ON5)

[WI-A-nH] "875.6 (4-)
1168.1 (3-)
[M+Py-nH] n_
1036.5(4-)

[(a10-B10-nH] Wh
956.6 (3-)

[w 2 -nH] (n+1) 634.4(1-)

Scheme 3.6: Fragmentation of the [M+Py-4H] 4 " ion of 5'-d(CGTAAATTTACG)-3' (ON5)

and PyA
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A s shown in figure 3.15, w h e n the [M+Py-4H] 4 " ion (m/z 1036.5) was selected as the
precursor ion, the resulting MS/MS spectrum is relatively simple, indicating only two
reaction pathways. In the one pathway, the depurinated [M-A-3H]3" ion is evident at m/z
1168.1 together with the complementary [Py+A-H]" ion at m/z 640.8. In the second
pathway, the precursor ion fragments to yield the [M-A-4H]4" species at m/z 875.6 and a
neutral [Py+A] adduct. The depurinated ion then further fragments to give the singly
charged W2-ion ([(d(CG)+H20)-H]") at m/z 634A and the complementary 5'-sequence (aioBi0)-ion ([M-A-(d(CG)+H20)-3H]3") at m/z 956.6. These ions enabled A10 to be identified
as the site of binding, rather than the expected binding site of A6 (more below).

The oligonucleotide, 5'-d(CGTAAATTTACG)-3' (ON5), was reacted with pyrindamycin A

to examine the effect that thymine in the fourth 5'-position from the alkylation site wou
have on the sequence selectivity of the ligand. Thus, binding was expected to occur to the
high affinity site, 5'-(AAA)-3' at A6. The MS/MS spectra of this adduct showed the
depurinated species and the w2 (m/z 634.4) and (aio-Bio)-sequence ions (m/z 956.6). This
was unexpected and indicated that the site of alkylation was A10, a lower affinity 5'(TTA)-3' site. On the basis of other sequencing studies, (Boger et al, 1990) the
pyrindamycins are only expected to bind this site in the absence of a 5'-(AAA)-3' binding
site.

To explore the influence of the location of the binding site within the sequence,
pyrindamycin A was also reacted with the oligonucleotide, 5'-d(CGTTTATAAACG)-3'
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(0N7). This sequence was designed to incorporate the same two binding sites in reversed
positions within the oligonucleotide.
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Figure 3.16: ESI-MS/MS spectrum of the [M+Py-4H]4" ion of the major adduct formed
between pyrindamycin A and 5'-d(CGTTTATAAACG)-3' (ON7)
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Scheme 3.7: Fragmentation of the [M+Py-4H]4" ion of 5'-d(CGTTTATAAACG)-3' (ON7)
and PyA

Figure 3.16 shows the ES-MS/MS spectrum of the [M+Py-4H] " ion formed upon reaction
of pyrindamycin A and 5'-d(CGTTTATAAACG)-3' (ON7). The [M+Py-4H]4" ion yielded
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the depurinated form of O N 7 as is evidenced by the peaks at m/z 875.2 and 1167.5. The
sequence ions [w2]" and [ai0-Bi0-4H]3" at m/z 635.0 and 956.4 were also present.

The alkylation site was again determined to be A10, owing to the presence of the w2 and

(aio-Bio)-sequence ions form the depurinated oligonucleotide (table 3.5). Hence, in this cas
binding occurs to the higher affinity 5'-(AAA)-3' at A10 rather than to the 5'-(TTA)-3' at
A6. This shows that the position of the alkylation site within these short oligonucleotides

may influence relative sequence selectivities. This is presumably because sites closer to th

terminii are more accessible owing to the "fraying" of the ends of the duplex. Alternatively
these data may reflect sequence-dependent conformational changes on the minor groove.
These data suggest that the sequence selectivity observed for short oligonucleotides, such
as those used in this study, may differ from that observed in longer segments of DNA and
may indicate the need for longer sequences of DNA in any subsequent studies arising from
this work.
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Figure 3.17: ESI-MS/MS spectrum of the [M+Py-4H]4' ion of the major adduct formed
between pyrindamycin A and 5'-d(CTAAAATTTTAG)-3' (ON6)
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Scheme 3.8: Fragmentation of the [M+Py-4H]4" ion of 5'-d(CTAAAATTTTAG)-3' (ON6)
and PyA

Figure

3.17 shows

the M S / M S

spectrum

of the [M+Py-4H]4"

ion of 5'-

d(CTAAAATTTTAG)-3' (ON6) and PyA. The MS/MS spectrum shows two clear

fragmentation pathways. The first of which involves depurination yielding the [M-
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ion at m/z 876.2. The second (and presumably subsequent) pathway then gives rise to the
[w-}]" and [an-Bn-4H]3" sequence ions at m/z 346.4 and 1053.2 respectively. Thus the
reaction of pyrindamycin A with the oligonucleotide, 5'-d(CTAAAATTTTAG)-3' (ON6)

resulted in alkylation occurring at A11, and hence binding occurred to the 5'-(TTA)-3'
rather than to the higher affinity 5'-(AAA)-3' site (Boger et al, 1990) at A5 and A6.
was similar to the binding observed to the oligonucleotide, 5'-d(CGTAAATTTACG)-3'

(ON5), where alkylation also occurred at A10 and again reinforces the suggestion that t

influence of the position of the binding site within these short oligonucleotides is o
importance.
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Figure 3.18: ESI-MS/MS spectrum of the [M+Py-4H] 4 " ion of the major adduct formed
between pyrindamycin A and 5'-d(CGCAAAGCTTTG)-3' (ON8)
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Scheme 3.9: Fragmentation of the [M+Py-4H] 4 " ion of 5'-d(CGCAAAGCTTTG)-3' (ON8)
and PyA

Figure 3.18 shows the MS/MS spectrum of the [M+Py-4H]4" ion of 5'd(CGCAAAGCTTTG)-3' (ON8) and PyA. This experiment was designed to explore the
binding of pyrindamycin A to single-stranded DNA as the sequence described here is nonself-complementary. The spectrum shows ions formed via four simple reaction pathways.
In the one pathway, the depurinated [M-A-3H]3" ion is evident at m/z 1168.8 together with
the complementary [Py+A-H]' ion at m/z 641.3. In the second pathway, the precursor ion
fragments to yield the [M-A-4H]4" species at m/z 875.2 and a neutral [Py+A] adduct. The

expected pathways for fragmentation for binding at A6 would yield the w6 and (a<5-B6)-i
which were observed at m/z 931.0 and 814.5. However, the intact adduct ion, [M+Py-4H]4"
ion also fragmented to yield the depurinated [M-G-3H]3" ion at m/z 1162.3 along with the
complementary [Py+G-H]" ion at m/z 656.8. The [M-G-4H]4" species was observed at m/z

871.6 and further fragmented to give the ws-ion at m/z 111. 1 and corresponding (a7-B7)
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at m/z 971.3. In this case, the ions corresponding to alkylation at the guanine at position G 7
in the oligonucleotide were of greater intensity than those owing to the A6 adduct.

This was the first observation of guanine alkylation for any of the sequences studied and
presumably because this particular oligonucleotide can not adopt a double-stranded
conformation in solution as the sequence was non-self-complementary. The alkylation of
guanine can be explained in terms of the nucleophilicity of the nucleobases, which follows

the order: G > A > C > T, U (i.e. ligands show a greater affinity for guanine as it is more
nucleophilic than the other bases). (Barton & Lippard, 1980) Nucleophilic sites within
DNA at physiological pH follow the order: guanine-N7, adenine-N7, adenine-Nl, cytosineN3. (Martin & Mariam, 1979; Marzilli, 1977) The N3 of the purines is sterically hindered
by the sugar moiety but may become available upon changes in the glycosidic torsion
angles. (Kazakov, 1996)

ON8 was designed to be non-self-complementary, the binding that occurred to the adenine
at A6 was unexpected. It was postulated that this binding resulted from the formation of a
double-stranded conformation by the overlap of two strands of the oligonucleotide as
follows:
5'-CGCAAAGCTTTG-3'
3'-GTTTCGAAACGC-3'

To test this hypothesis we designed a new oligonucleotide, which would not be able to
adopt the same overlapping conformation. To achieve this guanine and a cytosine were
added to the 3'-end of a new oligonucleotide, i.e. 5'-CGCAAAGCTTTGGC-3'. The
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additional bases would not be able to form base-pairs at the termini causing fraying and
destabilisation of the double-stranded conformation as is shown below.
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Figure 3.19: ESI-MS/MS spectrum of the [M+Py-4H]4" ion of the major adduct formed
between pyrindamycin A and 5'-d(CGCAAAGCTTTG)-375'-d(GCGTTTCGAAAC)-3'
(ON8/ON9)
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Scheme 3.10: Fragmentation of the [M+Py-4H] 4 " ion of 5'-d(CGCAAAGCTTTG)-375'
d(GCGTTTCGAAAC)-3' (ON8/ON9) and PyA

Figure 3.19 shows the ESI tandem mass spectrum of the [M+Py-4H] 4 " ion of either 5'd(CGCAAAGCTTTG)-3' (ON8) and PyA or 5'-d(GCGTTTCGAAAC)-3' (ON9) and PyA.
It is impossible to distinguish between the two as the oligonucleotide-pyrindamycin
have the same nominal mass. In the MS/MS spectrum, however, there were three

fragmentation pathways evident, namely decomposition to yield the [M-A-3H]3" ion at m/

1168.4 and [Py+A]" ion at m/z 640.8 (which is not sequence specific) and loss of neut
(Py+A) to yield [M-A-4H]4" at m/z S71.4. The latter ion decomposes to either the
complementary [w6-H]2" (m/z 937.5) and [a6-B6-3H]2" (not observed) ions of ON8 or the
[wi]" (not observed) and [an-Bn-4H]3" (m/z 1066.8) ions of ON9. These show that the

ligand is binding to both A6 of ON8 and Al 1 of ON9 respectively. No evidence of gua
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alkyation was observed. This confirms that the ligands alkylate adenine rather than guanine
when a double-stranded conformation is present in solution.
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Figure 3.20: ESI-MS/MS spectrum of the [M+Py-4H]4" ion of the major adduct formed
between pyrindamycin A and 5'-d(CGAAAGCTTTCG)-3' (ON10)
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(ONlO)andPyA
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O N 1 0 ( 5 ' - C G A A A G C T T T C G - 3 ' ) was designed to incorporate an identical binding site to
ON8, i.e. 5'-AAAG-3'. Binding to ON8 occurred at both the underlined adenine and
guanine bases. It was thought that binding to guanine only occurred as a result of the

absence of the double-stranded complex required for the minor groove interaction. As such
the self-complementary oligonucleotide, ON 10, was used to examine whether guanine
alkylation would be observed in the presence of double-stranded conformation of the
oligonucleotide. The ESI mass spectrum (not shown) of the reaction mixture yielded a
number of ions similar to that shown for ON8 (figure 3.15). The subsequent MS/MS
spectrum of the [M+Py-4H]4" species at m/z 1036.5, as shown in figure 3.20 was relatively
simple. As was the case for the other oligonucleotides studied, depurination occurred,
yielding only the pyrindamycin-adenine adduct and both the [M-A-3H]3" and [M-A-4H] '
ions at m/z 1168.6 and m/z 874.5 respectively. Only the [w7-H]2" ion at m/z 1081.1 and of

low intensity (and not the corresponding [a5-B5-3H]2" ion) was observed suggesting that the
adduct was more stable than previous adducts observed with different sequences. There
was no evidence of guanine alkylation for this self-complementary oligonucleotide.
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5

'-d(CGCAAAGCTTTGGC)-3''(0N11)

An additional non-self-complementary oligonucleotide, 5'-CGCAAAGCTTTGGC-3'

(ON11), was also reacted with pyrindamycin A in order to clearly establish that guanin
alkylation occurred to single-stranded DNA and hence that the double-stranded

conformation was a prerequisite for adenine alkylation by these ligands. Figure 3.21 s
the ESI-MS/MS spectrum of the [M+Py-5H]5" ion at m/z 952.6. The first fragmentation

pathway yielded the [M-G-4H]4" ion at m/z 1027.1 and the corresponding [Py+G-H]" ion a

m/z 657.5. The latter ion was observed to undergo neutral guanine loss to give the [Py-

ion at m/z 506.4. The depurinated [M-G-4H]4" species fragmented by a second pathway to
produce the [w7-H]2" and [a7-B7-3H]2" sequence ions at m/z 1082.4 and m/z 970.2
respectively. These ions show that alkylation by pyrindamycin A occurred at the G7 as

postulated. No evidence of adenine alkylation was observed for this single-stranded no
self-complementary oligonucleotide.
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Figure 3.21: ESI-MS/MS spectrum of the [M+Py-4H] 4 " ion of the major adduct formed
between pyrindamycin A and 5'-d(CGCAAAGCTTTG)-3' (ON8)
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3.7 Conclusions
The ESI mass spectra of each of the reaction mixtures clearly establish that the
pyrindamycins bind to each of the oligonucleotides examined. The ESI mass spectra also
provide some indication of the stability of the adduct(s) formed, and therefore indirectly a
measure of the strength of the non-covalent interactions occurring between the ligand and
the oligonucleotide. The adducts formed between pyrindamycin A and O N 1 - O N 4 and O N 7
involved alkylation at a 5'-AAA site within the oligonucleotides, whilst O N 5 and O N 6
involved alkylation at a 5'-TTA site. O N 5 and O N 6 were less stable than O N 1 - O N 4 as the
relative intensity of sequence ions produced were greater for both sequences. These data
can be explained in terms of the greater affinity of the ligand for the 5'-AAA site over the
5'-TTA site. O N 7 , however, showed a similar trend to O N 5 and O N 6 . Hence, the lower
stability is postulated to be a consequence of the position of the alkylation site (terminal
versus internal) within these short oligonucleotides. The results obtained for adducts of
each of the pyrindamycins A or B were comparable, thus providing further support for the
proposal that these ligands interact with D N A via a mechanism involving conversion to a
c o m m o n intermediate as shown in scheme 1.2.

As a consequence of the gentle nature of the ESI ionisation process, sequence ions were
only observed in ESI mass spectra of some reaction mixtures. This necessitated the use of
ESI-MS/MS to identify the site(s) of alkylation of the ligands on the full range of sequences
examined.

MS/MS spectra were obtained for [M+Py-4H]4" and [M-A-4H]4" ions of all the adducts
formed. Each spectrum showed relatively few product ions indicating that only two or three
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fragmentation pathways dominated decomposition of the adduct. This contrasts with the
MS/MS spectra of free oligonucleotides (Iannitti, 1999) in which cleavages across the

entire oligonucleotide backbone are generally observed. In the case of ligands that alkylate
guanine (Iannitti et al, 1997; Iannitti-Tito et al, 2000) it was proposed that the dominance
of one or two major fragmentation pathways is a consequence of alkylation labilising the
glycosidic bond in the alkylated purine residue. The present study has shown that alkylation
of adenines has the same influence on the fragmentation in MS/MS spectra. In all cases, the
same dominant pathway is evident in the MS/MS spectra of the alkylated oligonucleotides,
namely depurination followed by cleavage of the 3'-CO bond in the alkylated residue to
yield complementary 3' and 5' sequence ions. The MS/MS spectra were also much simpler
than the corresponding ESI mass spectra since the charge of the precursor is defined. In
contrast, in the ESI mass spectra, a number of ions with different charge were observed for

each the species present in the reaction mixtures. Ions resulting from cleavage to the 3'-si
of the alkylation site (w-ions) were found to be generally more intense than the
corresponding cleavage to the 5'-side (a-Bn ions). The same trend is observed in the
MS/MS spectra of free oligonucleotides for which w-ions are generally more abundant.
(Iannitti, 1999)

The work described further demonstrates the potential of electrospray tandem mass
spectrometry for the characterisation of chemically modified oligonucleotides. This work
has extended earlier studies to demonstrate that alkylation of adenine occurs to double
stranded oligonucleotide sequences at the high affinity sites, however, binding was

observed to lower affinity terminal sites, suggesting that longer oligonucleotides need to b
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examined in order to mimic conditions in intact D N A . E S I - M S and E S I - M S / M S provides

considerable detail about the binding and selectivity of these ligand-DNA interactions. The
binding of the ligands occurred for all oligonucleotides and subsequent studies by tandem
mass spectrometry allowed the elucidation of the binding site. Adenine (presumably N3) is
the primary target for the alkylation event, however, guanine alkylation by the
pyrindamycins was observed when the single-stranded, non-self-complementary
oligonucleotide used. Hence, the requirement that DNA is in a duplex form for adenine
alkylation to occur has been further confirmed. It should be noted that no attempt was made
to determine the absolute sensitivity of these techniques, which could have been improved
by the use of nanoelectrospray or capillary LC-MS on the Q-TOF, an approach that should
be pursued in any subsequent studies resulting from this work.

136

Bibliography

Barry, J.P.; Vouros, P.; van Schepdael, A. and Law, S-J. (1995) J. Mass Spec. 30, 993-1006

Barton, J.K. and Lippard, S.J. (1980) in Metal Ions in Biology (Spiro, T.G. Ed.) Vol.
Wiley, New York, pp 31

Boger, D.L.; Ishizaki, T.; Zarrinmayeh, H; Munk, S.A.; Kitos, PA. and Suntornwat, O.
(1990) J. Am. Chem. Soc. 112, 8961-8971

Boschenok, J. and Sheil, M.M. (1996) Rapid Commun. Mass Spectrom. 10, 144-149

Caruthers, M.H.; Barone, A.D.; Beaucage, S.L.; Dodds, D.R.; Fisher, E.F.; McBride, L.J
Matteuchi, M.; Stabinsky, Z. and Tang, J.Y. (1987) Methods Enzymol. 154,287-313

Iannitti, P. (1999) Electrospray tandem mass spectrometry of oligonucleotides and li
oligonucleotide adducts. PhD thesis, University of Wollongong, Wollongong

Iannitti-Tito, P.; Weimann, A.; Wickham, G. and Sheil, M.M. (2000) The Analyst 125, 6
634

Kazakov, S.A. (1996) in Bioorganic Chemistry: Nucleic Acids (Hecht, S.M. Ed.) Oxford
University Press, New York

137

Martin, R.B. and Mariam, Y.H. (1979) Metal Ions in Biological Systems Marcel Dekker,
New York

Marzilli, L.G. (1977) Prog, Inorg. Chem. 23, 255-378

McLuckey, S.A. and Habibi-Goudarzi, S. (1993) J. Am. Chem. Soc. 115, 12085-12095

Metzler, D.E. (1977) Biochemistry: The Chemical Reactions of Living Cells Academic
Press, New York

Sambrook, J.; Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory
Manual (2n Edition) Cold Spring Harbor Laboratory Press, New York

Sinha, N.D.; Biernat, J.; McManus, J. and Koster, H. (1984) Nucleic Acids Research
4539-4557

138

C H A P T E R F O U R : The Novel DNA Structures and

NMR

4.0 Introduction
D N A exhibits a wide range of structural topologies (duplex, triplex, quadruplex, bulged
structures and hairpin loops), which have been associated with specific biological
function(s) and are formed in a highly sequence-dependent manner. These structures may
be recognised or stabilised by small molecule ligands, which in turn has significant bearing
on the efficacy of these compounds as drug molecules. For example, some intercalators
have been shown to bind more tightly to bulged structures than normal B - D N A with the
possibility of perturbing the recognition of D N A defects by repair enzymes, or inducing a
stabilising frame shift. Similarly, D N A lesions and strand breaks are also susceptible to the
influence of ligand binding. Many D N A intercalators inhibit the activity of topoisomerase I
and II, though it is not known whether binding to the D N A cleavage site is involved
directly in inhibiting the strand religation step in the replication cycle. The next two
chapters detail structural studies of ligand binding to a range of unusual D N A structures
that have been engineered to include the unusual features of hairpin loops, strand breaks in
the form of a nicked backbone and single base bulges to examine the effect that ligand
binding may have on similar features in in vitro D N A .

4.1 The Nicked Site Analogues: Hairpins and Loops
In the current study, the formation of a double hairpin structure from the oligonucleotide,
5 ' - d ( G C G A A G C A C G A A G T ) - 3 ' has been examined. A s in the case of hairpin structures
described previously, (Hirao et al. 1992) there is a single-stranded loop region closed by a
base paired stem. However, these oligonucleotides were designed to incorporate two of
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each, such that they would form a double hairpin and as such were named 'loop sequences'.
The loop region consisted of a 5'-GAA, which has been previously found to be of greatest
stability. (Hirao et al, 1992) The stem region contained predominantly G-C base pairs,
although an A-T base pair was also included as there have been no reports to date on
hairpins containing A-T base pairs in the stem region. It was envisaged that the sequence
5'-d(GCGAAGCACGAAGT)-3' would fold to give two hairpins that would be mutually

stabilised by co-axial stacking, but with a single break at the centre of the double stran
stem region. Thus, the double hairpin mimics a DNA damage site (single strand break),
providing a model system for drug recognition, with potential implications for the DNA
repair process.

The binding of a well-known and characterised intercalating agent, nogalamycin (figure
1.7) to this oligonucleotide, was explored for a number of reasons. First* the question of

whether nogalamycin further stabilises the hairpin structures was addressed as nogalamycin
and closely-related compounds have been shown to stabilise duplex DNA. (Searle et al,
1988; Searle & Wakelin, 1990) Secondly, it was hoped to further probe the molecular basis

for binding this intercalator to the double loop structure. It is well established that the
binding kinetics of nogalamycin are very slow, (Fox & Waring, 1984) which is thought to
be a consequence of the requirement for the DNA duplex to be disrupted to enable the

bulky sugar substituents to thread through the structure. By providing a broken or 'nicked'

backbone, it was hypothesised that intercalation of the agent would be facilitated, thereb
enabling an investigation of the importance of the phosphate backbone in nogalamycin
binding to DNA.
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4.2 Sample Preparation
The nogalamycin were generously donated by Upjohn Corporation and was used without
further purification. A stock solution of 5 mM nogalamycin was prepared in D20. The
concentration was achieved by acidifying the suspension using 0.1 M DC1 until the ligand
dissolved. The pH was then adjusted to ca. 7 using 0.1 M NaOD.

The oligonucleotides used in this study were purified by reverse-phase HPLC using a
similar method to that described in chapter 3. The column used was an YMC packed CI8
semi-preparative column. A Hewlett Packard (Agilent) Series 1100 HPLC equipped with
HP Chemstation™ software and a variable wavelength detector set to 260 nm was utilised.
After the initial stage of HPLC, the fractions were pooled and excess acetonitrile was

removed with the aid of a rotary evaporator. The volume of solvent was then reduced to ca.
10-15 mL by freeze-drying. An equal volume of 50% acetic acid was added to remove the
DMT-protecting group. Ether extraction (3 x 200 mL diethyl ether) was then undertaken to
separate the oligonucleotide from the protecting group and acid. Any remaining ether was
removed with the aid of the rotary evaporator. The oligonucleotide solution was then
dialysed using Cellusep™ dialysis tubing with a molecular weight cut-off of 1000 Da. Five

solutions were used during the dialysis. Solutions 1, 2, 4 and 5 were distilled water, whi
solution 3 was composed of a high salt buffer (100 mM NaCl / 10 mM NaH2P04). Each
solution was allowed to equilibrate for eight hours at 4 °C with constant stirring. The
resulting solution after dialysis was then freeze-dried.
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Oligonucleotide samples were dissolved in 99.9% D 2 0 that contained 10 m M N a H 2 P 0 4 ,

100 mM NaCl and trimethylsilylpropionate (TSP) was added to give a final concentration
of-1 mM. The samples were ultrasonicated and freeze-dried, redissolved in 99.9% D20 to

a final volume of 700 pL and then placed in an NMR tube under a stream of dry nitrogen
gas.

4.3 Titration of Nogalamycin with 5'-d(GCGAAGCACGAAGT)-3'
A 1:1 complex between nogalamycin and 5'-d(GCGAAGCACGAAGT)-3' was formed by

titrating 40 pL aliquots of a 5 mM solution of nogalamycin into a solution of ca. 5 mM
d(GCGAAGCACGAAGT)-3'. NMR spectra up to and including the 1:1 complex were

acquired immediately after the addition of each aliquot of the nogalamycin solution. T

pH of the samples was adjusted to pH -7 after completion of the titration. The samples
were then lyophilised several times from solutions of D20. The sodium salt of
trimethylsilylpropionate was used as an internal reference compound. Sodium azide was

added to act as an anti-bacterial agent, whilst EDTA was utilised to complex any heavy
metal ions present.

4.4 Data Acquisition

4.4.1 ID 'H-NMR Experiments

The progress of the titrations was monitored by ID 'H-NMR experiments at 298 K (25 °C)
on a Bruker DRX500 NMR spectrometer. A spectral width of 9.997 ppm (4988.5 Hz) over

32k (32768) data points was employed. The transmitter frequency was placed at the cent
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of the spectrum at the position of the D 2 0 solvent resonance. The solvent resonance was

suppressed using low power irradiation (60 Db) during the relaxation delay of 1.5 s. T

titration was undertaken via the addition of the ligand (nogalamycin) to the oligonucl

in D20. The ligand was added in small aliquots until a 1:1 complex was formed. Formation
of the complex was judged by the changes to the ID H-NMR spectrum, in particular by

the appearance and disappearance of the cytosine H5 resonances. The complex was allowe
to equilibrate for 24 hours. A series of lD-'H-NMR spectra were also acquired on the
resulting complex between 276 K (3 °C) and 328 K (55 °C) on the same instrument.

4.4.2 2D NMR Experiments
Two-dimensional spectra of 5'-d(GCGAAGCACGAAGT)-3' and its resulting complex
with nogalamycin were recorded at 500 MHz. These were acquired at 288 K (15 °C), with
a spectral width of 9.977 ppm in both dimensions. Nuclear Overhauser Spectroscopy
(NOESY) spectra were acquired over 1024 complex data points in the t2 dimension and >
400 tl increments. Generally, 64 scans were summed to give the final spectra. The D20
resonance was suppressed using low power irradiation during the mixing time and the

relaxation delay of ca. 1.5 s. NOESY spectra were acquired at mixing times of 75, 100,
and 300 ms. Double Quantum Filtered Correlation Spectroscopy (DQF-COSY) and Total
Correlation Spectroscopy (TOCSY) experiments were acquired with 1024 data points with
up to 64 scans per increment. A spin lock of 84 ms was employed for the TOCSY
experiment.
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All spectra were processed on a Silicon Graphics Indy workstation using X W I N N M R ™
software. -

4.5 Nomenclature
The nucleotide residues within this oligonucleotide were numbered as follows:
5'-d(GiC2G3A4A5G6C7A8C9GIoA1iA12G13Ti4)-3' and 5'-d(A8C9G1oA11A12Gi3T14)-3'. The
hairpin was numbered starting from nucleotide 8 for ease of comparison with the loop
sequence.

(a)

(b)

.A—G—T G -

:A
A
S3—C—A
C—G—A'
•c -A C
(C)

A

•G •T G

A
—C-A-C—G-A'
• ••

••

• • •

• • •

• •

_

Figure 4.1: Structure of the hairpins and loop sequence studied: (a) 5'-d(ACGAAGT)-3';
(b) 5'-d(GCGAAGC)-3' (Hirao et al., 1994) and (c) 5 ' - d ( G C G A A G C A C G A A G T ) - 3 '
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4.6 Evidence for the Formation of these Unique Structures
The formation of the 5'-GAA loop involves a non-Watson-Crick anti-anti base pair
between G3 and A5 as is shown in figure 4.2. G-A mismatches have been investigated
extensively because this is a common structural element in RNA folding. (Gao & Patel,
1988) Structural studies demonstrated that the sheared G(anti)-A(anti) conformation was
adopted at neutral pH. (Kan et al, 1983; Patel et al, 1984; Prive et al, 1987)

HN-

^2 NH2

A
Figure 4.2: Anti-anti base pairing between G10 and Ai2 in the sequence d(Gi0AnAi2).
Hydrogen bonds are formed between the N3 and C2-amino of guanine and the N7 and C6amino of adenine respectively. In Watson-Crick base pairs, the 06, Nl and C2-amino of
guanine and the Nl and C6-amino of adenine are involved in hydrogen bonding
interactions.

Three base pairs are involved in formation of the hairpins, although it appears that the

base pair is critical for the unusual stabilisation that is observed. The central A appea

be less critical and has been replaced with other bases in previous studies (Yoshizawa et
1997) and relatively little effect on the stability was noted as a result.
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In general, the chemical shifts of oligonucleotide protons fall within particular ranges
depending on the type of proton. The HI' protons of the sugar occur between 5.0 and 6.5
ppm, whilst the H2' and H2" protons generally occur at around 2 ppm. The chemical shifts
of the H8 and H6 protons of the bases occur between 7.0 and 8.5 ppm. Additional peaks are
observed in the HI' region corresponding to the cytosine H5 protons. These are J coupled
to the cytosine H6 protons and are good markers that can be used in the identification of
CH6 protons. The method for sequential assignment of the DNA backbone is illustrated in
figure 4.3. This method allows the unambiguous assignment by stepping from base H8 or
H6 proton to the HI' of its internucleotide sugar to the next base proton and so on. The
same can be done for the H2' and H2" of the sugar. Figure 4.3 shows the sequential
connectivity between the H8/H6-H1'.
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NH2
N
A

Figure 4.3: Sequential assignment of the D N A backbone. N O E crosspeaks are observed
between intranucleotide sugar H I ' protons and aromatic base H8/H6 protons and between
adjacent internucleotide sugar H I ' protons and aromatic base H8/H6 protons as shown.

Figure 4.4(a) shows the sequential assignment of d^gCgGioAnAnGuTn) between the
H8/H6 of the bases and the H 2 7 H 2 " of the sugars. Connectivities were observed along the
AsCpGioAn and A] 2 GnTi4 moieties of the oligonucleotide, but no N O E s were observed
between the A n and Aj 2 . This connectivity can also be followed through the H8/H6 of the
bases to the H I ' of the sugars as is shown in figure 4.4(b).
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Figure 4.4(a): 300 ms NOESY spectrum showing H8/H6-H27H2" connectivities for 5'd(ACGAAGT)-3' (3 mM) in D20 containing 0.1 M NaCl/100 mM NaH2P04 (pH 7.0). The

solid lines represent the sequential connectivity observed for the A8-C9-Gio-Aii stran

through the A]2-Gi3-Ti4 strand. There is a loss in connectivity owing to the unusual 5
loop.
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Figure 4.4(b): 300 m s N O E S Y spectrum showing H 8 / H 6 - H 1 ' connectivities for 5'd(ACGAAGT)-3' (3 mM) in D20 containing 0.1 M NaCl/100 mM NaH2P04 (pH 7.0). The
solid lines represent the sequential connectivity observed for the DNA backbone. There is a
break in connectivity owing to the unusual 5'-GAA loop and is represented by the dashed
lines.
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Owing to the relative simplicity of the N O E S Y spectra of the hairpin compared to the

double hairpin or loop structure, the assignment of the hairpin facilitated the subsequen
assignment of the loop sequence and is shown in figure 4.5. Figure 4.5(a) shows the
connectivity observed along the G6-C7-A8-C9-G10 and A12-Gi3-Ti4-Gi-C2-G3 strands. In
NOESY data recorded at 15 °C, there were NOEs observed across the break in the DNA

backbone, i.e. between G13 and Tj4. This acts as evidence toward the formation of the loop
sequence in which the two hairpins are involved in co-axial stacking. There were no NOEs
observed along the backbone for the loop regions, owing to the unusual conformations
adopted by the nucleotides in this region.
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Figure 4.5(a): Section of the 300 ms NOESY spectrum showing H8/H6-H27H2"
connectivity for 5'-d(GCGAAGCACGAAGT)-3' (3 mM) in D20 containing 0.1 M
NaCl/100 mMNaH2P04 (pH 7.0). The intranucleotide H8/H6-H27H2" NOEs are labelled.
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Figure 4.5(b): Section of the 300 ms NOESY spectrum showing the H8/H6-H1'
connectivity for 5'-d(GCGAAGCACGAAGT)-3' (3 mM) in D20 containing 0.1 M
NaCl/100 mM NaH2P04 (pH 7.0).

Figure 4.5(b) shows the H8/H6-H1' region of the NOESY spectrum for 5'd(GCGAAGCACGAAGT)-3'. The solid lines show the connectivity along the G,-C2-G3
strand and Ai2-Gi3-T14 strand. It is interesting to note that NOEs are observed across
break in the DNA backbone, i.e. between G]H8 and Ti4Hl\ as is indicated by the
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continuation of the dashed lines between these resonances. The continuation of the solid
lines show the connectivity along the G6-C7-A8-C9-G10 strand. There is a break in
connectivity along the DNA backbone at each loop region. The observation of NOEs across
the break site provides unambiguous evidence for a significant population of co-axially
stacked hairpins.

The oligonucleotides used in this study, however, did not adopt typical double stranded
conformations and as such many resonances occurred at significantly different chemical
shifts to those observed for double stranded DNA. The initial NMR studies of the heptamer
sequence 5'-d(GCGAAGC)-3' by Hirao et al. provided some insights into features
characteristic of hairpin formation. For example, the H4' of A4 in the loop undergoes a
large up-field shift as a consequence of stacking interactions in the loop region. (Hirao
al, 1994) The chemical shift of the H4' was used as one of a number of indicators that the
hairpins are folded. The H4\ H5' and H5" resonances of the adenines thought to be in the
loop were observed up-field shifted by > 2 ppm compared to the other H4' signals from
nucleotides in the stem regions. The H2' and H2" sugar protons of A4 and An are observed
to be down-field shifted by 0.13 and 0.06 ppm respectively. These shifts are analogous to

those identified in the isolated hairpins (Hirao et al, 1994; Yoshizawa et al, 1997) and ca
be explained by the close proximity of the H4' of A5 and An to the non-Watson-Crick base
pairs of G3-A5 and Gi0-A,2 respectively. Further, the cytosine H2' and H2" resonances of
C2 and C9 were observed up-field of the thymine methyl resonances at 1.56 and 1.57 ppm

respectively. These data suggest that the loops are well formed. The similarity of the shi
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for the two 5'-GAA loop components of 5 ' - d ( G C G A A G C A C G A A G T ) - 3 ' suggest that they
are populated to similar extents.

Figure 4.6 shows the change in chemical shift occurring as a result of end-stacking, i.
difference in chemical shift between the protons of the hairpin and those of the loop
sequence. Detailed analysis of the NMR data for the isolated hairpin 5'-d(ACGAAGT)-3'
and the same sequence within the loop sequence revealed differences in chemical shifts

up to 0.2 ppm for nucleotides involved in end-stacking. Similar results (chemical shift

changes up to 0.2 ppm) were obtained when the chemical shift values reported for the 5'
d(GCGAAGC)-3' hairpin studied by Hirao et al. were compared to the values obtained for
the same sequence within 5'-d(GCGAAGCACGAAGT)-3'.

E 0.10
a.
a.
*»^*
©

en 0.00

s

-y^P^S^

(O
JC

VA

O -0.10

/

j^"5^

10

11

ssgi^g:
12

9

.E

</>

-0.20

O

E -0.30

13 \ ^ 4

H1'
H2'
H2"
H3'
H4'
H5'
H8/H6

0>

o
n

AI\

Base Number
Figure 4.6: Change in chemical shift observed in the lD-'H-NMR spectra as a
consequence of end-stacking. Comparison of the isolated hairpin 5'-d(ACGAAGT)-3' and
the same sequence within the double hairpin.
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Further evidence for the sheared G3(anti)-As(anti) conformation is provided by the fact that
the G3HT-G3H8 and AsHl'-AsHS crosspeaks are both weak in comparison to the NOEs

observed between the H5 and H6 of cytosine, consistent with anti-glycosidic torsion angles
for G3 and A5 in the mismatch site.
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Figure 4.7: Expanded stacked plots of the 300 m s N O E S Y spectra of 5'-d(ACGAAGT)-3'.

This region establishes distance connectivities between the base protons (6.5-8.5 ppm) and
the sugar HI' and cytosine H5 protons (4.5-6.5 ppm). The cytosine H5-H6 crosspeak and
the base to its own sugar HI' crosspeaks are labelled in the figure.

Figure 4.8 illustrates part of the deoxyribose spin systems for the H4' and H27H2" sugar
protons of the adenines involved in the loop region (A4 and An). The solid lines show the
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pattern of N O E s observed for A 4 , while the dashed lines represent the A n sugar protons.
The ID NMR spectrum has also been shown on the x- and y-axes.
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Figure 4.8: H4' to H27H2" section of the 300 ms NOESY spectrum for the loop sequence
5'-d(GCGAAGCACGAAGT)-3' (3 mM) in D20 containing 0.1 M NaCl/100 mMNaH2P04

(pH 7.0). The connectivity between the H4' and H27H2" sugar protons are shown for the
adenines involved in the 5'-GAA loop (A4 and An).

Figure 4.9 shows the !H-NMR spectra in the H17H5 region of 5'-d(ACGAAGT)-3' at a
range of different temperatures. Upon examination of the HI' sugar protons in the ID

NMR spectrum, some resonances were observed to exhibit selective broadening effects.
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For example, the H I ' sugar protons of A 8 , C 9 , G ) 3 and T u gave sharp peaks, whilst those of
Gio, An-and A52, i.e. those involved in the loop, gave broad signals in the spectrum

recorded at 25 °C. This was postulated to be due to dynamic processes occurring in the loop

region. The An base stacks on the guanine (Gio) as the oligonucleotide folds back on itself
however, the adenine appears to be in equilibrium between two conformations. This

postulate was confirmed by the sharpening of these peaks at higher temperatures (figure 4.9

b-e). These results are consistent with those obtained by Hirao et al. who proposed that th
adenine involved in the loop did not adopt any single conformation and "wobbles" around
anti and high-anti conformations. (Hirao et al, 1994)
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Figure 4.9: 'H NMR spectra in the HI 7H5 region of 5'-d(ACGAAGT)-3' (3 mM) at

(a), 25 °C (b), 35 °C (c), 45 °C (d) and 55 °C (e) in D20 containing 0.1 M NaCl
NaH2P04 (pH 7.0)
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4.7Melting Temperature Studies
The melting transition of both the free oligonucleotides (5'-d(ACGAAGT)-3' and 5'd(GCGAAGCACGAAGT)-3') and the complex with nogalamycin were determined using a
Pharmacia Biotech Ultrospec 2000 UV-Vis melting temperature apparatus. The
concentration of the solutions were -7 pM (0.5 pM per base) and the buffer used was 300
mM NaCl / 30 mM NaH2P04. The absorbance at 260 nm was recorded as the annealed

structure was heated from 25 °C to 100 °C at a rate of 1.0 °C / minute. The resulting chan
in absorbance with temperature is shown in figure 4.10. The hairpin was observed to
undergo a broad melting transition with a Tm of 48.5 °C. UV melting studies on the intact

double hairpin exhibited a broad, but intense absorbance change with a melting temperatur
calculated to be 65.3 °C. The hairpin containing the A-T base pair, 5'-d(ACGAAGT)-3\
was expected to have a lower Tm than the lm reported for 5'-d(GCGAAGC)-3' by Hirao et
al. (Hirao et al, 1994) owing to the weaker H-bonding interaction between A-T base pairs
compared to G-C base pairs. The observed melting temperature of 65.3 °C was lower than
had been previously reported for the hairpin, 5'-d(GCGAAGC)-3' (i.e. 16 °C). (Yoshizawa
et al, 1997) The absence of the low temperature transition seen for the isolated hairpin

provides further evidence for stabilisation through co-axial stacking between hairpins. I

postulated that the overlap of the melting transitions of the two hairpins is responsible
the unusual breadth of the melting transition for the loop sequence. Thus, the hairpins
appear to behave independently with flexibility at the site of the nick.

The stem region of the 5'-ACGAAGT-3' hairpin is not stable on its own as evidenced by

the low, broad melting transition and the rapid attenuation of the imino protons in the ID
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spectra (more below in chapter 5). However, the co-axial stacking of the two hairpins
dramatically stabilises the structure despite the break in the DNA backbone.
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Figure 4.10: U V melting curves of (a) hairpin 5'-d(ACGAAGT)-3' (3.5 p M ) and (b) loop
sequence 5'-d(GCGAAGCACGAAGT)-3' (7 pM) in 300 mM NaCl/30 mM NaH2P04 (pH
7.0).
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4.8 Imino Protons as Evidence for the Formation of the Stem

Figure 4.11 shows the imino region of the ID spectra for the hairpin (a) and loop sequence
(b). There is one strong peak and a very broad, low intensity peak at 5 °C for 5'd(ACGAAGT)-3' corresponding to the G]3 and T]4 imino protons respectively. As the A8-

TM base pair is terminal, it has less protection, hence the broad nature of the peak in th
spectrum. The observation of these highly exchange broadened imino proton resonances for
the Watson-Crick hydrogen bonded base pairs suggest that the stem region of 5'd(ACGAAGT)-3' is not particularly stable with the GeNH only visible at low temperature.
When the data for the isolated hairpin were compared with that for the double hairpin

sequence, it was evident that for the latter, there were four sharp peaks resolved at 25 °
corresponding to the four Watson-Crick base pairs of 5'-d(GCGAAGCACGAAGT)-3'.
The assignment of the imino protons was carried out by examining the sequential NOEs
(more below). The thymine imino (T14NH) at the break site showed some evidence of
exchange broadening. Figure 4.22 shows a study on the temperature dependence of the line
widths, which illustrates that the 5'-d(ACGAAGT)-3' hairpin melts first with the overall
process being biphasic, showing that the substitution of an A-T base pair in the stem

significantly destabilises the structure. The co-axial stacking of the two hairpins at th
nicked site may account for the increased stability of the terminal base pairs (Ag-Ti4 and
G1-C7) and hence the 5'-d(ACGAAGT)-3' sequence.
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Figure 4.11: I D N M R spectra at 5 °C of hairpin (a) and loop sequence (b) showing the
imino protons. The identities of the imino protons were confirmed by 2D-WatergateNOESY experiments as detailed in section 4.15.

Further evidence for the formation of the stem region comes from the observation of the
protected imino protons when the ID ^-NMR is acquired in water (10% D20). These

peaks are only observed if the imino protons are involved in hydrogen bonding interactions
and hence are protected from rapid exchange with the water.

The absence of the G3 and Gio imino protons involved in the G - A base pairs in the loops

indicate that the base paired conformation does not protect the guanine imino protons from
exchange. The exchange-broadened peak observed at 10.8 ppm is thought to correspond to

the amino protons of the adenines involved in the loops and is consistent with the propose
structure of the G-A base pair.

162

4.9 Chemical Shift Change with Temperature

The melting of a nucleic acid double helix into a single stranded molecule is a well-known
phenomenon and the melting behaviour can also be followed by a temperature-dependent
study of NMR spectra. The temperature could only be increased to a maximum of
approximately 70 °C owing to NMR technical limitations and as such the full melting curve
could not be obtained. However, these experiments showed agreement with the results of

the UV spectroscopy experiments (figure 4.10), i.e. the oligonucleotides began to melt at ~
35 °C.

-14TMe
-9CH6
2CH6
-14TH6
-7CH6
-8AH8 |

-0.2

Temperature (°C)
Figure 4.12: Chemical shift change of a number of DNA resonances with increased
temperature. The data presented here has been normalised to the data collected for 25 °C.

Figure 4.12 shows the change in chemical shift of a number of selected D N A resonances
observed in the NMR spectra with increasing temperature. The chemical shifts of the
aromatic base protons are affected significantly as the oligonucleotide undergoes the
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transition from a double stranded to a single stranded conformation. The methyl resonances
of thymine in s s D N A are shifted down-field by 0.24 p p m relative to those found in d s D N A .

4.10 Sugar Conformation
The deoxyribose sugar units serve as a semi-flexible linkage between the nucleobases and
the phosphate backbone. The conformation of the sugar is described in terms of
pseudorotation and glycosidic torsion angles. T w o stable ring conformations have been

identified: the North (N) conformation, with a pseudorational phase angle (P) of 0°, and t
South (S) conformation at 180°. The deoxyribose adopts a Cy-endo arrangement for the Nconformation and a CT-endo

arrangement for the S-conformation. In practice, nucleic

acids contain deoxyribose sugar in N - or S-type conformations, i.e. a narrow range of
pseudorotational phase angles are allowed (3-34° and 139-175° respectively).
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Figure 4.13: Stable conformations of deoxyribose: (a) North and (b) South

The experimentally determined coupling constants (table 4.1), JHi\ m- and JHi\ HT, or
alternatively, the combined value, L H 1 \ show that the sugar residues, A 8 , C 9 , A n and G 1 3
within the hairpin, 5'-d(ACGAAGT)-3\ take the CT-endo

sugar pucker conformation

(table 4.1). (Altona & Sundaralingam, 1972) This indicates that even these unusual D N A
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structures exist in the B-form. It was difficult to determine all coupling constants
experimentally, however, owing to overlap of the resonance signals in the ID N M R
spectra. The results obtained here agree with those in an earlier study by Hirao and coworkers. (Hirao et al. 1994) The sugar geometries for all nucleotides were also determined
following the method of Hosur et al (Hosur et al. 1986) utilizing D Q F - C O S Y data. The
intensities of the peaks in the C O S Y spectra are approximately proportional to the values of
the coupling constants (J) between the two nuclei. The three bond (vicinal) coupling
constants between sugar protons HI', H2', H2", H3' and H4' depend, in a predictable
manner, on the sugar geometry. Thus, from the analysis of the relative intensities of the
cross peaks, it was possible to determine the sugar pucker conformation. The conformation
was found to be C2'-endo for all nucleotides with the exception of the terminal Tj4, which
was observed to take the CT-endo conformation, typical of terminal sugar residues.

Table 4.1: Determination of sugar pucker conformation based on coupling constants
Hl'toH27H2".

Puckerb

a

__

__

_

-g4~£~

9C
11A
13G

15.37
15.10
14.46

S
S
S

91.9
88.9
81.8

Sum of all J couplings contributing to the HI' SHI' = J HI ;H2I + JHI \H2"- If SHI' > 1^.

Hz, there is a predominance of South (pS > 60%) or if SHI '< 12.5 Hz, there is a
predominance ofNorth (pS < 40%). (Altona & Sundaralingam, 1973)
b

The predominant sugar conformation based on the values obtainedfor EH1'.

'Percentage ofS confomer (Altona & Sundaralingam, 1973)
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Figure 4.14(b): D Q F - C O S Y spectrum of 5'-d(ACGAAGT)-3' (3 m M ) in D 2 0 containing
0.1 M NaCl/100 mM NaH2P04 (pH 7.0) showing coupling of sugar protons for C2.

A n example of the method for determining sugar conformation from the D Q F - C O S Y data
(Hosur et al, 1986) is shown in figure 4.14. The theoretical patterns for the CT-endo
V-endo conformations are illustrated in figure 4.14(a), whilst the DQF-COSY spectrum
acquired for 5'-d(ACGAAGT)-3' is shown in figure 4.14(b). The pattern observed for the
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C 2 sugar resonances have been highlighted as an example of this method. The figure clearly
shows that the C2 sugar protons give the same pattern as the C2'-endo conformation and is

further evidence that the stem sections of the loop sequence are B-form like. This method

was also applied to the determination of the sugar conformation for the loop sequence. Th

sugar protons involved in Watson-Crick base pairs in the stem'region gave similar pattern

(not shown) to those shown in figure 4.14(b), which is further evidence that the stem reg
is B-form like. The bases involved in the loop could not be analysed by these methods
owing to the unusual chemical shift values of the H4' and H27H2" and increased peak
widths.

4.11 Titration of5'-d(GCGAAGCACGAAGT)-3'with Nogalamycin
The titration experiment resulted in the formation of a 1:1 complex between nogalamycin
and 5'-d(GCGAAGCACGAAGT)-3'. The following section discusses the changes in the
oligonucleotide spectra upon addition of the ligand. Subsequent to the titration, 2D NMR
experiments allow the identification of ligand-DNA contacts and any changes in DNA
conformation upon ligand incorporation.

Figure 4.15 shows the ID NMR spectra resulting from the addition of aliquots of
nogalamycin up to and including the formation of a 1:1 complex between 5'd(GCGAAGCACGAAGT)-3' and nogalamycin. The addition of nogalamycin to 5'd(GCGAAGCACGAAGT)-3' causes significant changes to the 'H-NMR spectrum.
Immediately upon addition of the ligand, a number of the free DNA resonances diminish in
intensity and new peaks appear in the !H-NMR spectrum. This is most easily observed in
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the aromatic region (figure 4.15). The free and bound signals are in slow exchange at 25 °C
with the'change in complexity of the NMR spectrum indicative of the formation of a single
bound species.

Figure 4.15(a): I D stacked plot spectra (6.6-8.6 p p m ) acquired after the addition of
aliquots of a 5 mM solution of nogalamycin: (i) 0:1 (ii) 0.25:1 (iii) 0.5:1 (iv) 0.75:1
Arrows highlight a number of clearly defined signals, owing to free DNA signals that
decrease, as well as increasing signal intensity owing to complex formation.
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Figure 4.15(b): I D stacked plot spectra (1.0-4.0 p p m ) acquired after the addition of

aliquots of a 5 mM solution of nogalamycin: (i) 0:1 (ii) 0.25:1 (iii) 0.5:1 (iv) 0.75:1 (v
Arrows highlight a number of clearly defined signals, owing to free DNA signals that
decrease, as well as increasing signal intensity owing to complex formation.
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Figure 4.15(a) shows the aromatic region of the ID spectra acquired after titration of the
antibiotic-nogalamycin into the loop sequence, 5'-d(GCGAAGCACGAAGT)-3'. The peak
at -8.5 ppm corresponds to the aromatic H8 proton of An. The chemical shift change is
typical of the H8 of the adenine at the 5'-CpA intercalation site seen in previous studies.
(Williams & Searle, 1999) Another peak highlighted at -6.75 ppm corresponds to the Hll

proton of the nogalamycin. In addition to the emergence of new peaks as the drug is titrated
into the solution, a number of peaks corresponding to proton resonances from the single
stranded oligonucleotide are attenuated. For example, the peak at -7.3 ppm represents the
H6 proton of Tu in the free oligonucleotide. The peak appearing at -7.15 ppm represents
the same proton from the complex. It was observed that the intensity of the latter peak

increased as the intensity of the former diminished and that the free and bound forms are i
slow exchange with each other.

Figure 4.15(b) shows the stacked plot of the aliphatic region of the ID spectra
incorporating the methyl and methoxy resonances. In the methyl region, the single methyl
resonance from T)4CH3 at -1.15 ppm decreases in intensity upon binding of the ligand. In
addition a number of new peaks appear between 1.3 and 1.6 ppm corresponding to the
appearance of the nogalamycin methyl peaks. The ligand methyl peaks do not correspond
with the chemical shifts of the free nogalamycin methyl resonances and thus must arise as a
result of the bound ligand. The nogalamycin methoxy resonances also appear between 3.2
and 3.9 ppm. The appearance of the 3'-methoxy of the nogalose sugar of nogalamycin at
-3.3 ppm has been highlighted in the ID spectra.
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Figure 4.16: Section of the 300 ms NOESY spectrum of the 5'd(GCGAAGCACGAAGT)-3'-Ng complex (3 mM) in D20 containing 0.1 M NaCl/100
mM NaH2P04 (pH 7.0) showing the sequential H8/H6-H27H2" connectivity along the
DNA backbone.
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Figure 4.16 shows the H 8 / H 6 - H 2 7 H 2 " sequential connectivity observed (solid lines) for
the 5'-d(GCGAAGCACGAAGT)-3'-Ng complex. The dashed lines indicate the loss of
sequential connectivity as the backbone is contorted in the loop regions. The squares show
where the NOEs would have been observed if the sequence had adopted a 'normal' double
stranded conformation. The dotted lines show the interaction of the T7 nucleobase with the
HI 1 proton of nogalamycin. The spectrum here differs from that of the free oligonucleotide
in that there are a number of resonances, which have been up-field or down-field shifted as
a result of ligand binding. In addition, internucleotide NOEs across the intercalation site
between Gi and Tj4 as observed for the free oligonucleotide are no longer evident. The
drug, however, acts as a surrogate base pair with the aromatic HI 1 proton giving NOEs to
both GiHl' and T]4H1', consistent with intercalation between the hairpins.

4.12 Chemical Shift Perturbations upon Ligand Binding
The examination of chemical shift perturbations to the DNA resonances can provide an
indication of the binding site of a ligand. Generally, the largest perturbations were noted
the Ti4, Gi, A8 and C7, i.e. at the intercalation site.

Table 4.2 shows the changes in chemical shift for the aromatic base protons (H8/H6) and
sugar HI' resonances upon binding of the ligand. A negative value is indicative of a down-

field shift, whilst a positive value indicates an up-field shift. The table is arranged in t
loop-type conformation thought to be adopted by the oligonucleotide to allow direct

173

comparison of chemical shift differences and location within the sequence and hence
structure.

The A8H8 and C7H6 resonances were observed to be down-field of the shifts noted for the
free loop sequence, whilst the THH6 was shifted up-field and the G1H8 showed no change

(table 4.2). This is consistent with drug aglycone stacking preferentially with the T)4 an
bases. (Searle & Wakelin, 1990) Deoxyribose sugar protons show similar trends with the
HI' protons best resolved. The largest change was observed for the minor groove-oriented

protons localised to the base pairs either side of the intercalation site. The C7H1' and A
protons were all shifted down-field, whilst the GiHl' and T14HI' were up-field shifted.
These data are consistent with drug aglycone stacking preferentially with the TM and Gi
bases. (Searle & Wakelin, 1990)

Table 4.2: Change in chemical shift upon nogalamycin binding: (a) H8/H6 and (b) HI'.
(a) H8/H6

12A

13G

14T

1G

2C

3G

11A

-0.056

-0.076

-0.195

-0.010

-0.176

-0.061

4A
0.016

10G

9C

8A

7C

6G

5A

0.000

0.000

0.355

0.108

-0.004

0.000

12A

13G

14T

1G

2C

3G

11A

-0.049

-0.071

-0.051

-0.395

-0.069

-0.082

4A

0.028

10G

9C

8A

7C

6G

5A

0.048

0.025

0.129

0.269

0.147

0.891

0.000

0.013

(b) nr
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Figure 4.17: Structure of nogalamycin showing the numbering scheme of nogalamycin

The assignment of the 'H-NMR spectrum of nogalamycin was undertaken using a
combination of NOESY, TOCSY and DQF-COSY prior to the complex in order to gain an
understanding of the drug-drug NOEs that were observed in the NMR spectra. In this way,
the resulting NMR spectra of the complex were simplified by elimination of the DNADNA and drug-drug NOEs, leaving only the drug-DNA NOEs. Table 4.3 shows the NOEs
that were observed in the NOESY spectra and have been separated into the three distinct

regions of the ligand: the nogalose sugar, the aglycone chromophore and the bicyclic sug

Generally, drug-drug NOEs were observed between the protons of the nogalose sugar (tabl
4.3a), between the protons of the aminoglucose sugar (table 4.3c) and between protons
present on the aglycone chromophore (table 4.3b), although some drug-drug NOEs were
noted between these three distinct regions of the ligand. When referring to protons on
ligand, the nomenclature as shown in figure 4.17 was used. Where two protons or groups,
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i.e. methyl or methoxy groups, were present, the proton or group extending up from the

plane of the chromophore was given the identity (1) and those pointing down were assigne

as (2). For example, on the 3' carbon of the nogalose sugar, two groups are present (met
and methoxy groups). The methyl protons are referred to as NgH3'(l) while the methoxy
protons are referred to as NgH3'(2) owing to their spatial orientation.

Table 4.3(a): Drug-drug N O E s observed in N M R spectra: nogalose sugar protons
NgH1'

NgHT
NgH2'(1)
NgH2'(2)
NgH3'(1)
NgH3'(2)
NgH4'(1)
NgH4'(2)
NgH5'(1)
NgH5'(2)
NgH7
NgH8(1)
NgH8(2)
NgH9

NgH2'(1) NgH2'(2) NgH3'(1) NgH3'(2) NgH4'(1) NgH4'(2) NgH5'(1) NgH5'(2)
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Table 4.3(b): Drug-drug N O E s observed in N M R spectra: protons on the chromophore
NgH7

NgH8(1) NgH8(2)

NgH9

NgH10

*
•

*
*
*

NgH11

NgH3 invwi'iv
NgH7
NgH8(1)
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NgH9
NgH10
NgH11
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Table 4.3(c): Drug-drug N O E s observed in N M R spectra: aminoglucose protons
NgH1"

NgH2"

NgH3"

NgH4"

*

.
.

NgHl" B B H B L _
NgH2"
•

NgH3"
NgH4"
NgH5"
NgN3"(1)
NgN3"(2)
Other

NgH5" NgN3"(1) NgN3"(2)
.
.
.

•
*

*

*
•

•
-

*
*

.

*

*

-

.

^ » ^ ^ ^

*
*
*

^

*

*
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The assignment of the drug and D N A resonances provides the starting point for identifying
intermolecular NOEs that define the position and orientation of the bound antibiotic.
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Figure 4.18: Section of the 300 ms NOESY spectrum of 5'-d(GCGAAGCACGAAGT)-3'
(3 mM) in D20 containing 0.1 M NaCl/100 mM NaH2P04 (pH 7.0) highlighting drug-DNA
NOEs that clearly show the intercalation site.
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Figure 4.18 shows a portion of the N O E S Y spectrum highlighting the N O E s that are

important in defining the position and orientation of the ligand within the intercalation s

The solid lines represent the connectivity through G13-T14 and Gi-C2, whilst the dotted lin
show the connectivity through the ligand, i.e. Tu-Ng-Gi. The solid lines show the

connectivity through the stem region on the other strand, i.e. G6-C7-A8. The data in figure
4.18 shows the sequential connectivity along the DNA backbone is lost. There are several
reasons for this. First, the unusual geometry of the loops causes a loss of sequential
connectivity in these regions. The intercalation of nogalamycin between the TpG(CpA)
bases in the stem region also results in no NOE crosspeaks being observed between T14 and
Gi as were observed in the free oligonucleotide. NOE crosspeaks were observed, however,
between T14HI' and the Hll of nogalamycin and between Ng-Hll and GiHl' as shown in
figure 4.18.

The antibiotic aglycone Hll provides an unambiguous indicator of the position and
orientation of the drug. NOEs are identified to the deoxyribose protons Ti4Hl' (Ti^l'NgHll) and GiHl' (NgHll-GiHl') and can only be satisfied by intercalation of the drug
at the 5'-TpG step such that the nogalose sugar points toward the centre of the duplex. A
large number of other intermolecular NOEs support this conclusion. For example, the
methoxy and methyl groups on the nogalose and ring A sugar provide evidence for
hydrophobic interactions in the minor groove and enable the precise determination of the

position and orientation of the nogalose with respect to the intercalation site. For exampl
NOEs from drug methyl protons on the nogalose sugar show specific hydrophobic
interactions with GiHl' and C2H1' on the floor of the minor groove. NOEs are detected
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from the nogalose H I ' and H 2 ' protons to the sugar and aromatic protons of C 7 and A 8 , i.e.
NgHl'-A8Hl'/H4'/H5', NgH2'-A8Hl'/H47H8 and NgH2'-C7Hr/H6. In contrast, the
number of contacts in the major groove is rather limited. NOEs from the aminoglucose
protons to the Tu protons predominantly, i.e. NgHl"-Ti4H6/Me and NgH2"-TMMe. These
characteristic NOEs are analogous to those observed for nogalamycin binding to the 5'TpG step in duplex DNA. (Williams & Searle, 1999)
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Figure 4.19: Schematic of the intercalation of nogalamycin between the 5'-TpG step.

Figure 4.19 shows the N O E s observed between the thymine and guanine bases involved in

the intercalation site and the nogalamycin chromophore. A loss of sequential connectivit

along the DNA backbone is observed, although connectivity can be followed via the HI 1 of
nogalamycin (as indicated by the blue arrows).
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4.13 Other Drug-DNA

NOEs

Approximately 39 NOEs between the nogalamycin and the loop sequence were observed at
300 ms mixing time. This number decreased to 16 as the mixing time was reduced to 100
ms.

Figure

4.20:

Schematic

illustration

of the

intercalation

site within

the 5'-

d(GCGAAGCACGAAGT)-3'-nogalamycin complex

Figure 4.20 is a schematic illustration of the nogalamycin bound at the TpG step showing

the position of the nogalose and aminoglucose sugar groups in relation to the flanking b

pairs. The planar chromophore stacks between the base pairs and the two sugar substituen
wrap around the GC base pair.
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Table 4.4: D r u g - D N A N O E s observed in the 300 m s mixing time of the N O E S Y spectrum
of the 5~d(GCGAAGCACGAAGT)-3'-nogalamycin complex
NgH1"-14TH6
NgH1"-14TMe
NgH2"-14TMe
NgH5"-7CH1'
NgH3-14TMe
NgH7-8AH1'
NgH7-8AH8
NgH8(1)-8AH1'

NgH8(2)-8AH1' NgH11-1GH1'
NgH11-1G4'
NgH9-1GH1'
NgH9-1GH2"
NgH11-1GH5*
NgH11-1GH5"
NgH9-1GH4'
NgH11-13GH2'
NgH9-2CH1'
NgH9-2CH3' LNgH11-14TH1'
NgH10-1GH1
NgH11-14TH2'
NgH11-14TH3'
NgH10-7CH1'

NgH1'-8AH1'
NgH2'(2)-8AH8
NgH1'-8AH4'
NgH3'-1GH1'
NgH1'-8AH5'
NgH3'-2CH1'
NgH2'(1)-8AH1' NgH3'-2CH2"
NgH2'(2)-7CH1' NgH3'-2CH3'
NgH2'(2)-7CH6
NgH3'-2CH6
NgH2'(2)-8AH1' NgH3'-13GH1'
NgH2'(2)-8AH4' NgH5'-7CH1'

4.14 Melting Temperature Studies of the Complex
Figure 4.21 shows the UV melting curve obtained for the complex formed between
nogalamycin and 5'-d(GCGAAGCACGAAGT)-3'. The duplex to single strand transition
occurred very rapidly over a few degrees, whereas a much broader transition was noted for

the free oligonucleotide. The free oligonucleotide was found to melt in two stages, with th

3'-hairpin melting first followed by the 5'-hairpin melting shortly after. Upon drug bindi
the two hairpins were stabilised and melted simultaneously as is shown by the sharp
melting transition in figure 4.21.

The complex was apparently stabilised by the intercalation of nogalamycin with a Tm of
72.4 °C, relative to a Tm of 65.3 °C for the free oligonucleotide. The intercalation of
nogalamycin, between the G-C and A-T base pairs at the nicked site, acts to remove the
flexibility that was observed for the free oligonucleotide through strong base stacking
interactions.
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Figure 4.21: UV melting curve of a 1:1 mixture of nogalamycin (7 pM) and 5'd(GCGAAGCACGAAGT)-3' in 300 mM NaCl/30 mM NaH2P04 (pH 7.0).

4.15 Imino Protons in the Complex

To examine further the stability of these novel structures, the samples were di
water (10% D20) and the presence of the imino protons was detected through the

lD-watergate experiment. The imino protons are only observed if they are protec

exchange through H-bonding interactions. Hence, their presence in the ID spectr

further evidence for the formation of the hairpin or loop structure. The A8, Gn

all form Watson-Crick base-pairs and as such their imino protons should be pro
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Figure 4.22: Stacked ID plots of the 10-15 p p m range of the hairpin (a-b), loop sequence
(c-g) and complex (h-m). The initial ID spectra were recorded at 5 °C and the temperature

was increased in 10 °C increments until the melting transition occurred as evidenced by the
attenuation of the imino peaks.
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Figure 4.22 is a section of the lD-watergate experiment, which shows the presence of the
imino protons. The experiments were carried out at 5 °C (278 K) for the hairpin, loop
sequence and nogalamycin complex. The temperature was increased in 10 °C increments

until the peaks disappeared, i.e. until the structures melted. Figure 4.22 (a-b) shows tha
hairpin, 5'-d(ACGAAGT)-3', was stable at 5 °C, with two peaks corresponding to the Gi3
and T14 imino protons present. At 15 °C, only a low intensity, broad peak was observed
owing to the G13 imino proton. The thymine imino peak is noted to be of greater peak width
owing to the lesser extent of H-bonding between adenine and thymine (two hydrogen
bonds) relative to guanine and cytosine (three bonds) and as it was terminal and therefore
less protected from hydrogen-deuterium exchange. These data agree with the low value of
Tm (48.5 °C) observed for the hairpin as well as the broad melting transition.

The free loop sequence (figure 4.22 c-g), in comparison, was stable at 25 °C, although the
T14 imino proton resonance was beginning to broaden. This peak was not observed at 35 °C
and the G13 imino peak underwent significant broadening as the 3'-end of the loop sequence
melted. The 5'-hairpin underwent a melting transition between 35 and 45 °C. These data
further explain the broad melting transition observed from the UV melting studies. As the

3'-end of the loop was observed to be stable to ca. 25 °C, compared to 5 °C for the hairpin
the data suggest that base stacking interactions between the two hairpins are responsible

the additional stability. A broad peak is also observed at ca. 10.7 ppm and is thought to b
from the imino protons of the non-Watson-Crick base pairs (G-A wobble pairs) formed in
the loop region. The four Watson-Crick base pairs were assigned by utilising the NOE
connectivities from the 2D Watergate NOESY experiment (figure 4.23), in which the imino
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peaks showed N O E s to both the amino peaks and the aromatic base protons within the base
pair as well as NOEs between the protons of neighbouring base pairs. Imino-amino NOEs
were observed for GiNH-GiNH2 and GeNH-G6NH2. Amino-amino NOEs were observed
for Gi, G6 and A8, i.e. GjNHz-GiNHz, G6NH2-G6NH2 and A8NH2-A8NH2. Both of the
amino protons of guanine show NOE crosspeaks to the H5 protons of the cytosine involved
in the G-C base pair, which allow the unambiguous identification of the amino protons and
hence the imino protons. NOEs were observed between GiNH2-C7H5 and also between
GeNH2- C2H5 as shown in figure 4.23.

The ID spectra for the complex formed with nogalamycin are shown in figure 4.22 (h-m)
and are characterised by very intense peaks for all four imino protons involved in WatsonCrick base pairing interactions. Examination of the temperature dependence of imino
proton line widths showed that the base pairs forming the intercalation site are highly
stabilised at 15 °C, optimising van der Waals interactions between the ligand and the

oligonucleotide. These are observed in all spectra up to 45 °C, where they begin to broade

as the complex melts. In contrast to the free oligonucleotide, there appears to be a single
melting process with all NHs showing the same temperature dependent line broadening,
with a sudden co-operative dissociation of the complex at high temperature. Hence, both
hairpins unfold simultaneously, and as such it is seen that the binding of Ng further

stabilises the hairpin structures via base stacking interactions. The imino proton of Gi i
also noted to have shifted down-field by 0.8 ppm relative to the free oligonucleotide. The
phenolic protons of nogalamycin also appear in the spectra at approximately 10.6 and 11.8
ppm, corresponding to H4 and H6 respectively.
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Figure 4.23 shows a section of the w g - N O E S Y spectrum in which the amino protons have
been traced across from the amino-imino crosspeaks (not shown). There are two amino
protons per adenine or guanine and hence, strong NOEs are observed between the amino
protons of individual bases. The amino protons also show NOE crosspeaks to the H5
protons of the cytosine involved in the base pair. These connectivities are illustrated

figure 4.23. The blue lines show the connectivity observed for the C2-G6 base pair, while

the pink lines represent the G1-C7 base pair. The A8-Ti4 base pair was identified through
examination of the NOEs seen for the amino protons of A8 to the A8H2 protons. The C9-G13
base pair also showed NOE crosspeaks between the Gi3NH-A8NH2 (green lines).
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Figure 4.23: Section of the 300 ms w g - N O E S Y of 5'-d(GCGAAGCACGAAGT)-3' (3
mM) in H20 containing 0.1 M NaCl/100 mM NaH2P04 (pH 7.0) showing connectivity of
amino protons to amino protons and amino protons to base sugar protons.
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4.16 ESI-MS Analysis

Electrospray ionisation mass spectrometry (ESI-MS) has been applied to the study of a
number of non-covalent complexes of drug molecules with double-stranded DNA. (Beck et

al, 2001; Mazerska et al, 2001; Gale et al, 1995) In earlier studies using gentle ionisat
conditions for the detection of the non-covalent complexes, we examined the binding of
nogalamycin to a range of oligonucleotides forming duplex DNA. (Kapur et al, 1999)
Recently, the binding of the neocarzinostatin chromophore to unusual DNA structures
including bulged DNA and RNA/DNA hybrids has been explored by ESI-MS. (Gao et al,
1996; Zheng etal, 1998)

The free oligonucleotide and the complex formed between nogalamycin and the
oligonucleotide 5'-d(GCGAAGCACGAAGT)-3' were both analysed by ESI-MS. NMR
solutions initially contained salt concentrations of 100 mM NaCl/10 mM NaH2P04 in order
to stabilise these non-standard conformations. Previously, samples containing high salt
concentrations have not been amenable to analysis by ESI-MS since the presence of sodium
both reduces ionisation efficiency and limits mass accuracy owing to the presence of

multiple species with different numbers of sodium ions bound. (Greig & Griffey, 1995) The
recent use of newly introduced ESI mass spectrometers with the ion source in the Z-spray
configuration, designed to minimise contamination, (Morris et al, 1996) allowed the
analysis of protein-DNA complexes in solutions containing high salt concentrations.
(Kapur et al, 2001) Hence in this work the possibility of using solutions directly from
NMR without further purification or desalting was explored. The samples from NMR
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studies were diluted using 100 m M

ammonium acetate (pH 7.0) to give a final

concentration of the complex of 10 pmol/pL and 5 mM NaCl/0.5 mM NaH2P04. An

electrospray probe tip potential of -2 kV and a source temperature of 40 °C were us
Electrospray analysis was performed in negative ion mode using a Micromass Q-TOF 2.

Other conditions were similar to those described recently for protein-DNA complexes
(Kapur et al, 2001)
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5'-

The ESI mass spectrum of the unbound oligonucleotide ( 5 ' - d ( G C G A A C G A C G A A G T ) - 3 ' )
is shown in figure 4.24(a). The peaks at m/z 1079.4 and 1439.6 represent the [M-4H]4" and
[M-3H] ' ions of the free oligonucleotide. There were a large number of peaks owing to

multiple sodium adducts making interpretation of the spectrum difficult. In contrast, in t
ESI mass spectrum of the complex formed with nogalamycin (Ng-5'd(GCGAACGACGAAGT)-3') (figure 4.24b), peaks from sodium adducts were fewer in
number and of lower intensity. The peak at m/z 786.2 is owing to the free form of the
ligand [Ng-2H]\ The spectrum shows abundant ions from the drug-DNA complex at m/z
1276.6, [M+Ng-5H]4", and m/z 1702.9, [M+Ng-4H]3", confirming a binding stoichiometry
of 1:1. The fact that the sodium adducts are suppressed when the complex is formed is

particularly interesting. It is possible that the stabilisation of the complex by the dru

precludes the need for stabilising alkali metal counter ions along the polyanionic backbo
We are currently exploring this phenomenon with a wider range of DNA structures. The
observation of the complex by ESI-MS in itself was somewhat unexpected as intercalation

at the site of the single strand break was expected to introduce additional flexibility a
reduced binding affinity, however, the conditions were sufficiently gentle to allow the
detection of this relatively weak interaction. The presence of unbound oligonucleotide

suggests that, even under the gentle ionisation conditions employed here, some dissociatio
of the complex occurred during ionisation/detection.
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4.16 Conclusions
NMR and UV spectroscopy were utilised for the complete characterisation of the

interaction between nogalamycin and this unusual oligonucleotide, which contained a brea
in the DNA backbone. The hairpin 5'-d(ACGAAGT)-3' was first examined and the
resonances assigned by NMR spectroscopy. These assignments facilitated the complete
assignment of the double hairpin (loop sequence) 5'-d(GCGAAGCACGAAGT)-3'. The
NOESY, TOCSY and DQF-COSY spectra, as well as the ID-Watergate spectra, provided
evidence of the formation of the loop and stem regions. Anomalous chemical shift values

for the sugar H4', H5' and H5" protons were characteristic of the adenine involved in the
loop. The presence of imino protons in the ID NMR spectra measured in water provided

evidence for the formation of the double stranded stem as these were only observed if th
were protected from exchange through hydrogen bonding interactions between base pairs.

The reaction between nogalamycin and 5'-d(GCGAAGCACGAAGT)-3' was monitored by
ID NMR experiments. The appearance of new peaks in the spectra owing to the complexed
form and the attenuation of peaks owing to the free oligonucleotide were evidence of the
formation of a 1:1 complex. Nogalamycin was found to bind at the TpG step with a large
number of NOEs observed between the ligand and the Ti4 and Gi bases in particular. Upon
ligand binding, changes in chemical shift values for the DNA resonances were observed,

with the largest differences noted for the nucleotides in the intercalation site, i.e. T
and A8.
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The 3'-hairpin, 5'-d(ACGAAGT)-3', was observed to be far less stable than that of the
hairpin, studied previously, 5'-d(GCGAAGC)-3' with Tm values of 48.5 °C and 76 °C
respectively. (Yoshizawa et al, 1997) The loop sequence was found to have a Tw of 65.3
°C. It is proposed that the co-axial stacking of the hairpins at the nicked site provides
additional stability to the overall structure. The width of the melting curve, however,

suggested that there was an overlap of the two transitions of the individual hairpins. Thu
the hairpins appear to behave independently with flexibility at the site of the nick.
Nogalamycin had a stabilising effect on this unusual DNA structure with base stacking
interactions between the aglycone chromophore and the base pairs accounting for an
elevated melting temperature for the complex. Where previously the free loop sequence had
been observed to undergo two melting events, in which the individual hairpins melted

separately, the complex was observed to melt in one event with simultaneous attenuation of
all peaks in the ID spectra. The intercalation of nogalamycin lead to a significant
sharpening of the melting curve.

Electrospray ionisation mass spectrometric analysis was undertaken using very gentle
ionisation conditions and the intact Ng-5'-d(GCGAAGCACGAAGT)-3' complex was
detected. The applicability of mass spectrometry to the detection of non-covalent
complexes direct from NMR solutions was demonstrated.
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C H A P T E R F I V E : Bulge Sequences, a variation on the Hairpin

5.0 Introduction

Bulge structures in DNA have been shown to act as potential targets for therapeutic drugs
They are simple and common, non-helical, features of RNA and DNA and may vary from

single nucleotide bulges to multiple base bulges. In DNA, bulges play a role in frame sh
mutagenesis in sequences with repeating base pairs. (Okada et al, 1972) A more detailed

description of the structural aspects of bulged sequences may be found in section 1.4. T
have been relatively few detailed reports on the structural characterisation of the
interactions of bulged DNA with ligands.

The importance of bulge sites as recognition elements has been established by a number of
studies. The intercalator, ethidium was found to bind selectively to cytosine bulges in
preference to duplex DNA by an order of magnitude greater in strength. (Nelson & Tinoco,
1985; White & Draper, 1987) Another example of the heightened affinity of drugs for
bulge sites in DNA is 9-aminoacridine, which preferentially binds DNA molecules that
contain an extrahelical base. (Woodson & Crothers, 1988) The cleavage of duplex DNA by

the neocarzinostatin chromophore, at the 3'-side of cytosine and thymine bulges, has bee
investigated extensively. (Kappen & Goldberg, 1993a; Kappen & Goldberg, 1993b;
Stassinopolous & Goldberg, 1995; Kappen & Goldberg, 1997; Xi et al, 1999; Gu et al
2000) The neocarzinostatin chromophore has been demonstrated to have up to 20 times

higher selectivity for bulged adenine sites over control sites. (Gu et al, 2000) Saito an
workers recently showed that an altromycin analogue selectively alkylates guanines
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opposite a bulge. (Nakatani et al, 1999) The syntheses of drugs designed to bind
specifically to duplex D N A containing a single guanine bulge was carried out by Nakatani
et al. (Nakatani et al, 2000) These naphthyridine derivatives acted as recognition
molecules that differentiated between the types of bulged bases. Caceres-Cortes and W a n g
used nogalamycin as a probe for the binding of intercalators to bulged sites in D N A , but
their results appear to be strongly influenced by end-effects (see discussion below).

Unpaired bases arise either as a result of recombination between strands that are not
completely homologous, or from errors during replication. Duplex D N A with bulged bases
present have been proposed as intermediates inframe-shiftmutagenesis, (Streisinger et al,
1966) as well as having implications in site-specific protein recognition. ( W u & Uhlenbeck,
1987) The examination of the structure and stability of these bulged sequences m a y aid the
understanding of their biological roles. D N A repair mechanisms are governed by the
conformation and stability of the unpaired base at the helix interruption site in duplex
D N A . (Hare et al, 1986) Unpaired, or bulged sites, in D N A are repaired by specific repair
enzymes, which act to repair errors m a d e during D N A replication or as a result of some
types of chemical damage to D N A . These enzymes have also been implicated in base
excision repair in the repair of physical and/or chemical damage to D N A and as a part of a
cell-cycle check-point control system in which they recognise certain types of D N A
damage and trigger cell-cycle arrest. (Kolodner, 1995) Mismatch repair is crucial in
biochemical processing as shown by its role in the cancer repair systems, whereby defects
in components of mismatch repair have been implicated in hereditary and sporadic
tumours. (Kolodner, 1996) M u t S proteins carry out the recognition of mispaired or
unpaired bases during mismatch repair. (Malkov et al., 1997)
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5.1 The Bulge Sequences
Two hairpin oligonucleotides incorporating a bulged thymine (Tb) within the stem region
were designed to investigate further the binding of nogalamycin to DNA with distorted
backbones. Nogalamycin shows sequence selectivity to 5'-TpG (CpA) sites. The hairpin

oligonucleotides were designed to incorporate this high affinity site. The oligonucleotide
5'-d(GTGCGAAGCTbAC)-3' and 5'-d(GCTbACGAAGTGC)-3', were purified as
described previously (section 4.2) and analysed by NMR prior to titration with
nogalamycin and the subsequent assignment of the resulting complex.

The possible modes of folding for these sequences are shown in figure 5.1. Nogalamycin

(Ng) requires a TpG step as described earlier. It is thought that the G-C base pair is also
required for Ng recognition. To satisfy this requirement, upon Ng binding to the
oligonucleotide sequence, 5'-d(GCTACGAAGTGC)-3', the thymine at T3 must adopt a
bulged conformation as opposed to a frame-shift event to maintain a G-C base pair at the
intercalation site (figure 5.1b). The sequence 5'-d(GTGCGAAGCTAC)-3' may form a

thymine bulge at T!0. Alternatively, frame shift may occur resulting in the formation of T
and G-A "wobble pairs" (figure 5.1a). Hence the cross in figure 5.1 is indicative of an
unfavourable frame shift event for 5'-d(GCTACGAAGTGC)-3'. In this work, the question
of the relative stability of the bulged hairpin structures is addressed. Further, we have
examined the way in which the Ng sequence specificity influences the propensity for
bulged or frame shift events to occur upon binding of the ligand.
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Figure 5.1: Possible modes of folding for 5'-d(GTGCGAAGCTAC)-3'

and 5'-

d(GCTACGAAGTGC)-3' upon binding to nogalamycin.
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5.2 Evidence for Loop Formation

The investigations of these unusual structures were undertaken by first characterisin

free oligonucleotides followed by the examination of the complexes formed upon reacti
with nogalamycin. Figure 5.2 shows the H4'-H27H2" region of the 300 ms mixing time
NOESY spectrum of 5'-d(GCTACGAAGTGC)-3\ The NOEs between the H2'-H2", H4'H2' and H4'-H2" resonances are indicated. The loops were determined to be formed

through the observation of the up-field shifted H4' and H5'/H5" sugar resonances as sh
in figure 5.2. For the bulge sequence 5'-d(GTGCGAAGCTAC)-3\ the A6 H4' and H57H5"
protons (loop region) were observed at 2.094 and 2.299 ppm whilst the An H4' and
H5'/H5" protons (stem region) were observed at 4.163 and 4.073 ppm respectively. This

shows a difference in chemical shift between the stem adenine and loop adenine H4' and
H57H5" sugar protons of greater than 2 ppm. The H5' and H5" sugar proton resonances

were overlapped for both and hence an average value is given. The NMR spectrum of bulg
sequence 5'-d(GCTACGAAGTGC)-3' (data not shown) showed similar trends with the A7
sugar H4\ H5' and H5" protons observed at 2.116, 2.241 and 2.361 ppm respectively.
These were again greater than 2 ppm up-field of the stem region A4 sugar H4', H5' and
H5" protons at 4.414, 4.024 and 4.122 ppm each. The A7 sugar H2' and H2" protons were

also noted to be down-field shifted by 0.35 and 0.56 ppm respectively for the adenines
involved in the loop with the largest shift observed for A6 for 5'-d(GTGCGAAGCTAC)-3'
and A7 for 5'-d(GCTACGAAGTGC)-3'.
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Figure 5.2: Section of the 300 m s N O E S Y spectrum showing the H4'-H2'/H2" resonances
of A6 in the sequence 5'-d(GTGCGA6AGCTAC)-3' (3 mM) in D20 containing 0.1 M
NaCl/100 mM NaH2P04 (pH 7.0).

5.3 Evidence for Stem Formation
Figure 5.3 shows the ID NMR spectra recorded when each of the oligonucleotides were
dissolved in water (10% D20), together with the corresponding NMR spectra of the
mplexes with nogalamycin. Figure 5.3(a) shows two sharp peaks corresponding to the

CO
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imino protons of the G 3 and G 8 bases (13.128 and 13.060 p p m respectively) for 5'd(GTGCGAAGCTAC)-3'. One sharp and one broader signal were observed at 12.784 and
13.860 ppm corresponding to the imino protons of G9 and T10 for the sequence 5'd(GCTACGAAGTGC)-3' (figure 5.3c). The identities of these imino protons were
confirmed through the 2D-Watergate-NOESY experiment showing the connectivity

between the imino protons and the aromatic base protons. Figure 5.3(b) and (d) show t

ID spectra of the complexed form of these oligonucleotides with Ng and will be discus
in more depth later.

T.
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_j

14

13

12

11

ppm

14

J
13

12

11

ppm

Figure 5.3: ID spectra showing the imino protons of the bulge sequences: (a) 5'd(GTGCGAAGCTAC)-3' and (c) 5'-d(GCTACGAAGTGC)-3' and the complexes with
nogalamycin: (b) 5:-d(GTGCGAAGCTAC)-3'-Ng and (d) 5'-d(GCTACGAAGTGC)-3'-Ng
recorded at 15 °C.

The G3-C9 and C4-G8 Watson-Crick base pairs of 5'-d(GTGCGAAGCTAC)-3' are formed

in the free oligonucleotide as evidenced by the presence of their imino peaks in the ID

spectra. The Gi and T2, T!0 imino peaks are absent, however, suggesting that the termin
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section of the stem, i.e. after the mispaired thymine, is not formed. Hence, it was observed
that the unpaired thymine has a destabilising effect on the terminal base pairs. It is
interesting to note, however, that although the terminal base pairs are not formed, the
individual strands still exist to a significant extent as B-form DNA as is evidenced by

sequential connectivity observed along the backbone. If the strands were adopting a rand
conformation, there would be no discernable pattern of backbone NOEs to follow, which is
not the case as shown in figure 5.4. Many of the sequential NOEs are, however, quite weak
suggesting some degree of conformational averaging.

Figure 5.4 shows the H8/H6-H27H2" and H8/H6-H1' sequential connectivity along the
DNA backbone for (a) 5'-d(GTGCGAAGCTAC)-3' and (b) 5'-d(GCTACGAAGTGC)-3'.
The solid lines show the observed NOEs and connectivity, while the dashed lines show the
loss of sequential connectivity caused by the 5'-GAA loop. The squares indicate where
NOEs between the nucleotides in the 5'-GAA loop would have been observed if the

oligonucleotide was adopting a B-type conformation. A loss of sequential connectivity is
also observed between C4-G5 in the HI' region of the NOESY spectrum for 5'd(GTGCGAAGCTAC)-3'. Many NOEs are weak suggesting that the structure may be
dynamic, i.e. very weak NOEs are observed between the C9 and T10 and between T10 and
An, presumably because of dynamic changes between a bulged T conformation as well as a
frame-shifted conformation. In the NOESY spectrum of 5'-d(GCTACGAAGTGC)-3\
(figure 5.4b) a complete loss of sequential connectivity is observed through the T3

nucleotide, i.e. the unpaired thymine, (dashed lines) suggesting that this thymine is not

stacking strongly with its adjacent bases. Again, as was the case for the oligonucleotide
203

d(GTGCGAAGCTAC)-3', loss of sequential connectivity through the 5'-GAA loop of 5'd(GCTACGAAGTGC)-3' as well as between C5-G6 is observed suggesting a high-anti
conformation.
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Figure 5.4(a): Section of the 300 m s N O E S Y spectrum showing sequential connectivity
along the oligonucleotide chain for 5'-d(GTGCGAAGCTAC)-3' (3 mM) in D20 containing
0.1 M NaCl/100 mM NaH2P04 (pH 7.0): H8/H6-H2'/H2" (top) and H8/H6-H1' (bottom).
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The C5-G9 and A4-T10 Watson-Crick base pairs of 5 ' - d ( G C T A C G A A G T G C ) - 3 ' are formed
in the free oligonucleotide, however, there was no evidence for the formation of the C 2 -Gn
or Gi-Ci 2 base pairs indicating fraying at the end of the chain as was the case for the
previous oligonucleotide sequence (figure 5.5). Although, the absence of the imino protons
is indicative of the fraying of the stem, the oligonucleotide still appears to be in the Bconformation as evidenced by internucleotide stacking along each strand. N O E s allowing
the sequential connectivity along the D N A strand were observed.

A
G

A

C=--i==G

/•

r

5'-G

Figure 5.5: Schematic of the proposed structures of the bulge sequences showingfrayingat
end of stem.

In general, it has been noted that the inclusion of an unpaired base in the hairpin sequen
had a significant destabilising effect on the duplex region. (Dodgson & Wells, 1977;
Wallace et al, 1979) The work presented here shows that the oligonucleotide 5'd ( G T G C G A A G C T A C ) - 3 ' was in dynamic equilibrium between bulged and frame-shifted
conformations. Destabilisation and end-fraying were observed for both sequences studied,
however, the single strands remained in a B-type conformation.
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Figure 5.6: I D N M R spectra acquired after the addition of 5 m M nogalamycin: (i) 0:1 (ii)
0.25:1 (iii) 0.5:1 (iv) 0.75:1 (v) 1:1 complex. The arrows highlight a number of clearly
defined signals, owing to free DNA that decrease upon addition of the nogalamycin.
Arrows also indicate new signals that increase owing to complex formation.
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5.4 Complex Formation with Nogalamycin
The following section describes the results of structural studies of the complexes of
nogalamycin with oligonucleotides that adopt the novel bulge conformations. The
nomenclature scheme for nogalamycin is shown in figure 4.17. NMR spectroscopy was

utilised for the elucidation of the intercalation site, orientation of the drug molecule w
this site and overall structure of the complexes. Melting temperature studies were also
undertaken to complement the results gained from the NMR studies.

5-d(GTGCGAAGCTAC)-3'
Figure 5.6 shows ID NMR spectra acquired after the addition of aliquots of nogalamycin to
the free oligonucleotide, 5'-d(GTGCGAAGCTAC)-3'. These 1D-NMR titration studies
showed that Ng formed a clean 1:1 complex with 5'-d(GTGCGAAGCTAC)-3', with
resonances from the free DNA replaced by those of a complex containing a single-bound
nogalamycin. For example, the resonance at 8.24 ppm corresponding to the AnH8 of the
free oligonucleotide decreases in intensity upon addition of nogalamycin, whilst a
resonance appears at 8.43 ppm corresponding to the AnH8 of the bound species. The
observed down-field shift results from nogalamycin intercalating between the base pairs
consistent with other studies, in which such a shift has been found to be typical of an
adenine involved in a 5'-CA intercalation site. (Williams & Searle, 1999)
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Figure 5.7: Section of the 300 m s N O E S Y spectrum of the 5'-d(GTGCGAAGCTAC)-3'Ng complex (3 mM) in D20 containing 0.1 M NaCl/100 mM NaH2P04 (pH 7.0), showing
H8/H6-H2'/H2" sequential connectivity along the DNA backbone.

Figure 5.7 shows a portion of the N O E S Y spectrum of the 5'-d(GTGCGAAGCTAC)-3'-Ng
complex indicating the H8/H6-H27H2" sequential connectivity along the DNA backbone.

The solid lines show the sequential connectivity along the DNA backbone including th
loop region, i.e. GiT2G3C4G5A6A7G8C9 and AnCi2. A loss of sequential connectivity
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(dashed lines) and weak N O E s observed between Cg and Ti 0 , give further weight to the

suggestion that the oligonucleotide has a dynamic structure such that there is an equilib
between different conformations. NOEs were also observed between the Ng-Hll and
T2H2'/H2" as shown by the dotted lines in figure 5.7. It is interesting to note that upon
ligand binding, a number of resonances have been further shifted. For example, the AnH8
resonance is down-field shifted by 0.192 ppm, while the T2H6 has been shifted up-field by

0.284 ppm. This is typical of an adenine involved in a 5'-(CpA) intercalation site. (Will
& Searle, 1999)

U p o n binding of the ligand to the oligonucleotides, the most pronounced changes in

chemical shift occurred to the nucleotides within the intercalation site, i.e. T2, G3, C9,
and An. The change in chemical shift upon binding for the aromatic base protons (H8/H6)
and the sugar HI' protons are given in table 5.1.

Table 5.1: Change in chemical shift upon nogalamycin binding: (a) H8/H6 and (b) HI'.
1G

2T

3G

4C

5G

-0.059

0.284

0.013

0.163

0.066

6A

12C

11A
-0.165

9C

8G

7A

0.003

-0.067

0.051

0.124

0.078

1C>T
-0.242

1G

2T

3G

4C

5G

0.025

0.050

0.321

0.102

—

6A

12C

11A
-0.' 67

9C

8G

7A

0.031

-0.175

0.092

0.026

0.062

1C>T
-0.249
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Figure 5.8: 300 m s N O E S Y spectrum of 5'-d(GTGCGAAGCTAC)-3' complexed with
nogalamycin (3 mM) in D20 containing 0.1 M NaCl/100 mM NaH2P04 (pH 7.0), showing

the resonances that define the intercalation site. H8/H6-H1' region highlighting the dru
DNA NOEs.

Figure 5.8 highlights the N O E s that define the intercalation site. The sequential
connectivity can be followed along the DNA backbone through the intercalation site with
the ligand bridging the gap between the T2 and G3 resonances. Connectivity was observed
for T2 through to C4. The connectivity, however, did not follow from T2 to G3, as was the

case in the free oligonucleotide (dashed lines). Instead it stepped from T2H1' to the Hll
nogalamycin to G3H1' (dotted lines). These data clearly define the intercalation site to
the TpG step as was expected. The backbone could then be followed from C4 to C12,
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however, N O E crosspeaks between A 6 , A 7 and G 8 were significantly weaker than in the
stem region of the oligonucleotide. NOEs were also observed between C9-T10, C9-An and
Tio-An. A number of other drug-DNA NOEs were observed in the NOESY spectrum.

These are given in table 5.2 and indicate that nogalamycin is oriented so that the nog

sugar moiety points into the minor groove, whilst the aminoglucose sugar moiety points

into the major groove. A large number of NOEs were observed between the nogalose sugar
and the protons of the T[0 and C9 bases in DNA, i.e. NgH2'-Ti0H2"/H47H5', NgH2'C9H17H6 and NgH3'-G3H5', whilst only a single NOE was observed for the
bicycloaminoglucose sugar (NgHl"-T2Me). This is consistent with earlier studies of
nogalamycin binding to duplex DNA (Searle et al, 1988; Zhang & Patel, 1990; Searle &
Bicknell, 1992; Searle & Lane, 1992; Williams & Searle, 1998, 1999).

Table 5.2: Drug-DNA NOEs observed in the 300 ms mixing time of the NOESY spectrum
of the 5'-d(GTGCGAAGCTAC)-3'-nogalamycin complex.
NgH1"-2TMe
NgH5"-12CH3'
NgH3-12CH3'
NgH7-2TH4'
NgH7-3GH1'
NgH7-3GH2'
NgH7-3GH4'

NgH7-3GH8
NgH9-3GH1'
NgH9-3GH2'
NgH9-3GH5'
NgH10-3GH1'
NgH10-3GH2'
NgH10-3GH8

NgH11-2TH1'
NgH11-2TH2'
NgH11-2TH2"
NgH11-2TH3'
NgH11-2TH4'
NgH11-3GH1'
NgH11-3GH4'

NgH14-1GH3'
NgH14-1GH5'
NgH14-1GH8
NgH14-2TH1'
NgH14-2TH2'
NgH2'-9CH1'
NgH2'-9CH6

NgH2'-10TH2"
NgH2'-10TH4'
NgH2'-10TH5'
NgH3'-3GH5'
NgH3'-4CHr
NgH3'-4CH5'

The assignment of this section of the spectrum recorded at 15 °C (288 K ) was made
considerably more difficult by the overlap of the C9H6 and Ti0H6 resonances. The NOESY

experiment was run at an elevated temperature of 25 °C (298 K) in order to resolve the
crosspeaks and confirm the NOE connectivity through C9-Ti0-An as was the case for the

free oligonucleotide. The NOE connectivities seen here point towards the observation o
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more than one form of the complex, in which an equilibrium between a frame-shifted
conformation and a bulged conformation exists in solution. NOEs were observed between
Ti0H2'/H2"-AnH8 and C9H2'/H2"-AnH8 as well as Ti0Hl'-AnH8 and C9Hl'-AnH8. The
sequential NOEs, i.e. Tio-An were less intense, suggesting that the equilibrium slightly
favours the bulged conformation. The sugar H2'/H2" protons were observed at similar

chemical shifts to those in the free oligonucleotide, whereas in the bulged oligonucleoti
5'-d(GCTACGAAGTGC)-3', these protons would be observed considerably down-field
shifted. The methyl proton of Tio, however, was observed to be considerably down-field
shifted (by 0.5 ppm).
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Figure 5.9: ID NMR of the 10-15 ppm range of 5'-d(GTGCGAAGCTAC)-3' (a-e) and the
nogalamycin complex (f-k). The initial ID spectra were recorded at 5 °C and the
temperature was increased in 10 °C increments until the melting transition occurred as
evidenced by the attenuation of the imino peaks.
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Figure 5.9 shows the ID N M R spectra of the 5'-d(GTGCGAAGCTAC)-3'-Ng complex
recorded in water, allowing examination of the imino protons present in the complex. The
NMR spectra showed an additional four peaks in the 12-15 ppm region of the spectrum

(figure 5.9). Two of these peaks were from the phenolic protons of the nogalamycin at 11.6
and 11.7 ppm respectively, whilst the other two peaks are of great interest. The peaks
occurred between 13.0-13.1 ppm and were only resolved at a temperature of 5 °C (278 K).
Above this temperature they merged to appear as one broad peak. The peaks were of equal,

but lower intensity than those of the G3 and G8 imino protons, and as such it was postulat

that they may be from a T-T "wobble-pair" arising as a result of frame shift induced by th
binding of the antibiotic. Alternatively, the peaks observed may be from the T2 and Gi
imino protons of the Watson-Crick base pairs that form as a result of the complexed

oligonucleotide adopting a bulged conformation. As is shown in figure 5.9(f-h), these imin
protons were only stable at low temperature and were only present up to 25 °C. The G3 and
G8 imino protons were stable up to 45 °C after which the attenuation of these peaks was

observed. Owing to the temperature instability of these peaks in the ID NMR spectra, it is
proposed that these imino protons were from the formation of the T-T "wobble pair" rather
than Watson-Crick base pairs. Above 25 °C, the ends of the oligonucleotide are thought to
fray, with the nogalamycin stabilising the oligonucleotide above the intercalation site.
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Figure 5.10: T-T "wobble pair" conformation

The latter possibility was further explored by examination of the Watergate-NOESY
spectrum of the 5'-d(GTGCGAAGCTAC)-3'-Ng complex, as shown in figures 5.11 and
5.12. In the spectra, the imino protons show connectivities to the amino peaks, which in

turn show connectivities to the aromatic base protons. Peaks are also observed showing the
connectivity between the imino protons of one Watson-Crick base pair and the adjacent
Watson-Crick base pair, i.e. between the T2 imino proton and the G3 imino proton. Figure
5.11 shows a section of the wg-NOESY spectrum in which the amino protons have been
traced across from the amino-imino crosspeaks (not shown). There are two amino protons
per adenine or guanine and hence, strong NOEs are observed between the amino protons of
individual bases. The amino protons also show NOE crosspeaks to the H5 protons of the

cytosine involved in the base pair. These connectivities are illustrated in figure 5.11. T
blue lines show the connectivity observed for the C4-G8 base pair, while the pink lines
represent the G3-C9 base pair. The NOEs seen for the amino protons of An to the NH2
protons (green lines) could have been the result either of a T-T "wobble pair" or a T-A
Watson-Crick base pair. The exact identity could not be confirmed by the method
employed. No evidence of the terminal GrCi2 base pair was observed.
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Figure 5.11: N O E s between imino protons and amino protons of base pairs and imino
protons of adjacent base pairs in DNA.

Figure 5.11 is an illustration of the base pairing arrangement between the Watson-Cric
base pairs in DNA. The blue arrows indicate the NOEs between the imino and amino

protons of the individual base pairs, whilst the red arrow shows the NOE present betwe
the adjacent base pair. Crosspeaks observed in the wg-NOESY spectrum corresponding to
these types of NOEs allow the identification of the imino protons (as shown in figure
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ppm

ppm
Figure

5.12:

Section

of the

300

ms

wg-NOESY

spectrum

of the 5'-

d(GTGCGAAGCTAC)-3'-Ng complex (3 mM) in H20 containing 0.1 M NaCl/100 mM
NaH2P04 (pH 7.0), showing the connectivity of amino protons to amino protons and
protons to aromatic base protons.
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Figure 5.13: Portion of the 300 m s

Watergate-NOESY

spectrum

of the 5'-

d(GTGCGAAGCTAC)-3'-Ng complex (3 mM) in H20 containing 0.1 M NaCl/100 mM
NaH2P04 (pH 7.0), showing NOE crosspeaks between the imino protons of adjacent base
pairs.

Figure 5.13 shows the wg-NOESY spectrum of the 5'-d(GTGCGAAGCTAC)-3'-Ng
complex, in which NOE crosspeaks are observed between the adjacent base pairs of the

complex. There are two crosspeaks resolved in this spectrum. The first is between the G8
imino proton of the C4-G8 base pair and the G3 imino proton of the G3-C9 base pair. The
second crosspeak corresponds to the NOE between the G3 imino proton and the T2 imino

proton of either the T-T "wobble pair" or T-A base pair. The last peak in the ID spectru
was from either the TJ0 or Gi imino proton of the T2-T]0 pair or the Gi-C]2 base pair. It
not possible to distinguish between the latter two possibilities.
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There were extensive drug-DNA N O E s observed in the 5'-d(GTGCGAAGCTAC)-3'-Ng
complex, between nogalamycin methyl resonances and the T2 sugar as would be expected

as the thymine was positioned within the intercalation site. NOEs were observed betwe
NgHl"-T2Me, NgH7-T2H4', NgHll-T2H17H2'/H2"/H3'/H4' and NgH14-T2H17H2'.
There was no evidence of any NOEs to the adenine (An), which if base paired with the
would also have been positioned similarly. There were, however, NOEs noted for the

nogalose sugar protons (H2", H4' and H5') to Tio, suggesting that this thymine was no

bulged conformation and had taken the place of the An as would occur for a frame shif
event.

5-d(GCTACGAAGTGC)-3'
Figure 5.14 shows the ID NMR spectra resulting from the addition of aliquots of
nogalamycin to the free oligonucleotide, 5'-d(GCTACGAAGTGC)-3'. These 1D-NMR
titration studies showed that nogalamycin (Ng) formed a clean 1:1 complex with 5'd(GCTACGAAGTGC)-3', with resonances from the free DNA replaced by those of a
complex containing a single-bound ligand.
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Figure 5.14: ID NMR spectra acquired after the addition of 5 mM nogalamycin: (i) 0:1 (ii)

0.17:1 (iii) 0.35:1 (iv) 0.70:1 (v) 1:1 complex. The arrows highlight a number of clear
defined signals, owing to free DNA that decrease upon addition of nogalamycin. Arrows
also indicate new signals that increase owing to complex formation.
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As was seen with 5'-d(GTGCGAAGCTAC)-3', the most pronounced changes to chemical

shifts upon ligand binding to 5'-d(GCTACGAAGTGC)-3'occurred at the intercalation sit

i.e. at the 5'-TpG step. In particular, the A4H8 proton was shifted down-field to 8

Figure 5.15 shows the chemical shift perturbation upon ligand binding. The resonance

C2, A4, T10 and Gn are most dramatically affected, as are the T3 resonances, which w

discussed separately. These data provide a clear indication of the position of the b
site within the oligonucleotide sequence.

0.600

-1.000
Base number

Figure 5.15: Chemical shift perturbation in the N M R spectra upon ligand binding to 5'd(GCTACGAAGTGC)-3'.
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Figure 5.16 shows a portion of the N O E S Y spectrum of 5'-d(GCTACGAAGTGC)-3'-Ng
complex -indicating the H8/H6-H2'/H2" connectivity along the DNA backbone. The

connectivity can be followed from Gi to C2 to T3, although the latter NOEs are significan
weaker than the afore-mentioned. Connectivity through A4G5A6A7 is also observed (solid

lines). A loss of sequential connectivity is noted for the loop region, i.e. between A7 an

The connectivity along the 3'-strand can then be seen from A8 to G9, G9 to T10 (solid line
then from T10 to Ng-Hl 1 and Ng-Hl 1 to Gu (dotted lines) and from Gn to Q2. As was the
case with 5'-d(GCTACGAAGTGC)-3', the connectivity along the DNA backbone can be
followed with the drug bridging the gap between T10 and Gn- These data clearly establish
that the site of nogalamycin intercalation is between the expected TpG step.
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Figure 5.16: Section of the 300 ms NOESY spectrum of 5'-d(GCTACGAAGTGC)-3'-Ng
complex (3 mM) in D20 containing 0.1 M NaCl/100 mM NaH2P04 (pH 7.0) showing the
H8/H6-H2'/H2" connectivities. The solid lines show sequential connectivity, whilst the
dashed lines show loss of connectivity. The dotted lines show connectivity observed
through the nogalamycin at the intercalation site.

225

Table 5.2 shows the change in chemical shift upon ligand binding for the aromatic base

protons (H8/H6) and the sugar HI' protons. It is notable that the largest chemical sh
changes observed were for the T3 resonances (more later).

Table

5.2: Change

in

chemical

shift

upon

nogalamycin

binding

to 5'-

d(GCTACGAAGTGC)-3': (a) H8/H6 and (b) HI'

3T
-0.529

1G

2C

4A

5C

6G

-0.048

0.088

-0.222

-0.066

—

7A

12C

11G

10T

9G

8A

0.016

0.042

-0.018

0.039

0.087

0.04

3T
0.745

1G

2C

4A

5C

6G

-0.019

-0.348

0.149

-0.102

—

7A

12C

11G

10T

9G

8A

0.016

0.241

0.434

-0.055

0.039

0.033

A large number of drug-DNA contacts (32) were observed in the 300 m s N O E S Y spectrum
of the complex and are given in table 5.4.

Table 5.4: Drug-DNA N O E s observed in the 300 m s mixing time of the N O E S Y spectrum
of the 5'-d(GCTAGGAAGTGC)-3'-nogalamycin complex
NgH1"-10TH6
NgH1"-10TMe
NgH5"-10TMe
NgH3-10TMe
NgH9-11GH1'
NgH9-11GH4'
NgH9-12CH1'

NgH11-11GH8 NgH3'(2)-12CHr
NgH9-12CH5'
NgH10-10TH6 NgH3'(1)-12CH1' NgH4'-2CH1'
NgH11-10TH1' NgH3'(1)-12CH2" NgH4'-2CH2'
NgH11-10TH2' NgH3'(1)-12CH5' NgH4'-2CH2"
NgH4'-2CH5'
NgH11-10TH3' NgH3'(2)-2CH1'
NgH4'-3TH3'
NgH11-11GH1' NgH3'(2)-2CH4'
NgH3'(2)-3TMe
NgH4'-3TH6
NgH11-11GH4'

NgH4'-3TMe
NgH4'-4AH4'
NgH4'-4AH8
NgH5'-4AH4'
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Figure 5.17: Section of the 300 m s N O E S Y spectrum of the 5'-d(GCTACGAAGTGC)-3'N g complex (3 m M ) in D 2 0 containing 0.1 M NaCl/100 m M N a H 2 P 0 4 (pH 7.0) showing
resonances that define the intercalation site. The H8/H6-H1' connectivities along the D N A
backbone are shown by solid lines while the N O E s highlighting the drug-DNA N O E s are
shown by dotted lines.

Figure 5.17 illustrates the sequential connectivity observed along the 3'-strand of the bulged
hairpin in the 5'-d(GCTACGAAGTGC)-3'-Ng

complex. The solid lines show the

sequential connectivity along the D N A backbone while the dotted lines depict loss of
connectivity at the intercalation site. N O E s are seen between the Ti 0 Hl' and Hll of
nogalamycin and the N g H l l and G „ H 1 \ The square is indicative of further loss of
sequential connectivity in the loop region (dashed lines). The 3'-strand can be followed
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from Gi to G5, where a loss of connectivity is observed in the loop region, and from A 7 to
C]2 for the 5'-strand. NOE crosspeaks are observed between T10HI' and Ng-Hl 1 and NgHl 1 and GnHl', showing clearly that nogalamycin is bound at the 5'-TpG step. It is
important to note the NOEs between C2 and T3 are weaker relative to the other NOEs

observed (figure 5.17). This suggests that the thymine is adopting an unusual conformation
such as a bulge, so that its protons are no longer sufficiently close in space to produce
crosspeaks with the adjacent bases (more later).
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Figure 5.18: ID N M R of the 10-15 p p m range of 5'-d(GCTACGAAGTGC)-3' (a-e) and
the nogalamycin complex (f-k). The initial ID spectra were recorded at 5 °C and the

temperature was increased in 10 °C increments until the melting transition occurred as
evidenced by the attenuation of the imino peaks.
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Figure 5.18 shows the ID N M R spectra of 5 ' - d ( G C T A C G A A G T G C ) - 3 ' and its complex
with Ng recorded in water. Examination of the imino protons present in the complex
showed five peaks in the 12-15 ppm region of the spectrum. Two of these peaks are again
from the H4 and H6 phenolic protons of the nogalamycin at 11.5 and 12.1 ppm
respectively. The peak observed at -13.3 ppm was that owing to the Tio imino proton and

was slightly up-field compared to the T]0 in the free oligonucleotide. The G9 imino proto
was shifted up-field by ca. 0.5 ppm at -13.3 ppm. This peak, however, had a much greater

line width and was proposed to be the result of an overlap of the G9 and Tio imino proton
These were resolved at elevated temperature (35 °C) as shown in figure 5.18(i). The peak
13.2 ppm was from the Gi imino proton. This peak was of greater intensity owing to the
overlap occurring with the peak at 13.3 ppm. The peak observed at -12.7 ppm was that
owing to the Gn imino proton. These data indicate that the Gi-Ci2> C2-Gn, A4-T10 and C5G9 Watson-Crick base pairs are all formed and hence protected from hydrogen-deuterium
exchange. The T3 bulge was thus stabilised by the binding of the ligand.

Table 5.5 shows the chemical shift values for all of the observed T3 resonances for both
free and complexed forms of 5'-d(GCTACGAAGTGC)-3'. A large number of differences
between the free and complexed oligonucleotide were observed, with particular reference
the T3 base. The T3 methyl peak was observed to be down-field shifted considerably at
2.022 ppm, compared to 1.110 ppm for the T10 methyl peak of the complex, and 1.546 and
1.355 ppm respectively for the T3 and Tio of the free oligonucleotide.
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Table 5.5: Chemical shift values for the T3 resonances upon nogalamycin binding to 5'd(GCTACGAAGTGC)-3'.
H1'
d(GCTACGAAGTGC)
5.920
d(GCTACGAAGTGC) +Ng 6.665

H2'1

H2'2

H31

H4'

H5'1

H6

Me

1.699
2.540

2.077
2.645

4.766
4.987

4.239

4.102
—

7.299
7.828

1.546
2.022

4.449

For the thymine (T3) to adopt a bulged conformation, the torsion angles must be vastly

different from those present in B-form DNA for this section of the backbone. The lo

sequential connectivity (figure 5.3b) through the T3 arises as a result because the
T3H1' are no longer close enough in space to observe NOEs between these resonances.

Hence, these data compare to the chemical shift values of the free thymine nucleotid
which has been shown to have chemical shift values for TH6 between 8.0-8.5 ppm and

TMe between 2.3-2.4 ppm. (Cantor & Schimmel, 1980) T3H1' has a shift characteristic

single-stranded DNA where no base stacking or ring current effects are observed. Th
evidence further implies that the thymine is adopting a bulged conformation as the
acting as a free nucleotide.

5.5 Melting Temperature Studies
Figure 5.19 shows the UV melting curves for (a) 5'-d(GTGCGAAGCTAC)-3' and (b) the
5'-d(GTGCGAAGCTAC)-3'-Ng complex. The UV melting temperature studies gave
melting transitions of 73.7 °C for the free bulge sequence, 5'-d(GTGCGAAGCTAC)-3',
and 63.6 °C for the complex with nogalamycin. The melting temperatures observed for
both the free and complexed forms of 5'-d(GCTACGAAGTGC)-3' were 65.6 °C and 64.3
°C respectively. The higher Tm noted for 5'-d(GTGCGAAGCTAQ-3' compared to 5'-
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d ( G C T A C G A A G T G C ) - 3 ' can be explained in terms of the H-bonding interactions in the
free oligonucleotides with two G-C base pairs for the former and one G-C and one A-T

base pair for the latter. Three hydrogen bonds are formed in each G-C base pair compa
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Figure 5.19: UV melting curves of (a) 5'-d(GTGCGAAGCTAC)-3' (6 pM) and (b) the
complex formed between 5'-d(GTGCGAAGCTAC)-3' and nogalamycin (6 pM) in H20
containing 300 mM NaCl/30 mM NaH2P04 (pH 7.0).
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The

melting temperature

data suggest that the complex

formed

between

5'-

d(GTGCGAAGCTAC)-3' and nogalamycin is less stable than the free oligonucleotide. The

decrease in Tm observed is proposed to result from the destabilising effect of the formation
of the T-T and G-A "wobble pairs" formed. Upon ligand binding, an equilibrium between a
frame-shifted conformation containing "wobble pairs" and a bulged conformation exists in
solution at low temperature. As the temperature is increased, fraying at the ends occurs
owing to the lower stability of the terminal non-Watson-Crick base pairs. The melting
curve is broad as a result of the dynamic nature of the oligonucleotide resulting from the
conformational changes and end-fraying. Watson-Crick base pairs are formed between G\C12 and T2-An, however, the additional stability imparted from their formation is less than
the destabilisation arising as a result of bulge formation.
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Figure 5.20: U V melting curves of (a) 5'-d(GCTACGAAGTGC)-3' (6 p M ) and (b) the
complex formed between 5'-d(GCTACGAAGTGC)-3' and nogalamycin (6 pM) in H20
containing 300 mM NaCl/30 mM NaH2P04 (pH 7.0).

Figure 5.20 shows the U V melting curves for (a) 5'-d(GCTACGAAGTGC)-3' and (b) the
5'-d(GCTACGAAGTGC)-3'-Ng complex. The complex formed between 5'-

d(GCTACGAAGTGC)-3' and the ligand has approximately (within the range of error)
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same melting temperature. It was postulated that the degree of stabilisation brought about
by ligand binding was approximately equal to the destabilisation of the oligonucleotide

structure caused by inclusion of a single base bulge within the intercalation site. In cont
to the previous oligonucleotide, 5'-d(GTGCGAAGCTAC)-3', the two Watson-Crick base

pairs formed are both G-C base pairs and as such, impart further stability than would resul
from a single G-C and an A-T base pair. The melting curves for both the free bulge
sequences and the complexed form of 5'-d(GTGCGAAGCTAC)-3' were seen to be broad
in comparison to the melting curve for the 5'-d(GCTACGAAGTGC)-3'-Ng complex. This

can be explained in terms of the terminal fraying observed for this oligonucleotide and the
frame shift event occurring for the Ng complex of 5'-d(GTGCGAAGCTAC)-3'. The

destabilisation of the terminal base pairs results in the melting transition occurring over
greater temperature range accounting for the width of the curves. Four Watson-Crick base
pairs are formed in the Ng complex of 5'-d(GCTACGAAGTGC)-3' and as such a sharper
melting transition is noted (figure 5.20). In a temperature dependent study of the imino
proton line widths, it was also observed that all of the imino protons underwent
simultaneous attenuation at -45 °C (figure 5.18).
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5.6 Electrospray Ionisation Mass Spectrometry (ESI-MS)

The complexes were also analysed by electrospray ionisation mass spectrometry. The
procedures used were the same as described in section 4.16. Figure 5.21 shows the ESI
mass spectrum of the T-bulge complex (Ng-5'-d(GCTACGAAGTGC)-3'). The peaks
observed at m/z 1113.7 And 1485.3 represent the complexed forms of the oligonucleotide,
i.e. the [M+Ng-5H]4" and [M+Ng-4H]3" ions respectively. The free form of the ligand, [Ng-

H]", was observed at m/z 786.2. In this case, the ions from the drug-DNA complex were less
abundant relative to the free oligonucleotide than was the case for the complex with the

double hairpin under similar ionisation conditions (figure 4.24b). We examined the binding
of nogalamycin to the bulged hairpin 5'-d(GTGCGAAGCTAC)-3'. In the ESI mass
spectrum (not shown), the intact adduct was not detected, but rather only the unbound
oligonucleotide was observed, indicating that this was the least stable complex. This is
consistent with the NMR data for the Ng-5'-d(GTGCGAAGCTAC)-3' complex that
suggest that the complex is in equilibrium between a bulged and frame-shifted
conformation, the latter resulting in the formation of a significant population of nonWatson-Crick base pairs (T-T and G-A) which are expected to have lower stability.
Consequently, these unstable non-complementary base pairs, which the NMR imino proton
exchange measurements suggest, are dynamic and involved in end-fraying, do not interact
strongly with the drug on one side of the intercalation site.
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Figure 5.21: ESI-MS spectrum of the 5'-d(GTGCGAAGCTAC)-3'-Ng complex

5.7 Comparison with Previous Studies
The binding of nogalamycin to two DNA heptamers, 5'-CTbGTACG-3' and 5'CGTACTbG-3', containing a bulged T nucleotide (Tb) has been examined previously by
Caceres-Cortes and Wang (Caceres-Cortes & Wang, 1996). They found that both duplexes

were significantly stabilised by the binding of the ligand and that the binding induced th
extra T and opposing base to form "wobble-pairs" which stacked on the aglycone
chromophore. This resulted in base mispairing and, rather than a bulged T, a frame-shift

event. The data obtained in that study illustrate that this frame-shift resulted in "dangl

3'-G and 5'-C nucleotides. The results gained in those studies, however, contrast with tho
gained here since nogalamycin binding to the oligonucleotides 5'-GTGCGAAGCTAC-3'
and 5'-GCTACGAAGTGC-3' stabilised the bulged T nucleotide (figure 5.22). In the case
of 5'-GTGCGAAGCTAC-3', the complex was thought to be in dynamic equilibrium
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between different conformations. The data obtained for theframe-shiftedconformation are
similar to the results described by Caceres-Cortes and Wang and can be explained in terms
of the requirement for the G-C base pair for Ng recognition. As the G-C base pair is

internal to the oligonucleotide, the ligand may still bind and the frame-shift event does no
disturb this essential base pairing conformation. For the oligonucleotide, 5'GCTACGAAGTGC-3', however, the G-C base pair will only remain intact if the mispaired
T adopts a bulged conformation.

The results gained by Caceres-Cortes and Wang were strongly influenced by end-effects as
upon formation of a T bulge, only one Watson-Crick base pair would be formed. Two base
pairs form upon T bulge formation for the oligonucleotides examined here giving rise to

additional stability. It was postulated that if longer sequences of oligonucleotide in which
the number of base pairs between the intercalation site and the termini were increased, the
frame-shifted conformation observed for 5'-GTGCGAAGCTAC-3' would no longer be
observed. This is the subject of further investigation.
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5.8 Conclusions

NMR spectroscopy was utilised for the complete characterisation of the bulged hairpin
d(GTGCGAAGCTAC)-3' and 5'-d(GCTACGAAGTGC)-3'. For both of the bulge
sequences studied, the unpaired base had a destabilising effect on the terminal base
causing fraying the end of the duplex. The strands maintained a B-form conformation,
however, as was evidenced by the sequential connectivity observed along the DNA
backbone. A loop region was formed as evidenced by the unusual chemical shift values
observed for the sugar H4', H5' and H5" protons. The stem region above the bulge

(unpaired thymine) was also formed with Watson-Crick base pairs between the G3-C9 and
C4-G8 for 5'-d(GTGCGAAGCTAC)-3' and between A4-T10 and C5-G9 for 5'd(GCTACGAAGTGC)-3'.

The reactions between nogalamycin and each of the bulge sequences were monitored by I
NMR experiments. The appearance of new peaks in the spectra owing to the complexed

form and the attenuation of peaks owing to the free oligonucleotide were testimony to
formation of a 1:1 complex with both oligonucleotides. This was further confirmed by
MS. Nogalamycin was found to bind at the 5'-TpG step with a large number of NOEs
observed between The ligand and the T2 and G3 bases (5'-d(GTGCGAAGCTAC)-3') and
Tio and Gn bases (5'-d(GCTACGAAGTGC)-3'). Upon ligand binding, changes in

chemical shift values for the DNA resonances were observed, with the largest differen

noted for the nucleotides in the intercalation site, i.e. T2, G3, C9, Tio and An for 5
d(GTGCGAAGCTAC)-3' (C2, A4, T,0 and Gn for 5'-d(GCTACGAAGTGC)-3').
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The intercalation of nogalamycin gave rise to an equilibrium in solution between a frame
shifted cpnformation and bulged conformation in 5'-d(GTGCGAAGCTAC)-3' resulting in

the 3'-C 'dangling' and the formation of a 'T-T' wobble pair for the former conformation.
The equilibrium is thought to favour the bulged conformation as evidenced by stronger
NOEs observed in the NOESY spectra for the C9-An resonances over the Tio-An
resonances. The ID Watergate spectrum showed four peaks owing to imino protons present
in the hydrogen bonds formed between G3-C9, C4-G8 and T2-Tj0 (or T2-Au and G1-Q2).
The peaks owing to T2 and Tio (or T2 and Gi) were of equal but lower intensity compared
to the peaks owing to the guanine imino protons. Formation of either the T-T "wobble
pair", or the base pairs after the bulged site, was only seen at low temperatures and
attenuation of these peaks was observed prior to melting of the complex. Therefore, the

binding of the ligand apparently resulted in a dynamic equilibrium between a frame-shifte
conformation and a bulged conformation. The melting temperature of the complex was

noted to be lower than that of the free oligonucleotide and can be accounted for in terms

the destabilising effect of the frame shift event. The unusual breadth of the melting cur
was a consequence of the dynamic conformational changes occurring.

The binding of nogalamycin to 5'-d(GCTACGAAGTGC)-3' stabilised the bulge positioned
at T3. This was a consequence of the requirement of the G-C base pair below the
intercalation site for nogalamycin recognition. In this case, four imino protons were
observed in the ID NMR spectrum of the complex corresponding to Gi-C]2, C2-Gn, A4-T10
and C5-G9. The melting curves were noted to be sharper than those of the previous

oligonucleotide owing to the simultaneous melting of the entire structure. The Tm obtaine
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for the complex was approximately the same as the free oligonucleotide, suggesting that the

stabilising effect of nogalamycin intercalation is approximately equal to the destabilisin
effect of the bulge.

The ESI-MS data indicate that the relative stability of the complexes formed with
nogalamycin is in the order: Ng-5'-d(GCGAAGCACGAAGT)-3' > Ng-5'd(GCTACGAAGTGC)-3' > Ng-5'-d(GTGCGAAGCTAC)-3'. These results were
significant because they show that interactions in non-covalent drug-DNA complexes

involving destabilising effects from single strand breaks and bulged-bases are much weaker
than those in other studies, in which drug-DNA complexes have been examined by ESIMS. (Beck et al, 2001) We propose this is because the ionisation conditions can be

controlled more carefully using salt-tolerant ESI source configurations. The relative orde
of binding affinities to this family of unusual DNA substrates could be qualitatively
determined from the ESI-MS data, and drug binding stoichiometries of 1:1 in all cases has
been confirmed, consistent with intercalation at the preferred 5'-TG step.

The results gained by Caceres-Cortes and Wang were thought to be strongly influenced by
end-effects. Comparison of their results to those gained here, show that additional base
pairs terminal to the intercalation and hence to the bulged site, stabilised the bulge.
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